Page last updated: 2024-08-23

etoposide and Acute Myelogenous Leukemia

etoposide has been researched along with Acute Myelogenous Leukemia in 639 studies

Research

Studies (639)

Timeframe	Studies, this research(%)	All Research%
pre-1990	72 (11.27)	18.7374
1990's	220 (34.43)	18.2507
2000's	143 (22.38)	29.6817
2010's	168 (26.29)	24.3611
2020's	36 (5.63)	2.80

Authors

Authors	Studies
Advani, AS; Becker, PS; Bixby, DL; DeAngelo, DJ; Feldman, EJ; Jonas, BA; Liesveld, JL; Magnani, JL; Marlton, P; O'Dwyer, ME; Thackray, HM	1
Minari, JB; Ndiokwelu, UF; Ogunkanmi, LA; Uzoma, IC	1
Kaspers, GJL; Kipng'etich, M; Klein, K; Langat, S; Mostert, S; Njuguna, F; Olbara, G; van Weelderen, RE; Vik, TA	1
Al-Mansour, Z; Alonzo, TA; Aplenc, R; Cao, X; Cogle, C; Elsayed, AH; Gamis, A; Kolb, EA; Lamba, JK; Meshinchi, S; Mitra, AK; Pounds, S; Raimondi, S; Ribeiro, RC; Rubnitz, J; Wu, H	1
Angelopoulou, MK; Arapaki, M; Chatzidimitriou, C; Liaskas, A; Plata, E; Rondogianni, P; Tsirigotis, P; Vassilakopoulos, TP	1
Labbozzetta, M; Notarbartolo, M; Occhipinti, C; Poma, P; Sajeva, M	1
Ariyan, Z; Baradaran, B; Karami, H; Nazmabadi, R; Sakhinia, E	1
Noto, A; Obeid, M; Pantaleo, G; Segot, A; Spertini, O; Stalder, G; Suffiotti, M	1
Alexeyevsky, DA; Artemov, AV; Gavrilov, AA; Lomov, NA; Razin, SV; Rubtsov, MA; Ulianov, SV; Viushkov, VS	1
Cao, X; Cogle, CR; de Jesus Sosa, AK; Downing, J; Elsayed, AH; Gbadamosi, M; Lamba, JK; Loguinov, A; Nguyen, NHK; Pounds, SB; Rafiee, R; Ribeiro, R; Rubnitz, J; Seligson, N; Sobh, A; Tagmount, A; Vulpe, CD	1
Chen, Y; Deng, K; Ju, W; Li, L; Ni, W; Wang, L	1
Kaspers, GJL; Klein, K; Njuguna, F; Olbara, G; van Weelderen, RE; Vik, TA; Wijnen, NE	1
Arcese, W; Ciceri, F; Gedde-Dahl, T; Gorin, NC; Labopin, M; Lanza, F; Maertens, J; Meijer, E; Mohty, M; Montoro, J; Pabst, T; Pérez-Simón, JA; Sanz, J; Schaap, N; Van Gorkom, G; Versluis, J; Vrhovac, R	1
Atra, A; Carceller, F; Ethell, M; Guerra-García, P; Hirsch, SG; Khabra, K; Lancaster, D; Malik, R; Marshall, LV; Moreno, L; Petterson, T; Potter, M; Taj, M	1
Dührsen, U; Flasshove, M; Hanoun, M; Noppeney, R; Schmitz, C; Westhus, J	1
Papadantonakis, N	1
Ballen, K; Bhatt, S; Brunner, A; Burgess, M; Carr, SA; DeAngelo, DJ; Ebert, BL; Fell, G; Garcia, JS; Keshishian, H; Letai, A; Medeiros, BC; Neuberg, D; Sperling, AS; Stone, RM; Yilma, B	1
Abu Samra, M; Basara, N; Benner, A; Bentz, M; Döhner, H; Döhner, K; Fiedler, W; Gaidzik, VI; Ganser, A; Girschikofsky, M; Götze, K; Greil, R; Hertenstein, B; Heuser, M; Horst, HA; Kapp-Schwoerer, S; Kindler, T; Koller, E; Krauter, J; Krzykalla, J; Leis, C; Lübbert, M; Martens, U; Mayer, K; Nachbaur, D; Paschka, P; Schleicher, J; Schlenk, RF; Schroeder, T; Thol, F; Wattad, M; Weber, D; Wulf, G	1
Amrein, PC; Attar, E; Ballen, KK; Behnan, T; Bergeron, MK; Bertoli, C; Blonquist, TM; Brunner, AM; Burke, M; Chen, YB; Connolly, C; Duong, VH; Emadi, A; Fathi, AT; Foster, JE; Graubert, TA; Hasserjian, RP; Hobbs, G; Hock, H; Lescinskas, C; Lesho, P; Macrae, M; Mann, ML; McAfee, SL; McGregor, K; Moran, JA; Narayan, R; Neuberg, DS; Preffer, FI; Rae, J; Ramos, AY; Som, TT; Story, JL; Vartanian, MK; Wey, MC	1
Hao, J; Jing, Y; Wu, W; Xu, Q	1
Charoenprasert, K; Chinthammitr, Y; Kasyanan, H; Panoi, N; Phinyo, P; Pongudom, S; Purattanamal, J; Surawong, A; Wongyai, K	1
Abbenante, MC; Arpinati, M; Baccarani, M; Baldazzi, C; Bertamini, L; Bochicchio, MT; Bonifazi, F; Caso, L; Cavo, M; Cristiano, G; Curti, A; de Polo, S; Fontana, MC; Marconi, G; Martinelli, G; Nanni, J; Olivi, M; Ottaviani, E; Paolini, S; Papayannidis, C; Parisi, S; Ragaini, S; Sartor, C; Sessa, M; Talami, A; Testoni, N	1
Agrawal, V; Arain, S; Cahill, K; Calip, GS; Christian, S; Esen, A; Griffin, S; Khan, I; Konig, H; Odenike, O; Patel, P; Quigley, JG; Shergill, A; Stock, W; Sweiss, K	1
Kajita, N; Makimoto, A; Miyahara, S; Saito, Y; Yuza, Y	1
Bakhshi, S; Chopra, A; Ganguly, S; Garg, A; Vishnubhatla, S	1
Areco, K; Deus, DF; Maranhão, RC; Morikawa, AT; Oliveira, JSR; Rohr, SS; Tavoni, TM	1
Adachi, S; Goto, H; Hasegawa, D; Horibe, K; Iwamoto, S; Kinoshita, A; Koh, K; Kosaka, Y; Kudo, K; Miyachi, H; Moritake, H; Nakahata, T; Nakayama, H; Saito, AM; Shimada, A; Taga, T; Takahashi, H; Tawa, A; Terui, K; Tomizawa, D; Watanabe, T	1
Bin, T; Chen, S; Chen, X; Cheng, J; Liao, Y; OUYang, J; Zou, W	1
Cavo, M; Curti, A; Iannarone, C; Ocadlikova, D; Redavid, AR	1
Adachi, S; Goto, H; Hasegawa, D; Iwamoto, S; Kakuda, H; Koh, K; Miyamura, T; Moritake, H; Nakayama, H; Saito, A; Shiba, N; Shimada, A; Taga, T; Tanaka, S; Terui, K; Tomizawa, D; Yuza, Y	1
Abe, K; Dowsett, L; Hutchins, K; Wada, R	1
Ahmed, S; Farah, T; Ghafoor, T; Khalil, S; Sharif, I	1
Dykes, J; Håkansson, Y; Król, L; Pronk, C; Toporski, J; Turkiewicz, D	1
Akbar, MW; Demirkol Canli, S; Gure, AO; Haznedaroglu, IC; Isbilen, M; Kucukkaraduman, B; Malkan, UY; Okay, M; Sayinalp, N; Turk, C; Turk, S; Ucar, G	1
Burnett, AK; Clark, RE; Drummond, M; Freeman, S; Hills, RK; Huntly, B; Kell, J; Kjeldsen, L; Knapper, S; McMullin, MF; Russell, NH; Spearing, R; Thomas, IF	1
Chen, XJ; Chen, YM; Guo, Y; Liu, F; Liu, LP; Liu, TF; Liu, XM; Quan Qi, B; Ruan, M; Yang, WY; Zhang, AL; Zhang, L; Zhu, XF; Zou, Y	1
Atkin, ND; Raimer, HM; Wang, YH; Wang, Z; Zang, C	1
Absalon, MJ; Ahmed, A; August, K; Baker, SD; Boklan, J; Brown, PA; Cooper, TM; Gore, L; Li, L; Macy, ME; Magoon, D; Narendran, A; Pollard, J; Sison, EAR; Trippett, T	1
Balakrishnan, VS	1
Becker, PS; Buckley, SA; Chen, TL; Estey, EH; Halpern, AB; Hendrie, PC; Huebner, EM; Orlowski, KF; Othus, M; Percival, MM; Pogosova-Agadjanyan, EL; Scott, BL; Stirewalt, DL; Walter, RB	1
Alexander, TB; Inaba, H; Pounds, S; Pui, CH; Ribeiro, RC; Rubnitz, JE; Triplett, BM; Wang, L	1
Ali, AM; Cooley, SA; DiPersio, JF; Miller, JS; Rashidi, A; Romee, R; Shanley, R; Ustun, C; Vij, KR; Weisdorf, DJ; Westervelt, P	1
Shand, JC	1
Fuji, S; Ohno, N; Shimada, N; Suzuki, Y; Tanosaki, R; Tojo, A; Uchimaru, K; Yuji, K	1
Killian-Benigno, C; Kuo, DJ	1
Cuglievan, B; Garces, S; Menegaz, BA; Rytting, ME	1
Alvaro, F; Arceci, RJ; Arndt, C; Barnette, P; Boklan, J; Carpten, J; Cooper, T; Farrar, JE; Gooden, GC; Gore, L; Lee, D; Legendre, C; Liang, WS; Macy, ME; Martin, L; Meshinchi, S; Narendran, A; Pollard, J; Salhia, B; Triche, TJ; Wai, D	1
Abla, O; Boklan, J; DuBois, SG; Goldberg, J; Hijiya, N; Martin, A; Messinger, Y; Oesterheld, J; Weinstein, J	1
Amrein, PC; Attar, EC; Avigan, D; Ballen, KK; Brunner, AM; DeAngelo, DJ; Ebert, BL; Fathi, AT; Hobbs, GS; Luptakova, K; McMasters, M; Rosenblatt, J; Sperling, AS; Steensma, DP; Stone, RM; Stroopinsky, D; Wadleigh, M; Washington, A; Werner, L	1
Al Harthy, M; Gondek, LP; Murray, JC; Pallazola, VA; Webster, J; Zimmerman, SL	1
Becker, PS; Blau, CA; Celik, S; Chien, S; Dai, J; Estey, EH; Lee, SI; Logsdon, BA; Lundberg, SM; Martins, TJ; Miller, CP; Oehler, VG; Saxena, A	1
Chen, SN; Dai, HP; Ding, C; Drexler, HG; Macleod, RAF; Nagel, S; Sun, AN; Wu, DP	1
Accordi, B; Anselmi, L; Barozzi, P; Basso, G; Bertacchini, J; Chiarini, F; D'Avella, D; Forghieri, F; Frasson, C; Khosravi, A; Luppi, M; Marmiroli, S; Martelli, AM; Najmaldin, S; Rahim, F	1
Carabasi, M; Carroll, M; Filicko-O'Hara, J; Flomenberg, N; Frey, NV; Hexner, EO; Jeschke, GR; Kasner, MT; Loren, AW; Luger, SM; Mangan, JK; Mick, R; Perl, AE; Wagner, JL; Weiss, M	1
Chen, J; Chen, X; Gao, J; Guan, YY; Ke, K; Li, M; Liu, XL; Wang, YC; Wu, XM; Yang, F; Yang, XY; Yao, JF; Zhang, CL; Zheng, YS	1
Houssou, B; Lamchahab, M; Massi, R; Oukkache, B; Quessar, A	1
Huang, Y; Liu, DD; Lv, TT; Xu, J; Yuan, GL; Zhou, XF	1
Altman, JK; Broun, ER; Carroll, MP; Karp, JE; Kaufmann, SH; Ketterling, RP; Lazarus, HM; Litzow, MR; Luger, SM; Paietta, EM; Pratz, KW; Rowe, JM; Rybka, WB; Tallman, MS; Tun, HW; Wang, XV; Zhang, Y	1
Chen, T; Dong, M; Kong, L; Wang, Y; Xu, S; Zhang, G	1
Benner, A; Bernhard, H; Derigs, HG; Döhner, H; Döhner, K; Gaidzik, V; Ganser, A; Girschikofsky, M; Göhring, G; Grießhammer, M; Haase, D; Herr, W; Hertenstein, B; Heuser, M; Koller, E; Krauter, J; Kremers, S; Kuendgen, A; Lange, E; Martens, UM; Paschka, P; Ringhoffer, M; Salih, HR; Schlenk, RF; Teleanu, V; Thol, F; Wattad, M; Weber, D; Westermann, J; Wolf, D; Wulf, G	1
Chang, YT; Ghiaur, G; Hernandez, D; Jones, RJ; Su, M	1
Cao, L; Chen, P; Liu, Y; Ouyang, M; Tang, D; Wang, D; Xie, M; Xu, L; Yang, L; Yang, M	1
Advani, AS; Caimi, P; Carew, J; Carraway, H; Chan, R; Cooper, B; de Lima, M; Elson, P; Gerds, A; Hamilton, B; Kalaycio, M; Little, J; Maciejewski, J; Malek, E; Miron, A; Mukherjee, S; Nazha, A; Pink, J; Sekeres, MA; Sobecks, R; Tomlinson, B; Unger, A; Visconte, V; Wei, W	1
Bakhshi, R; Bakhshi, S; Pramanik, R; Singh, A; Tyagi, A; Vishnubhatla, S	1
Choi, J; Coustan-Smith, E; Degar, B; Heym, K; Inaba, H; Klco, J; Lacayo, NJ; McNeer, J; Pounds, S; Pui, CH; Raimondi, SC; Ribeiro, RC; Rubnitz, JE; Schiff, D; Taub, J; Triplett, B; Wang, L; Yeoh, AE	1
Ballerini, F; Cagnetta, A; Cea, M; Clavio, M; Colombo, N; Gobbi, M; Guolo, F; Lemoli, RM; Marcolin, R; Miglino, M; Minetto, P; Todiere, A	1
Anyang, BN; Baer, MR; Beumer, JH; Carrier, F; Espinoza-Delgado, I; Fang, HB; Gojo, I; Lapidus, R; Ross, DD; Sadowska, M; Srivastava, RK; Tan, M	1
Chen, TL; Estey, EH; Gardner, KM; Markle, LJ; Othus, M; Walter, RB	1
Aplenc, R; Bagatell, R; Fisher, BT; Huang, YS; Kavcic, M; Lee, GE; Li, Y; Seif, AE; Tasian, SK; Torp, K; Vujkovic, M; Walker, DM	1
Berger, W; Filipits, M; Glimm, H; Hackl, H; Hartl, K; Heffeter, P; Heilos, D; Hemmati, S; Herbacek, I; Herbst, F; Karakaya, K; Krämer, A; Rommer, A; Rondou, P; Schwarzinger, I; Steinleitner, K; Steinmetz, B; Wieser, R	1
Audisio, E; D'Ardia, S; Di Bello, C; Di Celle, PF; Frairia, C; Inghirami, G; Marmont, F; Messa, E; Pich, A; Riera, L; Sismondi, F; Toppino, D; Vitolo, U	1
Chen, X; Gao, L; Kong, P; Li, Y; Liu, Y; Su, Y; Wang, C; Wang, Q; Wang, S; Wen, Q; Yuan, Z; Zeng, Y; Zhang, C; Zhang, X; Zhang, Y	1
Andreadis, C; Giacomini, KM; Kubo, M; Matsuda, K; Mefford, JA; Percival, ME; Singh, N; Stecula, A; Takahashi, A; Witte, JS; Yang, K; Yee, SW	1
Creutzig, U; Dworzak, MN; Reinhardt, D; Ritter, J; Schellong, G; Zimmermann, M	1
Groothuis, T; Huijgens, P; Janssen, J; Janssen, L; Kerkhoven, R; Neefjes, J; Nieuwland, M; Ovaa, H; Pang, B; Qiao, X; Rottenberg, S; van Tellingen, O; Velds, A; Zwart, W	1
Akashi, K; Eto, T; Gondo, H; Harada, M; Kamimura, T; Miyamoto, T; Nagafuji, K; Ohno, Y; Takamatsu, Y; Takase, K; Taniguchi, S; Teshima, T	1
Cho, BS; Cho, SG; Eom, KS; Kim, DW; Kim, HJ; Kim, JH; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, WS; Park, CW; Shin, SH; Yahng, SA; Yoon, JH	1
Bowman, WP; Campana, D; Coustan-Smith, E; Dahl, G; Inaba, H; O'Hear, C; Pounds, S; Pui, CH; Ribeiro, RC; Rubnitz, JE; Shi, L; Taub, JW	1
Hatta, Y; Hirabayashi, Y; Horikoshi, A; Iriyama, N; Kobayashi, S; Kodaira, H; Matsukawa, Y; Miura, K; Takahashi, H; Takeuchi, J; Uchino, Y	1
Fernández-Sojo, J; Oliveras Vilà, T; Ribera, JM; Vives, S	1
Medeiros, BC	1
Aldoss, I; Haider, M; Ji, L; Pullarkat, V	1
Amadori, S; Beksac, M; Berneman, Z; Bron, D; Camera, A; Cantore, N; Cilloni, D; de Witte, T; Fabbiano, F; Fazi, P; Fillet, G; Guimaraes, JE; Hagemeijer, A; Halkes, CJ; Jansen, J; Labar, B; Lefrère, F; Leoni, P; Luppi, M; Magro, D; Mancini, M; Mandelli, F; Marie, JP; Marijt, EW; Meert, L; Melillo, L; Meloni, G; Mistrik, M; Mitra, ME; Muus, P; Nobile, F; Sborgia, M; Selleslag, DL; Sica, S; Specchia, G; Suciu, S; Thomas, X; Trisolini, SM; Venditti, A; Vignetti, M; Willemze, R	1
Allen, SL; Bakan, CE; Benson, DM; Bloomfield, CD; Caligiuri, MA; Deangelo, DJ; George, SL; Hars, V; Hoke, E; Kolitz, JE; Larson, RA; Maharry, K; Marcucci, G; Powell, BL; Shea, TC; Stock, W; Vij, R	1
Baradaran, B; Esfahani, A; Estiar, MA; Karami, H; Naghavi-Behzad, M; Sakhinia, E; Sakhinia, M	1
Kim, I; Kwon, JH; Lee, JS; Lee, YG; Park, S; Yoon, SS	1
Behringer, K; Böll, B; Borchmann, P; Diehl, V; Eichenauer, DA; Engert, A; Franklin, J; Fuchs, M; Halbsguth, T; Haverkamp, H; Klimm, B; Rothe, A; Sasse, S; Thielen, I; von Tresckow, B	1
Miyawaki, S	1
Brito-Ramirez, AS; Cantú-Rodríguez, OG; Gomez-Almaguer, D; Gutiérrez-Aguirre, H; Herrera-Garza, JL; Jaime-Pérez, JC; Pinzon-Uresti, MA	1
Papież, MA	2
Audisio, E; Boccadoro, M; Bruno, B; Crisà, E; Ferrero, D; Festuccia, M; Frairia, C; Gatti, T; Giai, V; Marmont, F; Passera, R; Riera, L	1
Forman, SJ; Kim, JH; Liu, A; Palmer, J; Rosenthal, J; Schultheiss, TE; Stein, A; Tsai, N; Wong, JY	1
Bi, K; Chen, F; Fan, J; Hou, M; Liu, G; Ran, X; Wang, J; Wang, L; Wang, M; Wang, X; Wang, Z; Xu, R; Yang, E; Yang, S; Yu, W; Zhao, H	1
Maherus, EM; Rashidi, A	1
Baik, H; Bossis, G; Boutzen, H; Brockly, F; Kaoma, T; Kifagi, C; Manenti, S; Pelegrin, M; Piechaczyk, M; Récher, C; Ristic, M; Saland, E; Salem, T; Sarry, JE; Vallar, L; Vergez, F	1
Adachi, S; Hamamoto, K; Hanada, R; Hayashi, Y; Horibe, K; Imaizumi, M; Kobayashi, R; Kudo, K; Miyamura, T; Morimoto, A; Moritake, H; Nakayama, H; Shimada, A; Tabuchi, K; Taga, T; Tawa, A; Tomizawa, D; Tsuchida, M; Tsukimoto, I; Yabe, H	1
Barber, L; Clay, J; Devlia, V; Feliu, J; Mufti, G; Pagliuca, A; Raj, K; Shaw, B	1
Adlard, K; Alonzo, TA; Ballard, J; Gamis, AS; Gerbing, RB; Horton, TM; Howard, DS; Jenkins, G; Kelder, A; Moscow, JA; Perentesis, JP; Schuurhuis, GJ; Smith, FO	1
Abbi, KK; Claxton, DF; Ehmann, WC; Rybka, W	1
Bradstock, KF; Collins, M; Cull, G; Di Iulio, J; Enno, A; Hahn, U; Lewis, ID; Link, E; Marlton, P; Schwarer, A; Seymour, JF; Szer, J	1
Cortes, JE; Feldman, EJ; Goldberg, SL; Hogge, DE; Kantarjian, H; Kolitz, JE; Larson, M; Louie, AC; Pigneux, A; Recher, C; Rizzeri, DA; Schiller, G; Warzocha, K	1
Amadori, S; Arcese, W; Buccisano, F; Cerretti, R; De Angelis, G; Del Principe, MI; Di Veroli, A; Ditto, C; Irno-Consalvo, M; Lo-Coco, F; Maurillo, L; Nasso, D; Panetta, P; Piciocchi, A; Refrigeri, M; Sarlo, C; Sconocchia, G; Venditti, A	1
DeFilippis, EM; Gaan, J; Garshick, M; Harp, J	1
Basso, G; Beqiri, V; Bisio, V; Buldini, B; Fagioli, F; Locatelli, F; Manara, E; Masetti, R; Pession, A; Pigazzi, M; Putti, MC; Rizzari, C; Rondelli, R; Tregnago, C	1
Krzyściak, W; Papiez, MA	1
Alonzo, TA; Aplenc, R; Bagatell, R; Fisher, BT; Gamis, A; Gerbing, RB; Hall, M; Huang, YS; Li, Y; Luger, S; Miller, TP; Rubin, D; Seif, AE; Sung, L; Torp, K; Troxel, AB	1
Ai, WZ; Andreadis, C; Benet, LZ; Damon, LE; Gaensler, KM; Kaplan, LD; Koplowicz, YB; Linker, CA; Logan, AC; Mannis, GN; Martin, TG; Olin, RL; Sayre, PH; Smith, CC; Sudhindra, A; Venstrom, JM; Wolf, JL	1
Gill Super, HJ	1
Huang, J; Liu, B; Lyu, H; Wang, J	1
Alebouyeh, M; Faranoush, M; Hedayati Asl, AA; Mehrvar, A; Niktoreh Mofrad, N; Reinhardt, D; Tashvighi, M	1
Bezerra, MA; Bezerra, MF; de Assis, RA; de Mello, MR; Duarte, BK; Fernandes, E; Lima, AS; Lorand-Metze, I; Lucena-Araujo, AR; Machado, CG; Oliveira, MM; Pagnano, K; Ramos, CF; Souto, FR	1
Briz, O; Díez-Martín, JL; Macias, RI; Marin, JJ; Rodríguez-Macias, G	1
Ben-Haroush, A; Even-Or, E; Stein, J; Yahel, A; Yaniv, I	1
Baradaran, B; Kachalaki, S; Majidi, J; Mansoori, B; Mohammadinejad, S; Shanehbandi, D; Yousefi, M	1
Alonzo, T; Auvrignon, A; Balwierz, W; Beverloo, HB; Bongers, M; Cloos, J; Creutzig, U; De Moerloose, B; Dworzak, M; Forestier, E; Fynn, A; Gibson, B; Harrison, CJ; Hirsch, B; Johnston, D; Kaspers, G; Klein, K; Lee, V; Pession, A; Popa, A; Raimondi, S; Reedijk, A; Reinhardt, D; Rubnitz, J; Salgado, C; Taga, T; Tawa, A; Zapotocky, M; Zeller, B; Zimmerman, M	1
Aliño, SF; Bosó, V; Herrero, MJ; Martínez-Cuadrón, D; Megías-Vericat, JE; Montesinos, P; Moscardó, F; Poveda, JL; Rojas, L; Sanz, MÁ	1
Bhatnagar, B; Blum, W; Canning, R; Devine, SM; Garzon, R; Geyer, S; Klisovic, R; Marcucci, G; Vasu, S; Walker, AR; Walsh, K; Wang, H; Wu, YZ	1
Bochennek, K; Creutzig, U; Gilfert, J; Hassler, A; Lehrnbecher, T; Perner, C; Reinhardt, D; Schöning, S	1
Bukowska-Straková, K; Bystrowska, B; Dulak, J; Hajduk, K; Jozkowicz, A; Kozakowska, M; Krzyściak, W; Papież, MA; Szade, K	1
Ashizawa, M; Fujiwara, S; Hatano, K; Ito, S; Kanda, Y; Kawasaki, Y; Mashima, K; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R	1
Baradaran, B; Ismail, P; Jafarlou, M; Jafarlou, V; Othman, F; Saedi, TA; Shanehbandi, D	1
Agha, M; Amjad, A; Boyiadzis, M; Dorritie, KA; Duggal, S; Farah, R; Hou, JZ; Im, A; Lim, S; McLaughlin, B; Raptis, A; Redner, RL; Sehgal, A; Shuai, Y	1
Arima, N; Kanamaru, H; Oae, M; Okumura, Y; Shiraishi, Y; Soda, T	1
Feng, DN; Pan, H; Song, L; Sun, LR	1
Bhola, PD; DeAngelo, DJ; Ebert, BL; Galinsky, I; Hogdal, LJ; Letai, A; Lindsley, RC; Mar, BG; Ryan, JA; Vo, TT	1
Kobos, R; LaQuaglia, MP; Modak, S; Pandit-Taskar, N; Sait, S	1
Beltrão, EI; Benicio, MT; Bezerra, MA; Bezerra, MF; Coelho-Silva, JL; Lucena-Araujo, AR; Machado, CG; Nascimento, JC; Rego, EM; Rocha, CR	1
Adachi, S; Goto, H; Hasegawa, D; Hayashi, Y; Horibe, K; Iwamoto, S; Miyamura, T; Mizutani, S; Moritake, H; Nakayama, H; Saito, A; Shiba, N; Shimada, A; Taga, T; Tanaka, S; Terui, K; Tomizawa, D	1
Abboud, CN; Andreeff, M; DiPersio, JF; Eades, W; Fletcher, TR; Jacoby, MA; Konopleva, MY; McFarland, K; Reineck, T; Rettig, MP; Shannon, W; Stockerl-Goldstein, K; Stone, RM; Uy, GL; Westervelt, P	1
Bleibel, WK; Bogni, A; Cai, X; Cheng, C; Dolan, ME; Fan, Y; Liu, W; Pei, D; Pui, CH; Relling, MV; Rocha, JC; Yang, J; Yang, W	1
Baer, MR; Baldus, CD; Bloomfield, CD; Caligiuri, MA; Carroll, AJ; Kolitz, JE; Langer, C; Larson, RA; Maharry, K; Marcucci, G; Mrózek, K; Paschka, P; Powell, BL; Ruppert, AS; Whitman, SP; Zhao, W	1
Bai, CH; Kim, YD; Song, SY; Woo, HJ	1
Amadori, S; Ammatuna, E; Arcese, W; Buccisano, F; Cerretti, R; de Fabritiis, P; Del Poeta, G; Del Principe, MI; Lo Coco, F; Maurillo, L; Neri, B; Ottaviani, L; Panetta, P; Quaresima, M; Rizzo, M; Sarlo, C; Spagnoli, A; Venditti, A; Venditti, D	1
Cavelier, C; Demur, C; Didier, C; Ducommun, B; Quaranta, M	1
Li, M; Liu, H; Rao, Q; Wang, D; Wang, J; Wang, M; Wang, Y; Xu, Z	1
Advani, A; Kalaycio, M; Pohlman, B; Rybicki, L; Sekeres, M; Sobecks, R; Tripp, B	1
Corallo, CE; Coutsouvelis, J	1
Chi, HS; Jang, S; Kang, YA; Kim, DY; Kim, SH; Lee, JH; Lee, KH; Lee, SS; Lee, YS; Lim, SN; Park, CJ; Ryu, SG; Seol, M; Yun, SC	1
Asbell, SO; Bae, K; Kerlin, KJ; Michalski, JM; Pienta, KJ; Rajan, R; Rosenthal, SA; Sandler, HM; Sobczak, ML	1
Jones, RL; Kulkarni, S; Mehta, J; Morgan, G; Potter, M; Powles, R; Saso, R; Singhal, S; Sirohi, B; Smith, K; Swansbury, GJ; Treleaven, J	1
Kim, KJ; Kim, YD; Lee, YH	1
Adjei, AA; Dai, NT; Feldman, EJ; Flatten, K; Garrett-Mayer, E; Gore, SD; Greer, JM; Ironside, V; Karp, JE; Kaufmann, SH; Le, SB; Levis, MJ; Loegering, DA; Meng, XW; Morris, LE; Ricklis, RM; Ritchie, E; Roboz, G; Schneider, PA; Smith, BD; Talbott, T; Wright, JJ	1
Alexander, C; Bashford, J; Jefferies, PD; Lee, GA; Whitehead, K	1
Karp, J	1
Burns, LA; D'Orazio, JA; Farhoudi, N; Kesler, MV; McBride, MT	1
Archer, LE; Damon, LE; Hurd, D; Larson, RA; Linker, CA; Owzar, K; Powell, B	1
Britt-Marie, F; Curt, P; Frost, BM; Gudmar, L; Hasle, H; Hellebostad, M; Henrik, H; Josefine, P; Jukka, K; Kanerva, J; Kjeld, S; Lönnerholm, G; Marit, H; Palle, J; Petersson, C; Schmiegelow, K	1
Ariffin, H; RamaChandran, S	1
Hromas, R; Lee, SH; Libby, E; Nickoloff, JA; Sheema, S; Williamson, EA; Willman, CL; Wray, J	1
Hu, NP; Hu, XM; Li, L; Liu, C; Liu, F; Ma, R; Wang, HZ; Xiao, HY; Xu, YG; Yang, XH; Zhang, SS; Zheng, CM	1
Erikci, AA; Ozturk, A; Sayan, O; Tekgunduz, E	1
Carrier, M; Cencic, R; Minden, M; Pelletier, J; Porco, JA; Trnkus, A	1
Candoni, A; Fanin, R; Malagola, M; Russo, D; Simeone, E; Tiribelli, M	1
Abichandani, R; Barry, E; Carroll, WL; Chu, R; Cooper, T; Gaynon, P; Hijiya, N; Jeha, S; Kadota, R; Rytting, M; Shen, V; Silverman, L; Steinherz, P; Thomson, B	1
Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P	1
Bagg, A; Carroll, M; Dierov, JK; Frey, NV; Gewirtz, AM; Goldstein, SC; Hexner, EO; Kasner, MT; Loren, AW; Luger, SM; Nasta, SD; Perl, AE; Porter, DL; Schuster, SJ; Stadtmauer, EA; Swider, CR; Tsai, DE; Vogl, DT	1
Eilers, M; Illmer, T; Meyer, M; Neubauer, A; Roth, P; Rübsamen, D; Slany, R; Stabla, K; Stiewe, T	1
Kurokawa, M; Nagai, S; Nannya, Y; Takahashi, T	1
Ishii, E	1
Burnett, AK; Duncombe, A; Gibson, B; Goldstone, AH; Hills, RK; McMullin, MF; Milligan, DW; Prentice, AG; Wheatley, K	1
Dessalvi, P; Di Tucci, AA; Emanuele, A; Pettinau, M; Romani, C	1
Aziz, A; Gosbell, IB; Sanghavi, R; Varghese, B	1
Arceci, RJ; Bernstein, M; Buck, S; Chang, MN; Dahl, GV; Kshirsagar, S; Lacayo, NJ; Lum, BL; O'Brien, MM; Ravindranath, Y; Sikic, BI; Weinstein, H	1
Ji, Z; McHale, CM; Peng, V; Ren, X; Smith, MT; Zhang, L	1
Adiguzel, U; Erkayhan, G; Sari, A; Unal, S	1
Green, KK; Keen, CL; Kwik-Uribe, C; Lanoue, L	1
Betts, DR; Bourquin, JP; Bradtke, J; Creutzig, U; Dworzak, MN; Haas, OA; Reinhardt, D; Sander, A; Stary, J; von Neuhoff, C; Zemanova, Z; Zimmermann, M	1
Airewele, G; Bowman, WP; Campana, D; Cao, X; Coustan-Smith, E; Dahl, G; Degar, B; Downing, JR; Inaba, H; Lacayo, NJ; Leung, W; Meshinchi, S; Onciu, M; Pounds, S; Pui, CH; Raimondi, SC; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Taub, J	1
Arai, S; Blume, K; Brown, J; Johnston, L; Laport, G; Lowsky, R; Miklos, D; Naik, S; Negrin, R; Shizuru, J; Wong, R	1
Fericean, AM; Kolokotronis, AE; Matiakis, AT; Papamanthos, MK; Skulakis, HE; Zorba, MT	1
Allen, SL; Baer, MR; Bloomfield, CD; DeAngelo, DJ; George, SL; Hars, V; Hoke, E; Kolitz, JE; Larson, RA; Maharry, K; Marcucci, G; Powell, BL; Shea, TC; Stock, W; Vardiman, JW; Vij, R	1
Barraco, F; Cannas, G; Chelghoum, Y; Derbel, O; Elhamri, M; Le, QH; Michallet, M; Nicolas-Virelizier, E; Nicolini, F; Thomas, X; Troncy, J	1
Celentano, M; Criscuolo, C; Ferrara, F; Izzo, T; Mele, G; Riccardi, C	1
Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Jeha, S; Kantarjian, H; Ouzounian, S; Pierce, S; Ravandi, F; Rytting, M	1
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M	1
Cesano, A; Covey, T; Fantl, WJ; Huang, YW; Minden, MD; Nolan, GP; Putta, S; Rosen, DB	1
Cros-Perrial, E; Demangel, D; Dreano, M; Dumontet, C; Herveau, S; Jordheim, LP; Keime, C; Plesa, A; Vendrell, JA	1
Agha, M; Boyiadzis, M; Foon, KA; Hou, JZ; Raptis, A; Redner, RL	1
Alizadeh, AA; Berube, C; Coutre, S; Gotlib, J; Ho, M; Kohrt, HE; Liedtke, M; Majeti, R; Medeiros, BC; Owen, T; Patel, S; Pollyea, DA	1
Briel, J; Gocke, CD; Hess, AD; Kanakry, CG; Karp, JE; Kos, F; Levitsky, H; Luznik, L; Meyer, C; Smith, BD; Thoburn, C	1
Teh, TC; Wei, A	1
Fernandez, HF; George, TJ; Ho, VQ; Kharfan-Dabaja, MA; Komrokji, RS; Lancet, JE; List, AF; Pinilla-Ibarz, J; Price, SL; Wetzstein, GA	1
Farah, RA; Farhat, HZ; Jalkh, KS; Kadri, AM; Sayad, PE	1
Agha, M; Boyiadzis, M; Duggal, S; Foon, KA; Hou, JZ; Luong, TM; Mehta, DR; Raptis, A; Redner, RL; Schlesselman, JJ	1
Baer, MR; Bloomfield, CD; Caligiuri, MA; George, SL; Kolitz, JE; Larson, RA; Moore, JO; Mrózek, K; Powell, BL; Sanford, BL; Stone, RM	1
Agrawal, AK; Golden, C; Guo, H	1
Czarnik-Matusewicz, H; Ganczarski, G; Gąsiorowski, J; Głowacka, K; Kuliczkowski, K; Orzechowska-Juzwenko, K; Wiela-Hojeńska, A; Wołowiec, D; Łapiński, Ł	1
Ganser, A; Göhring, G; Hofmann, W; Lehmann, U; Luna, JC; Manukjan, G; Otto, N; Scherer, R; Schlegelberger, B; Steinemann, D; Welte, K	1
Douer, D; Liu, SV; Tahbaz, A; Zneimer, S	1
Cassuto, JP; Cluzeau, T; De Matteis, M; Gratecos, N; Mannone, L; Mounier, N; Raynaud, S; Sirvent, A; Thyss, A; Ticchioni, M	1
Deweese, JE; Jacob, DA; Mercer, SL; Osheroff, N	1
Ahmad, J; Hussain, G; Kausar, S; Zafar, L	1
Brunet, S; Bueno, J; Duarte, R; Esteve, J; Guardia, R; Llorente, A; Martínez-Cuadrón, D; Montesinos, P; Ribera, JM; Sánchez-Ortega, I; Sanz, MA; Sierra, AJ; Tormo, M; Torres, JP; Valcárcel, D	1
Alonzo, TA; Arceci, RJ; Cooper, TM; Feusner, J; Franklin, J; Gamis, A; Gerbing, RB; Hirsch, B; Hurwitz, C; Iannone, R; Lavey, RS; Mathew, P; Meshinchi, S; Raimondi, SC; Smith, FO	1
Carillio, G; Kropp, M; Levato, L; Molica, S; Piro, E	1
De Graaf, SS; Gibson, BE; Harrison, CJ; Howman, AJ; Webb, DK; Wheatley, K	1
Barroso, RS; Chauffaille, ML; Ribeiro, JC; Sandes, AF; Silva, MR	1
Bargetzi, M; Cornelissen, JJ; Ferrant, A; Fey, MF; Gratwohl, A; Graux, C; Huijgens, PC; Löwenberg, B; Maertens, J; Ossenkoppele, GJ; Schaafsma, R; Schanz, U; Schouten, HC; Theobald, M; van Putten, W; Vellenga, E; Verdonck, LF	1
Bain, BJ; Innes, A; May, PC; Pavlů, J	1
Carraway, HE; Derecho, C; Feldman, EJ; Galkin, S; Garret-Mayer, E; Gocke, CD; Gore, SD; Greer, JM; Ironside, V; Karp, JE; Kaufmann, SH; Levis, MJ; Malek, S; McDevitt, MA; Morris, LE; Palma, J; Raponi, M; Ritchie, EK; Roboz, GR; Smith, BD; Vener, TI; Wang, Y; Wright, JJ	1
He, K; Li, Y; Rao, Q; Tang, KJ; Tian, Z; Wang, M; Xing, HY; Yu, P	1
Carroll, M; Kasner, MT; Luger, SM; Perl, AE; Shank, D	1
Altman, J; Carlson-Leuer, K; Coyle, K; Frankfurt, O; Mehta, J; Newman, D; Rademaker, AW; Tallman, MS; Trifilio, SM	1
Bender, B; Friberg, LE; Honoré, PH; Jensen, MK; Krogh-Madsen, M; Nielsen, OJ	1
Avilia, S; Battipaglia, G; Camera, A; Caranci, F; Morelli, E; Perna, F	1
Fukushima, T; Haba, T; Morinaga, K; Nakao, S; Origasa, H; Sugiyama, T; Ueda, M; Ueda, T; Umehara, H; Urasaki, Y; Yamaguchi, M	1
Levis, M	1
Abboud, CN; Cashen, AF; DiPersio, JF; Hladnik, LM; Kulkarni, S; McFarland, K; Motabi, IH; Rettig, MP; Stockerl-Goldstein, KE; Trinkaus, KM; Uy, GL; Vij, R; Westervelt, P	1
Christos, PJ; Feldman, EJ; Gergis, U; Mayer, S; Ritchie, EK; Roboz, GJ; Scandura, JM; Wissa, U	1
Baker, SD; Chen, Z; Hu, C; Hu, S; Lancaster, CS; Rubnitz, JE; Sparreboom, A; Zuo, Z	1
Huang, TS; Lin, HW; Shih, SR; Yao, M	1
Forman, S; Liu, A; Palmer, J; Radany, E; Rosenthal, J; Schultheiss, T; Somlo, G; Stein, A; Wong, JY	1
Adachi, N; Austin, CA; Cowell, IG; Jackson, GH; Lee, KC; Manville, CM; Padget, K; Rance, HA; Sidorczuk-Lesthuruge, M; Smith, K; Sondka, Z	1
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G	1
Bowman, WP; Campana, D; Cao, X; Dahl, G; Inaba, H; Jenkins, L; Pounds, S; Pui, CH; Ribeiro, RC; Rubnitz, JE; Taub, JW	1
Appelbaum, FR; Geraghty, DE; Godwin, JE; Ho, PA; Kutny, M; Meshinchi, S; Ostronoff, F; Othus, M; Petersdorf, SH; Radich, JP; Stirewalt, DL; Willman, CL	1
Colovic, M; Floros, KV; Gourgiotis, D; Pavlovic, S; Scorilas, A; Thomadaki, H; Tosic, N	1
Bozkurt, C; Dogru, M; Kocaoglu, AC; Ozmen, S	1
Alonzo, TA; Aplenc, R; Gamis, AS; Gerbing, RB; Sung, L	1
Creutzig, U; Reinhardt, D; Sander, A; Von Neuhoff, C	1
Bauer, K; Engert, A; Hübel, K; Monsef, I; Rancea, M; Skoetz, N	1
Ezoe, S	1
Dehkordi, AJ; Khajavinia, A; Varshosaz, J	1
Dirnhofer, S; Girsberger, S; Karow, A; Lehmann, T; Lundberg, P; Passweg, JR; Rovó, A; Skoda, R; Tichelli, A	1
Alimoghaddam, K; Bahar, B; Behfar, M; Ghavamzadeh, A; Hamdi, A; Hamidieh, AA; Iravani, M; Jahani, M; Jalali, A; Jalili, M; Mousavi, SA	1
Ahmed, AB; Bruserud, O; Hatfield, KJ; Kittang, AO; Reikvam, H; Sjo, M; Tvedt, TH	1
Colovic, N; Djunic, I; Djurasinovic, V; Jankovic, G; Palibrk, V; Suvajdzic, N; Tomin, D; Vidovic, A; Virijevic, M	1
Agha, M; Boyiadzis, M; Duggal, S; Hou, JZ; Im, A; Lin, Y; McLaughlin, B; Raptis, A; Redner, R; Smith, C	1
Fux-Arnold, C; Gavillet, M; Medinger, M; Tichelli, A	1
Abrahamsson, J; Forestier, E; Gustafsson, B; Ha, SY; Hasle, H; Heilmann, C; Heldrup, J; Jahnukainen, K; Jónsson, ÓG; Lausen, B; Palle, J; Wareham, NE; Zeller, B	1
Atenafu, EG; Brandwein, JM; Gupta, V; Hassanein, M; Minden, MD; Schimmer, AD; Schuh, AC; Yee, KW	1
Fenske, N; Morgan, MB; Sakalosky, PE	1
Anastasi, J; Baer, MR; Bloomfield, CD; Caligiuri, MA; Dodge, RK; George, SL; Kolitz, JE; Larson, RA; Minderman, H; O'Loughlin, KL; Powell, BL; Schiffer, CA	1
Bahng, HS; Jang, GD; Jeong, YH; Ji, HS; Kim, EK; Kim, SH; Kim, SW; Kim, WK; Lee, JS; Park, CJ; Park, IG; Suh, CW; Suh, EJ	1
Amir, G; Cohen, Y; Da'as, N; Gillis, S; Polliack, A; Rund, D	1
Behm, FG; Crews, KR; Gandhi, V; Plunkett, W; Pui, CH; Raimondi, SC; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Srivastava, DK; Stewart, CF; Tong, X	1
Castel, V; Dini, G; Fagioli, F; Ferrant, A; Frassoni, F; Labopin, M; Locatelli, F; Meloni, G; Messina, C; Ortega, J; Pession, A; Shaw, PJ; Sociè, G; Yaniv, I	1
Bolaños-Meade, J; Buddharaju, LN; Chen, TT; Guo, C; Karp, JE; Rapoport, AP; Sarkodee-Adoo, CB; Tidwell, ML	1
Kinnula, V; Koistinen, P; Mäntymaa, P; Savolainen, ER; Siitonen, P; Siitonen, T	1
Adil, SN; Burney, IA; Kakepoto, GN; Khurshid, M; Zaki, S	1
Bishop, WR; Nakajima, A; Ohyashiki, K; Sumi, M; Tauchi, T	1
Chen, J; Gu, L; Pan, C; Tang, J; Xue, H; Zhao, H	1
Beyan, C; Cetin, T; Kaptan, K; Nevruz, O	1
Kumagawa, M; Nagano, M; Suzuki, K; Suzumiya, J; Takamatsu, Y; Tamura, K	1
Adams, MT; Alonzo, TA; Arceci, RJ; Buckley, J; Buxton, AB; Dusenbery, K; Gamis, A; Masterson, M; Vik, T; Warkentin, P; Wells, RJ; Whitlock, JA	1
Chelghoum, Y; Elhamri, M; Le, QH; Michallet, M; Revesz, D; Thomas, X	1
Debatin, KM; Eckhoff, S; Meyer, LH; Mohr, A; Stahnke, K	1
Furuta, GT; Glickman, J; Köhler, H; Nurko, S	1
Baccarani, M; Malagola, M; Martinelli, G; Piccaluga, PP; Ronconi, S; Rondoni, M; Visani, G	1
Blijlevens, N; de Pauw, B; Donnelly, P; Levenga, H; Shirango, H; Verweij, P	1
Fouillard, L; Frassoni, F; Gorin, NC; Labopin, M; Meloni, G; Polge, E	1
Almqvist, A; Anttila, P; Elonen, E; Jantunen, E; Koistinen, P; Koivunen, E; Koponen, A; Mikkola, M; Nousiainen, T; Oksanen, K; Pelliniemi, TT; Pulli, T; Remes, K; Ruutu, T; Sarkkinen, R; Silvennoinen, R; Timonen, T; Vanhatalo, S	1
Arnold, R; Bergmann, L; Fiedler, W; Ganser, A; Heil, G; Hoelzer, D; Kirchner, H; Krauter, J; Lübbert, M; Noens, L; Raghavachar, A; Schlimok, G	1
Fonatsch, C; Geissler, K; Jäger, U; Knöbl, P; Lechner, K; Piribauer, M; Schwarzinger, I; Sperr, WR; Thalhammer-Scherrer, R; Valent, P; Wimazal, F	1
Furukawa, Y; Kitani, T; Shibano, M; Tsukaguchi, M	1
Bargay, J; Berlanga, J; Brunet, S; Bueno, J; Esteve, J; Granena, A; Guardia, R; Juliá, A; Martí, JM; Montserrat, E; Ribera, JM; Sierra, J	1
Creutzig, U; Dworzak, M; Lehrnbecher, T; Reinhardt, D; Stary, J; Zimmermann, M	1
Andresen, S; Ball, E; Bolwell, B; Cook, D; Kalaycio, M; Kuczkowski, E; Pohlman, B; Rybicki, L; Sobecks, R	1
Alymara, V; Bourantas, KL; Chaidos, A; Tsiara, S; Tzouvara, E; Vartholomatos, G	1
Chaoui, D; Legrand, O; Marie, JP; Peffault De Latour, R	1
Chen, Y; Findley, HW; Li, C; Qiao, Z; Wang, B; Zhou, J; Zhou, M	1
Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J	1
Barulli, S; D'Adamo, F; Guiducci, B; Isidori, A; Leopardi, G; Malagola, M; Malerba, L; Mele, A; Nicolini, G; Piccaluga, P; Politi, P; Sparaventi, G; Stramigioli, S; Talevi, N; Visani, G	1
Borkhardt, A; Bruch, J; Fuchs, U; Metzler, M; Perez, AV; Wilda, M; Woessmann, W	1
Böhm, A; Fonatsch, C; Geissler, K; Gisslinger, H; Jäger, U; Knöbl, P; Kyrle, PA; Lechner, K; Piribauer, M; Sperr, WR; Valent, P; Wimazal, F	1
Creutzig, U; Diekamp, S; Dworzak, M; Reinhardt, D; Stary, J; Zimmermann, M	1
Kawauchi, K; Ogasawara, T; Yasuyama, M	1
Koistinen, P; Savolainen, ER; Siitonen, T	1
Brandwein, J; Brown, R; Chopra, R; De Angelo, D; Ehmann, WC; Feldman, EJ; Frankel, SR; Jurcic, JC; Kalaycio, M; Miller, C; Moore, J; O'Connor, J; Roboz, GJ; Scheinberg, D; Schulman, P; Stone, R; Wedel, N	1
Kara, B; Kara, IO; Paydas, S; Sahin, B	1
Agoliati, G; Ahmed, T; Arshad, M; Galvin-Parton, P; Liu, D; Qureshi, A; Seiter, K	1
Chi, HS; Choi, SJ; Jang, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Park, CJ; Ryu, SG; Seol, M	1
Carroll, M; Thompson, JE; Xu, Q	1
Barbier, M; Bignon, J; Boutonnat, J; Colle, PE; Faussat, AM; Marie, JP; Ronot, X; Thierry, J; Wdzieczak-Bakala, J	1
Ahn, BM; Baek, JH; Jeon, SB; Kim, DH; Kim, JG; Lee, KB; Moon, JH; Sohn, SK; Sung, WJ	1
Ao, ZF; Chen, BA; Gao, F; Shen, HL; Xia, W; Xu, WL; Zhang, YN	1
Glasmacher, A; Gorschlüter, M; Mey, U; Schmidt-Wolf, IG; Schwerdtfeger, R	1
Armitage, ES; Balasis, M; Bali, P; Bhalla, K; Boyapalle, S; Fiskus, W; Greedy, B; Guo, F; Kumaraswamy, S; Lawrence, N; Pranpat, M; Rocha, K	1
Fujinami, K; Maruta, I; Miura, T; Osada, Y; Takizawa, A; Tanaka, M	1
Al-Jefri, A; Al-Mahr, M; Al-Seraihi, A; Ayas, M; Belgaumi, A; El-Solh, H; Elhassan, I	1
Burnett, AK; Craig, JI; Littlewood, T; Milligan, DW; Wheatley, K	1
Belch, A; Gluck, S; Larratt, L; Robinson, KS; Sheridan, D; Shustik, C; Stewart, K; Van Der Jagt, R; Wells, G; Yetisir, E	1
Billottet, C; Gale, RE; Grandage, VL; Khwaja, A; Quattropani, A; Rommel, C; Vanhaesebroeck, B	1
Gu, C; Wells, RA; Ye, T	1
Belevtsev, MV; Buglova, SE; Shman, TV	1
Bettaieb, A; Cortier, M; Filomenko, R; Jeannin, JF; Prévotat, L; Rébé, C; Solary, E	1
Libura, J; Richardson, C; Sung, PA	1
Hars, ES; Lin, CP; Liu, LF; Lyu, YL	1
Martin, PL; McLean, TW; White, MS	1
Carter, GI; Grundy, M; Hunter, HM; Lloyd-Lewis, B; Massip, AM; Pallis, M; Russell, NH; Seedhouse, CH; Shang, S	1
Lane, SW; Marlton, P; Mollee, PN	1
Bortul, R; Evangelisti, C; Grafone, T; Martelli, AM; Martinelli, G; McCubrey, JA; Papa, V; Tabellini, G; Tazzari, PL	1
Alfaro, EM; Alonso, CN; Baro, C; Corral, Mdel P; Felice, MS; Gallego, MS; Rossi, J; Solé, F; Villa, O	1
Hara, T; Kanemura, N; Kasahara, S; Moriwaki, H; Oyama, M; Sawada, M; Tsurumi, H; Yamada, T	1
Baxter, H; Di Iulio, J; Juneja, S; Leahy, M; Manoharan, A; Matthews, J; Reynolds, J	1
Caracciolo, F; Focosi, D; Galimberti, S; Papineschi, F; Petrini, M	1
Abla, O; Dror, Y; Shago, M	1
Fujiwara, M; Higashimura, M; Izumi, N; Koike, T; Satou, N; Shibasaki, Y; Tsukada, N	1
Büchner, T; Creutzig, U; Döhner, H; Reinhardt, D; Sauerland, MC; Schlenk, RF; Zimmermann, M	1
Huang, XF; Li, J; Liu, Q; Luo, SK; Wan, XB; Wang, LH; Wang, XR; Xu, DR; Xu, J; Yan, M; Zeng, YX; Zheng, FM	1
Horikoshi, A; Hosokawa, Y; Sawada, S; Takei, K	1
Basecke, J; Becker, A; Glass, B; Griesinger, F; Haase, D; Podleschny, M; Schmitz, N; Schwiers, I; Schwiers, R; Seiffert, E; Trumper, L	1
Arkenau, T; Cunningham, D; Horwich, A; Murphy, F; Norman, A; Oates, J; Powles, R; Sirohi, B; Wotherspoon, A	1
Arruga, F; Bracco, E; Carturan, S; Catalano, R; Cilloni, D; Defilippi, I; Iacobucci, I; Martinelli, G; Messa, E; Messa, F; Morotti, A; Nicoli, P; Panuzzo, C; Pautasso, M; Rosso, V; Saglio, G	1
Aisner, J; Collazo, C; Dutta, J; Gharibo, M; Gounder, M; Lin, Y; Nazar, A; Rubin, EH; Saleem, A; Saraiya, B; Schaar, D; Shih, W; Strair, RK; Zimmerman, L	1
Atra, AA; Baothman, A; Elimam, NA; Kassar, A; Khattab, TM; Zayed, A	1
Becker, H; Lübbert, M; Schäfer, HS; Schmitt-Gräff, A	1
Kell, J	1
Evans, JP; Prentice, HG	1
Cabanillas, F	1
DeBellis, R; Kasdorf, H; Schiffer, CA; Wiernik, PH	1
Dill, PL; Macaluso, CK; Marsden, JA; Weisenthal, LM	1
Achterrath, W; Balleisen, L; Büchner, T; Hiddemann, W; Kirchhof, B; Preusser, P; Stenzinger, W; Urbanitz, D	1
Bennett, JM; Cassileth, PA; Glick, JH; Lymann, GH; Oken, MM	1
Aisner, J; Van Echo, DA; Wiernik, PH	1
Zittoun, R	1
Fehr, J; Frick, P; Gmuer, J; Honegger, H; Martz, G; Sauter, C	1
Björkholm, M; Gruber, A; Liliemark, E; Liliemark, J; Paul, C; Peterson, C; Tidefelt, U	1
Aoyagi, A; Arimura, H; Furusawa, S; Koike, T; Noguchi, M; Saito, K; Sakuma, H; Waga, K; Yamada, K; Yamato, H	1
Ariyama, Y; Fujii, H; Nakagawa, H; Sonoda, Y	1
Miura, T; Moriwaki, H; Muto, Y; Nakamura, N; Oyama, M; Sawada, M; Takahashi, T; Tomoda, T; Tsurumi, H; Yamada, T	1
Kaya, H; Kumabashiri, I; Matsuda, T; Nakamura, S; Ohtake, S; Yamazaki, H	1
Gastineau, DA; Hoagland, HC; Letendre, L; Noel, P; Solberg, LA; Tefferi, A	1
Anastasi, J; Hayashi, Y; McGavran, L; Nucifora, G; Roulston, D; Rowley, JD; Rudinsky, R; Tsuchida, M; Zeleznik-Le, N	1
Liliemark, E; Liliemark, J; Peterson, C; Pettersson, B	1
Björkholm, M; Gahrton, G; Grimfors, G; Gruber, A; Hast, R; Järnmark, M; Juliusson, G; Killander, A; Kimby, E; Liliemark, J	1
Fujihara, M; Kyo, T; Myoken, Y; Sugata, T	1
Breeden, ES; Einhorn, LH; Loehrer, PJ; Nichols, CR; Williams, SD	1
Bajorin, DF; Bosl, GJ; Motzer, RJ; Murphy, B; Rodriguez, E	1
Abe, T; Hirao, A; Kawano, Y; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y; Watanabe, T	1
Bergmann, L; Fischer, JT; Ganser, A; Heil, G; Heimpel, H; Heit, W; Huber, C; Kolbe, K; Maschmeyer, G; Mitrou, PS	1
Mizuta, K; Okuma, M; Sawada, H; Sawai, H; Takeda, Y; Tashima, M; Toi, T	1
Appelbaum, FR; Bigelow, CL; Files, JC; Grever, M; Head, D; Kopecky, K; Lipschitz, DA	1
Eguchi, H; Ikuno, Y; Inada, H; Ishii, E; Koga, H; Matuzaki, A; Miyazaki, S; Nibu, K; Okamura, J; Ueda, K	1
Bolaños, F; Candelaria, M; Hurtado, R; Labardini, JR; Majluf, A; Vargas, F	1
Asschert, L; de Vries, EG; van der Kolk, D; Vellenga, E; Withoff, S	1
Bishop, JF; Cobcroft, R; Dodds, A; Herrman, R; Joshua, DE; Laidlaw, CR; Ma, D; Matthews, JP; Szer, J; Young, G	1
Reilly, JT; Snowden, JA; Wodziński, MA	1
Antin, JH; Miller, KB; Mitus, AJ; Parsons, SK; Ryan, HF; Schenkein, DP; Wheeler, C	1
Burris, H; Grunberg, SM; Livingston, R	1
Bourdin, S; Harousseau, JL; Le Tortorec, S; Mahe, B; Mahe, JM; Mechinaud-Lacroix, F; Milpied, N; Moreau, P; Rapp, MJ; Wu, DP	1
Burke, PJ; Cowan, K; Jones, RJ; Karp, JE; Kaufmann, SH; Miller, CB; Schneider, E; Wendel, K; Zwelling, LA	1
Eisterer, W; Hilbe, W; Ludescher, C; Niederwieser, D; Thaler, J	1
Fridborg, H; Killander, A; Kristensen, J; Larsson, R; Liliemark, J; Nygren, P; Oberg, G; Simonsson, B	1
Bartolucci, AA; Martelo, O; McCarley, DL; Moore, J; Omura, GA; Stagg, M; Vogler, WR	1
Archimbaud, E; Auzanneau, G; Bordessoule, D; Castaigne, S; Dupriez, B; Fenaux, P; Legros, M; Simon, M; Tertian, G; Tilly, H	1
Cedrych, I; Hołowiecka, B; Hołowiecki, J; Kachel, L; Krawczyk, M; Krzemień, S; Rudzka, E; Wacławik, A; Wojciechowska, M; Wojnar, J	1
Ishizaki, T; Itoyama, T; Kuriyama, K; Nakamura, H; Sadamori, N; Soda, H; Tomonaga, M; Yamada, Y; Yoshida, Y	1
Vogler, WR	1
Aricó, M; Broadbent, V; Gadner, H; Jakobson, A; Komp, D; Ladisch, S; Nicholson, S	1
Aisner, J; Belani, CP; Doyle, LA	1
Kobayashi, K; Ratain, MJ	1
Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM	1
Iida, H; Iida, M; Kodera, Y; Minami, S; Seto, M; Sugihara, T; Suzuki, R; Taji, H; Ueda, R; Yamamoto, K	1
Cesano, A; Cioé, L; Clark, SC; Rovera, G; Santoli, D; Visonneau, S	1
Bonanad, S; Martín, G; Sanz, GF; Sanz, MA	1
Asayama, R; Hagimoto, N; Harada, M; Higuchi, K; Hyodo, S; Katoh, M; Ohno, Y; Takita, A; Taniguchi, S; Yamasaki, K	1
Kumar, L	1
Berdel, WE; Ho, AD; Knauf, WU; Kreuser, ED; Thiel, E	1
D'Angio, GJ	1
Aricò, M; Egeler, RM; Favara, BE; Heitger, A; Neglia, JP; Nesbit, ME	1
Donaldson, SS; Ensign, LG; Heyn, R; Khan, F; Maurer, HM; Ruymann, F; Smith, MA; Vietti, T	1
Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Schmidt, GM; Snyder, DS; Stein, AS; Taguchi, J	1
Björkholm, M; Gruber, A; Liliemark, EK; Liliemark, J; Peterson, C; Pettersson, B	1
Barnett, MJ; Bredeson, CN; Dalal, BI; Horsman, DE; Phillips, GL; Ragaz, J	1
Hossfeld, DK; Shi, G; Weh, HJ	1
Andersson, M; Daugaard, G; Ersbøll, J; Hansen, SW; Hou-Jensen, K; Larsen, SO; Nielsen, D; Pedersen-Bjergaard, J; Philip, P; Sigsgaard, TC	1
Daenen, S; Huijgens, PC; Löwenberg, B; Sonneveld, P; van Putten, WL; van Veldhoven, M; Verdonck, LF; Verhoef, G	1
Cerutti, I; Fernández-Barbieri, MA; Gomel, M; Kvicala, R; Matus-Ridley, M; Negri-Aranguren, P; Rosso, A; Sackmann-Muriel, F; Santarelli, MT	1
Adachi, S; Akiyama, Y; Hirota, H; Kubota, M; Kuwakado, K; Matsubara, K; Mikawa, H; Wakazono, Y	1
Amess, J; Bower, M; Evans, GA; Gibbons, B; Lister, TA; Parry, P; Young, BD	1
Abe, Y; Hatanaka, T; Ito, T; Kamiya, O; Nagata, K; Ohara, K; Ono, Y; Saito, M	1
Brunet, S; Domingo-Albós, A; Mateu, R; Sureda, A	1
Damon, LE; Linker, CA; Ries, CA; Rugo, HS; Wolf, JL	1
Boogaerts, M; Bosly, A; Carli, MG; Castoldi, G; Cuneo, A; Demuynck, H; Doyen, C; Ferrant, A; Michaux, JL; Piva, N	1
Davidson, NE; Desnoyers, S; Kaufmann, SH; Ottaviano, Y; Poirier, GG	1
Bailey, CC; Curzon, ME; Duggal, MS; Hart, P; O'Sullivan, EA	1
Delmer, A; Marie, JP; Suberville, AM; Thevenin, D; Zittoun, R	1
Babacan, E; Bökesoy, I; Cavdar, AO; Gözdaşoğlu, S; Pamĭr, A; Sunguroğlu, A; Tanindi, S; Türker, A; Unal, E; Yavuz, G	1
Amylon, MD; Blume, KG; Chao, NJ; Forman, SJ; Long, GD; Negrin, RS; Stein, AS; Wong, RM	1
Carella, AM; Carlier, P; Iacopino, P; Liso, V; Mirto, S; Montillo, M; Pagano, L; Pungolino, E; Resegotti, L; Stasi, R	1
Björkholm, M; Gruber, A; Knochenhauer, E; Liliemark, J; Peterson, C; Pettersson, B	1
Archimbaud, E; Auzanneau, G; Cordonnier, C; Fenaux, P; Leblond, V; Marie, JP; Reiffers, J; Tilly, H; Travade, P; Troussard, X	1
Akatsuka, J; Furukawa, T; Nakazawa, S; Nishimura, K; Ohira, M; Okawa, Y; Sugita, K; Tsuchida, M	1
Barnett, MJ; Klingemann, HG; Nantel, SH; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ	1
Whitlock, JA	1
Berman, E; Golde, DW; Maslak, PG; Scheinberg, DA; Tyson, D; Weiss, MA; Yao, TJ	1
Bow, EJ; Cheang, MS; Loewen, R; Schacter, B	1
Amadori, S; Cenacchi, A; Latagliata, R; Mandelli, F; Manfroi, S; Petti, MC; Spadea, A; Tosi, P; Tura, S; Visani, G	1
Baldicchi, L; Corneo, GM; Mangiagalli, M; Miccolis, IR; Pioltelli, P; Pogliani, EM	1
Chau, WK; Chiu, CF; Ho, CH; Hsu, HC; Tan, TD; Tseng, CS	1
Camitta, B; Holbrook, T; Krischer, J; Land, V; Mahoney, D; Sexauer, C; Steuber, CP; Weinstein, H	1
Bandini, G; Belardinelli, A; Fiacchini, M; Geromin, A; Gherlinzoni, F; Manfroi, S; Mangianti, S; Miggiano, MC; Motta, MR; Ricci, P; Rizzi, S; Rosti, G; Testoni, N; Tura, S; Visani, G	1
Fey, MF; Hardegger, TP; Tobler, A; von Rohr, A	1
Gieseler, F; Glasmacher, A; Kämpfe, D; Kunze, J; Nuessler, V; Valsamas, S; Wandt, H; Wilms, K	2
Deguchi, S; Fujita, M; Honda, K; Kikuchi, T; Miyata, A	1
Fukuda, H; Hyouchi, N; Ishiwata, D; Kamai, T; Masuda, H; Okuno, T; Tachibana, Y; Touma, T; Yonese, J	1
Brack, N; Ehninger, G; Fackler-Schwalbe, I; Freund, M; Geer, T; Gramatzki, M; Hübner, G; Link, H; Löffler, B; Ohl, S; Poliwoda, H; Queisser, W; Raab, M; Schneider, B; Schneider, C; Schönrock-Nabulsi, P; Wandt, H	1
Ishida, Y; Ito, T; Kuriya, S; Miyairi, Y; Murai, K; Narigasawa, Y; Shimosegawa, K; Utsugisawa, T	1
Chai, A; Forman, SJ; Lee, J; Lipsett, J; Margolin, KA; Molina, A; Nademanee, A; Niland, J; O'Donnell, MR; Parker, PM; Schmidt, GM; Smith, EP; Snyder, DS; Somlo, G; Spielberger, R; Stein, AS; Stepan, DE; Vora, N	1
Kearns, P; Majumdar, G; Partridge, F; Richardson, W; Wilcox, R	1
Canpynar, H; Cetin, M; Hiçsönmez, G; Kansu, E; Tuncer, AM	1
Flaherty, L; Katato, K; Varterasian, M	1
Herngren, L; Liliemark, E; Liliemark, J; Peterson, C; Pettersson, B	1
Björkholm, M; Gruber, A; Liliemark, E; Liliemark, J; Osby, E; Peterson, C; Sirzea, F; Söderhäll, S; Zhou, R	1
Nishikawa, K	1
Ascensao, JL; Silva, MR	1
Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC	1
Avvisati, G; Capria, S; Giona, F; Mandelli, F; Meloni, G; Micozzi, A; Vignetti, M	1
Clark, M; Gieseler, F; Glasmacher, A; Kämpfe, D; Kunze, J; Valsamas, S; Zernak, C	1
Ezaki, K; Hirano, M; Ino, T; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Tsuzuki, M; Wakita, M; Yamaguchi, T	1
Ashihara, E; Fujita, N; Goto, H; Hatta, T; Hirai, H; Inaba, T; Kikuta, T; Nakagawa, M; Shimazaki, C; Sudo, Y; Sumikuma, T; Yamagata, N	1
Amadori, S; Andrizzi, C; Meloni, G; Moleti, ML; Orsini, E; Petti, MC; Pinto, RM; Vignetti, M	1
Ando, T; Ariyoshi, K; Hikiji, K; Kobayashi, M; Shinohara, K; Toyosawa, M	1
Degenhardt, F; Ganser, A; Geissler, RG; Hertenstein, B; Karthaus, M; Prahst, A	1
Larsen, AK; Skladanowski, A	1
Fujimoto, T; Gushiken, T; Horikoshi, Y; Ishida, Y; Kawakami, K; Kawamura, N; Kikuta, A; Koizumi, S; Maeda, H; Mimaya, J; Mugishima, H; Ohta, S; Oka, T; Okada, N; Sekine, I; Shimizu, H; Utsumi, J; Watanabe, A; Yamamura, Y	1
Bewermeier, P; Hossfeld, DK; Kruger, W; Mross, K; Reifke, J; Zander, A	1
Ezaki, K; Hirano, M; Ino, T; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Tsuzuki, M; Yamaguchi, T	1
De Terlizzi, M; Fears, TR; Gadner, H; Haupt, R; Heise, A; Loiacono, G; Tucker, MA	1
Aplan, PD; Chervinsky, DS; Stanulla, M; Wang, J	1
Andreeff, M; Consoli, U; Estey, E; Kantarjian, H; Keating, M; Kornblau, SM; Madden, T; Newman, RA; Sanchez-Williams, G; Snell, V; Tran, HT; Zhao, S	1
Becton, DL; Sawyer, JR; Saylors, RL; Stine, KC	1
Gelfand, R; Gulati, SC; Parikh, PM	1
Brøndum-Nielsen, K; Johansson, B; Karle, H; Pedersen-Bjergaard, J	1
Archimbaud, E; Thomas, X	1
Campanini, E; Fogli, M; Fortuna, A; Lemoli, RM; Mangianti, S; Motta, MR; Ratta, M; Rizzi, S; Tura, S	1
Ikeda, K; Ikeda, T; Kawachi, Y; Kuwajima, Y; Mori, M; Nishihara, T; Sasaki, K; Setsu, K; Takahara, J; Uchida, T	1
Advani, SH; Chougule, A; Gladstone, B; Kadam, PR; Kapoor, G	1
Carriço, MK; Coelho, AM; Klumb, CE; Maia, RC; Noronha, H; Ruimanek, VM; Vasconcelos, FC	1
Crump, M; Dubé, I; Girouard, C; Imrie, KR; Keating, A; Prince, HM	1
Behm, FG; Boyett, JM; Evans, WE; Nemec, J; Pui, CH; Relling, MV; Yanishevski, Y	1
Diehl, V; Knöppel-Schwark, S; Lathan, B; Schwonzen, M; Staib, P; Steinmetz, HT; Tesch, H; Voliotis, D; Wickramanayake, PD	1
Asami, K; Eguchi, H; Hatae, Y; Hirota, T; Iwai, A; Katano, N; Koizumi, S; Kono, Y; Matusita, T; Miyawaki, T; Mugisima, H; Nakayama, M; Nisikawa, K; Osima, K; Sekine, I; Simokawa, T; Suzumiya, J; Tanaka, A; Tsuchiya, T; Tsurusawa, M; Utumi, J; Yamamoto, Y; Yamamura, Y; Yanase, T; Yokota, S	1
Adachi, M; Horiike, S; Huang, CL; Ieki, Y; Konaka, Y; Miyake, M; Onishi, R; Taki, T; Yagita, M	1
Ariyoshi, K; Kameda, N; Shinohara, K; Takeda, K	1
Alfaro, E; Casak, S; Cygler, A; Felice, MS; Fraquelli, L; Gallego, M; Pérez, LE; Quinteros, R; Sackmann-Muriel, F; Zubizarreta, P	1
Almqvist, A; Elonen, E; Hänninen, A; Jansson, SE; Järventie, G; Koistinen, P; Koivunen, E; Lahtinen, R; Lehtinen, M; Nousiainen, T; Pelliniemi, TT; Rajamäki, A; Remes, K; Ruutu, T; Timonen, T; Vilpo, J; Volin, L	1
Bréard, J; Dimanche-Boitrel, MT; Droin, N; Dubrez, L; Eymin, B; Renvoizé, C; Solary, E	1
Furukawa, Y; Kitani, T; Tsukaguchi, M	1
Fusaoka, T; Kataoka, A; Tunamoto, K; Wakazono, Y	1
Braess, J; Büchner, T; Fuchs, R; Grote-Metke, A; Hiddemann, W; Hossfeld, DK; Kern, W; Kuse, H; Reichle, A; Wörmann, B	1
Akan, H; Arat, M; Arslan, O; Beksaç, M; Gürman, G; Ilhan, O; Koç, H; Konuk, N; Ozcan, M; Uysal, A	1
Lehman, S; Löfgren, C; Möllgård, L; Paul, C; Sundman-Engberg, B; Tidefelt, U	1
Hara, T; Moriwaki, H; Oyama, M; Sawada, M; Tsurumi, H; Yamada, T	1
Gruber, A; Liliemark, E; Liliemark, J; Vitols, S; Wang, Y; Zhou, R	1
Kiss, I; Tomasek, J	1
Advani, R; Covelli, A; Davis, E; Dugan, K; Greenberg, P; Litchman, M; Lum, B; Milligan, D; Paietta, E; Ramek, J; Rowe, JM; Saba, H; Sikic, B; Tallman, M; Villena, J; Visani, G; Wiernik, PH	1
Filipits, M; Geissler, K; Jäger, U; Lechner, K; Pirker, R; Pohl, G; Scheper, RJ; Stranzl, T; Suchomel, RW	1
Frost, BM; Larsson, R; Liliemark, E; Lönnerholm, G; Nygren, P; Peterson, C	1
Elgie, AW; Sargent, JM; Taylor, CG; Williamson, CJ	1
Chimishkian, K; Gurova, K; Litvinova, E; Mentkevich, G	1
Behnisch, W; Göbel, U; Hilgenfeld, E; Schneider, DT; Schwabe, D; Wessalowski, R; Zoubek, A	1
Ahmed, T; Baskind, P; Beer, M; Chiao, JW; Feldman, E; Goff, H; Seiter, K; Stein, M	1
Alaruikka, P; Franklin, CC; Kavanagh, TJ; Kinnula, V; Koistinen, P; Krejsa, CM; Mäntymaa, P; Savolainen, ER; Siitonen, T	1
Koistinen, P; Mäntymaa, P; Säily, M; Savolainen, E; Siitonen, T	1
Bodalski, J; Bolanowski, W; Nowak, K; Stolarska, M; Zalewska-Szewczyk, B	1
Guttorm, T; Kinnula, V; Koistinen, P; Mäntymaa, P; Säily, M; Savolainen, ER; Siitonen, T	1
Choi, CH; Chung, MH; Jeong, JH; Kim, HS; Kim, MS; Kweon, OS; Lee, TB; Lim, DY; Min, YD; Rha, HS; You, HJ	1
Aloe Spiriti, MA; Betrò, P; Breccia, M; D'Elia, GM; Latagliata, R; Luzi, G; Montefusco, E; Petti, MC; Pulsoni, A; Spadea, A	1
Arceci, RJ; Brophy, N; Chang, M; Dahl, GV; Dunussi-Joannopoulos, K; Lacayo, NJ; Sikic, BI; Weinstein, HJ	1
Akiyama, Y; Eguchi, M; Hayashi, Y; Hosoi, G; Ishii, E; Kato, K; Koike, K; Kojima, S; Nishimura, S; Ohara, A; Okamura, J; Okimoto, Y; Sako, M; Sato, T; Tsukimoto, I; Ueda, K; Yazaki, M; Yoshikawa, T	1
Frost, BM; Gustafsson, G; Larsson, R; Lönnerholm, G; Nygren, P	1
Mori, M	1
Fowler, JM; Greer, BE; Horowitz, IR; McGuire, WP; Rodriguez, M; Rose, PG; Waggoner, S	1
Hatake, K; Kobayashi, T; Kuriyama, K; Minami, S; Miyawaki, S; Ohno, R; Omoto, E; Saito, K; Tamura, J; Tanimoto, M	1
Bruno, AP; d'Orgeix, AT; Laurent, G; Lautier, D; Quillet-Mary, A	1
Arnaout, MK; Behm, FG; Belt, JR; Crom, WR; Mirro, J; Radomski, KM; Raimondi, SC; Ribeiro, RC; Santana, VM; Srivastava, DK; Tong, X	1
Coppes, MJ; Gamis, A; Hagg, R; Kamani, N; Mustafa, MM; Sandler, ES; Wall, D	1
Archimbaud, E; Cambier, N; Ecstein-Fraïssé, E; Leblond, V; Pautas, C; Reman, O; Soler-Michel, P; Taksin, AL; Thomas, X; Vekhoff, A	1
Goh, YT; Hwang, YK; Linn, YC; Tan, CH; Tan, HC	1
Anami, K; Ayukawa, H; Eguchi, H; Hara, T; Ikuno, Y; Inada, H; Ishii, E; Matsuzaki, A; Miyazaki, S; Nibu, K; Okamura, J; Sugimoto, T; Yanai, F	1
Bilgrami, S; Bona, RD; Clive, J; Edwards, RL; Fox, J; Furlong, F; Kazierad, D; Naqvi, BH; Tutschka, PJ	1
Albertioni, F; Gruber, A; Liliemark, E; Liliemark, J; Lindemalm, S; Wang, Y; Zhou, R	1
Kelleher, JF; King, AK; Konefal, S; Monteleone, PM; Steele, DA	1
Boos, J; Creutzig, U; Feldges, A; Gadner, H; Hermann, J; Kühl, J; Niemeyer, CM; Ritter, J; Sawatzki, DB; Schwabe, D; Selle, B; Zimmermann, M	1
Bieri, S; Chapuis, B; Helg, C; Miralbell, R	1
Hoffman, B; Liebermann, DA; Zhang, W	1
Douglas, R; Michael, B; Nabil, S; Thomas, F	1
Chang, J; Covelli, A; Isidori, A; Kelsey, S; Leoni, F; Litchman, M; Malagola, M; Marcus, R; Mayer, H; Milligan, D; Pfister, C; Piccaluga, PP; Powles, R; Schey, S; Visani, G	1
Frostvik-Stolt, M; Liliemark, E; Zhou, R	1
Bohgaki, T; Kohno, M; Kondo, M; Mukai, M; Notoya, A	1
Arai, K; Fukayama, M; Imashuku, S; Ito, E; Kitazawa, J; Yokoyama, M	1
Behm, FG; Pritchard, M; Pui, CH; Raimondi, SC; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Srivastava, DK; Tong, X	1
Amadori, S; Archimbaud, E; Aul, C; Boogaerts, M; de Witte, T; Ferrant, A; Gratwohl, A; Hagemeijer, A; Jehn, U; Labar, B; Mandelli, F; Muus, P; Selleslag, D; Suciu, S; Verhoef, G; Wijermans, P; Willemze, R; Zittoun, R; Zwierzina, H	1
Koistinen, P; Mäntymaa, P; Savolainen, ER; Siitonen, T	1
Nishimura, S; Sato, T; Ueda, H; Ueda, K	1
Gotto, H; Hartmann, F; Jacobs, G; Pfreundschuh, M; Schwamborn, J	1
Gadner, H; Mann, G; Trebo, MM	1
Eguchi, M; Hayashi, Y; Hibi, S; Hongo, T; Imaizumi, M; Ishii, E; Isoyama, K; Kamada, N; Kawasaki, H; Kinukawa, N; Kosaka, Y; Mizutani, S; Nishimura, S; Oda, M; Oda, T; Okamura, T; Okawa, H; Tsukimoto, I	1
Creutzig, U; de Vries, E; Hählen, K; Huismans, DR; Janka-Schaub, GE; Jansen, G; Kaspers, GJ; Peters, GJ; Pieters, R; Rots, MG; van Zantwijk, CH; Veerman, AJ; Zwaan, CM	1
Case, D; Damon, LE; Linker, CA; Navarro, WA; Ries, CA; Wolf, JL	1
Cañete, A; Carvajal, E; Castel, V; Fernández, JM; Verdeguer, A	1
Arceci, RJ; Loeb, DM	1
Eggen, BJ; Kruijer, W; Schuringa, JJ; Vellenga, E; Wierenga, AT	1
Lichtenfeld, KM; Van Echo, DA; Wiernik, PH	1
Beckmann, C; Flury, R; Frei, P; Holdener, E; Jungi, WF; Senn, HJ	1
Brunner, KW; Cavalli, F; Sonntag, R	1
Alberto, P; Cavalli, F; Sauter, C; Senn, HJ	1
Crist, WM; Pui, CH; Raimondi, SC	1
Belt, J; Brenner, MK; Crom, W; Hurwitz, CA; Krance, R; Mahmoud, H; Ribeirio, R; Roberts, WM; Santana, VM; Schell, MJ	1
Camitta, BP; Clavell, LA; Gelber, RD; Grier, HE; Link, MP; Weistein, HJ	1
Chiba, S; Hanazono, Y; Hirai, H; Miura, Y; Miyagawa, K; Miyazono, K; Piao, YF; Sakamoto, S; Taketazu, F; Yazaki, Y	1
Mizoguchi, H; Saito, H	1
Alberto, P; Mermillod, B; Zulian, GB	1
Crump, M; Keating, A	1
Brinch, L; Evensen, SA; Stavem, P; Tjønnfjord, G	1
Belin, T; Champlin, R; Gajewski, J; Lee, M; Nimer, S; Schiller, G; Territo, M	1
Bocheńska, J; Glejzer, O; Jaźwiec, B; Klimczak, A; Kołodziej, J; Pacuszko, T; Sedzimirska, M; Tomaszewska-Toporska, B; Tomeczko, J; Was, A	1
Bishop, JF	2
Kimura, F; Mizukami, H; Motoyoshi, K; Nagata, N; Ohtsuki, T; Takagi, S; Takemura, Y; Yamamoto, K	1
Bordier, C; Bousquet, C; Chiron, M; Dastugue, N; Demur, C; Jaffrezou, JP; Laurent, G; Muller, C; Pierson, V; Saivin, S	1
Bajko, G; Drozdowska, D; Hansz, J; Woźny, T	1
Acaba, L; Atzpodien, J; Berman, E; Clarkson, B; Crown, J; Doherty, M; Gulati, S; Motzer, R; Reich, L; Yahalom, J	1
Grever, MR; Gumbart, CH; Head, D; Hynes, HE; Kopecky, KJ; Lipschitz, DA; Ryan, DH; Shiaer, SM; Veith, RW; Vial, RH	1
Masauji, N; Matsue, K; Tohi, T; Tsukuda, K	1
Amadori, S; Avvisati, G; Cacciola, E; Cantore, N; De Laurenzi, A; De Rosa, C; Fioritoni, G; Mandelli, F; Spadea, A; Vegna, ML	1
Ambros, P; Emminger, W; Emminger-Schmidmeier, W; Ferstl, G; Fink, FM; Haas, OA; Höcker, P; Mann, G; Peters, C; Urban, C	1
Gray, RG; Rees, JK	1
Buckley, JD; Hammond, GD; Lampkin, BC; Woods, WG	1
Andoh, T; Ito, Y; Kawashima, K; Morishima, Y; Morishita, Y; Saito, H; Tanimoto, M; Towatari, M	1
Buckley, JD; Hammond, GD; Miller, LP; Pyesmany, AF; Rogers, PC; Siegel, SE; Wells, RJ; Wolff, LJ	1
Camitta, B; Holbrook, T; Krischer, J; Land, VJ; Sexauer, C; Steuber, CP	1
Challis, J; Farag, S; Garson, OM; White, J	1
Mandelli, F; Meloni, G	1
Bastida Vila, P; Giralt López, J; Javier Manchón, G; Olivé Oliveras, T; Ortega Aramburu, JJ; Sánchez, C	1
Beran, M; Estey, E; Kantarjian, H; Keating, M; Koller, C; McCredie, K; O'Brien, S	1
De Fabritiis, P; Mandelli, F; Meloni, G; Petti, MC; Pinto, MR; Testi, AM; Vegna, ML; Vignetti, M	1
Kashiwaba, M; Koyama, S; Saitou, H	1
Butturini, A; Gale, RP; Reizenstein, P	1
Dölken, G; Fauser, AA; Herbst, EW; Kreisel, W	1
Ishida, Y; Matusda, H; Tauchi, H; Yokota, Y	1
Baccarani, M; Cenacchi, A; Damiani, D; Fanin, R; Fogli, M; Gamberi, B; Revignas, G; Russo, D; Tura, S; Visani, G	1
Ho, AD; Hunstein, W; Knauf, WU; Körbling, M	1
Brado, B; Haas, R; Ho, AD; Hunstein, W	1
Bishop, JF; Cooper, IA; Joshua, D; Lowethal, R; Matthews, JP; Wolf, MM	1
Bishop, M; Marks, L; Schulz, WC; Stiff, PJ	1
Brodsky, I; Bulova, S; Conroy, J; Crilley, P; Gryn, J; Kahn, SB; Topolsky, D; Weiss, J	1
Clarkson, BD; Gasparetto, C; Gulati, SC; Lemoli, RM; Moore, MA; Scheinberg, DA	1
Archimbaud, E; Cordonnier, C; Devaux, Y; Dreyfus, F; Fenaux, P; Fiere, D; Jaubert, J; Leblond, V; Michallet, M; Travade, P	1
Bandini, G; Barbui, T; Bassan, R; Battista, R; Ciolli, S; D'Emilio, E; Leoni, F; Rosti, G; Todeschini, G; Zuffa, E	1
Mansberg, R; Rowlings, PA; Rozenberg, MC; Yip, MY	1
Clarkson, BD; Gee, T; Gulati, SC; Whitmarsh, K; Yahalom, J	1
Amadori, S; Arcese, W; Isacchi, G; Mandelli, F; Meloni, G; Monarca, B; Petti, MC; Testi, AM	1
Boesen, AM; Brincker, H; Christensen, BE; Drivsholm, A; Ellegaard, J; Hansen, OP; Hippe, E; Jans, H; Jensen, KB; Pedersen-Bjergaard, J	1
Creutzig, U; Ritter, I; Schellong, G	1
Ciolli, S; Leoni, F; Morfini, M; Patriarchi, S; Rossi Ferrini, P	1
Bostrom, B; Kersey, JH; Kim, T; Ramsay, NK; Weisdorf, DJ	1
Creger, RJ; Fox, RM; Lazarus, HM	1
Brenez, D; Devriendt, J; Lenclud, C; Schmerber, J	1
Creutzig, U; Ritter, J; Schellong, G	3
Ausserer, B; Fink, FM; Gadner, H; Grümayer, ER; Kardos, G; Mutz, I; Revesz, T; Schuler, D; Urban, C	1
Broccia, G; Caronia, F; Di Raimondo, F; Fioritoni, G; Ladogana, S; Leone, G; Liso, V; Musso, M; Neri, A; Petti, MC	1
Ehninger, G; Fackler-Schwalbe, E; Freund, M; Heil, G; Hoelzer, D; Kurrle, E; Link, H; Löffler, B; Lösch, A; Mitrou, PS	1
Ehninger, G; Fackler-Schwalbe, E; Freund, M; Heil, G; Henke, M; Hoelzer, D; Hoffmann, R; Kurrle, E; Link, H; Lösch, A	1
Austein, J; Diedrich, H; Fackler-Schwalbe, E; Freund, M; Henke, M; Hoffmann, R; Link, H; Schlimok, G; Wandt, H; Wilke, H	1
Andersen, J; Bennett, JM; Cassileth, PA; Hines, JD; Mazza, JJ; Oken, MM; Rowe, JM	1
Björkholm, M	1
Jacobs, P; Martell, RW; Wilson, EL	1
Benjamin, DR; Bernstein, ID; Buckley, JD; Feig, SA; Kim, TH; Lampkin, BC; Ruymann, FB; Smithson, WA; Srivastava, AK; Woods, WG	1
Chan, TK; Chiu, E; Liang, R; Todd, D	1
Akiyama, Y; Ito, M; Kamiya, H; Kawa, K; Mikawa, H; Miyazaki, S; Sakurai, M; Tujino, G; Ueda, K	1
Davis, RB; Holland, JF; Martelo, O; Paciucci, PA; Schiffer, CA	1
Gore, M; Helenglass, G; Milan, S; Parikh, P; Pinkerton, R; Powles, R; Rose, M; Smith, C; Talbot, D; Treleaven, J	1
Itou, S; Koyama, S; Shibata, A	1
Deconinck, E; Hervé, P; Tamayo, E	1
Lee, EJ; Reck, K; Schiffer, CA	1
Björkholm, M; Björnsdottir, J; Grimfors, G; Stenke, L	1
Briere, J; Casassus, P; Desablens, B; Gandhour, C; Harousseau, JL; Ifrah, N; Le Prise, PY; Milpied, N	1
Havemann, K; Koeppler, H; Pflueger, KH; Weide, R; Wolf, M	1
Choi, KE; Daley, KM; Kaminer, LS; Larson, RA	1
De Fabritiis, P; Mandelli, F; Meloni, G; Petti, MC	1
Dicke, KA; Estey, E; Horwitz, LJ; Jagannath, S; Kantarjian, H; Keating, M; McCredie, K; Spinolo, JA; Spitzer, G; Zander, AR	1
Bishop, JF; Cobcroft, R; Dodds, A; Joshua, D; Kronenberg, H; Lowenthal, RM; Ma, D; Matthews, JP; Todd, D; Whiteside, MG	1
Catovsky, D; Chessells, JM; Galton, DA; Goldman, JM; Hann, IM; Hoffbrand, AV; Marcus, RE; Newland, AC; Prentice, HG; Stevens, RF	1
Gray, R; Hayhoe, FG; Rees, JK	1
Helbig, W; Hofmann, U; Schulze, E; Woetzel, M	1
Kyo, T; Maehama, S	1
Alessandrino, EP; Bernasconi, C; Bernasconi, P; Bonfichi, M; Inverardi, D; Lazzarino, M; Merante, S; Morra, E; Orlandi, E; Pagnucco, G	1
Wahlin, A	1
Bennett, JM; Chang, AY; Rowe, JM	2
Bernhart, M; Fiedler, E; Kasparu, H; Krieger, O; Lutz, D; Weber, E	1
Berman, E; Clarkson, B; Cunningham, I; Flomenberg, N; Gee, T; Gulati, SC; O'Reilly, RJ; Sarris, A; Shank, B	1
Alessandrino, EP; Bernasconi, C; Bernasconi, P; Bonfichi, M; Caldera, D; Lazzarino, M; Merante, S; Morra, E	1
Amadori, S; De Fabritiis, P; Mandelli, F; Meloni, G; Petti, MC; Pulsoni, A; Sandrelli, A	1
Bernasconi, C	1
Forgeson, G; Gore, M; Goss, G; Lakhani, A; Maitland, J; Milan, S; Nandi, A; Perren, T; Powles, R; Treleaven, J	1
Appelt, M; Leuschner, S; Rister, M; Schaub, J; Schmitz, N; Suttorp, M	1
Carella, AM; Cerri, R; Giordano, D; Nati, S; Piatti, G; Pungolino, E; Risso, M	1
Akiyama, Y; Kubota, M; Mikawa, H; Tabata, Y; Yoshigi, M	1
Akagi, K; Asou, N; Goto, J; Hamasaki, N; Hidaka, M; Kawano, F; Kurisaki, H; Sawatari, T; Suzushima, H; Takatsuki, K	1
Delforge, A; Lagneaux, L; Marie, JP; Socquet, M; Stryckmans, P; Thevenin, D; Zittoun, R	1
Kaufmann, SH	1
Bakic, M; Chan, D; Freireich, EJ; Marton, LJ; Zwelling, LA	1
Glatte, P; Osieka, R; Pannenbäcker, R; Schmidt, CG; Seeber, S; Soll, D	1
Brix, F; Gassmann, W; Heit, W; Hertenstein, B; Holthuis, JJ; Johannson, W; Rister, M; Schaub, J; Schmitz, N; Suttorp, M	1
Brodowski, L; Drzewoski, J; Hołub, A; Krykowski, E; Matusewicz, W; Robak, T	1
Booth, F; Littlewood, TJ; Lydon, AP	1
Carter, C; Winfield, DA	1
Ehninger, G; Freund, M; Heil, G; Hoelzer, D; Kurrle, E; Link, H; Mitrou, PS; Ohl, S; Queisser, W; Schlimok, G	1
Ehninger, G; Freund, M; Ho, AD; Illiger, HJ; Körbling, M; Lipp, T; Meyer, P	1
Fink, FM; Gadner, H; Grümayer, ER; Kardos, G; Revesz, T; Schuler, D	2
Budde, M; Creutzig, U; Riehm, H; Ritter, J; Schellong, G	1
Dahl, GV; Kalwinsky, DK; Look, AT; Mirro, J	1
Linch, DC; Singer, CR	1
Covelli, A; De Fabritiis, P; Mandelli, F; Meloni, G; Petti, MC; Pulsoni, A; Sandrelli, A; Simone, F	1
Ehninger, G; Freund, M; Ho, AD; Hunstein, W; Illiger, HJ; Lipp, T; Meyer, P	1
Cavalli, F; Fopp, M; Gratwohl, A; Maurice, P; Sauter, C; Tschopp, L; von Fliedner, VE	1
Ehninger, G; Freund, M; Ho, AD; Hunstein, W; Lipp, T; Meyer, P	1
Beck, JD	1
Chang, TT; Chou, TC; Clarkson, B; Colvin, M; Gulati, S	1
Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Kohsaki, M; Masaoka, T; Nagai, K; Shibata, H; Tagawa, S; Tsubaki, K	1
Child, JA; Franks, CR; Norfolk, DR; Nys, G	1
Baba, N; Karasawa, M; Miyawaki, S; Nakura, M; Nemoto, K; Takada, M; Tanaka, H; Uchida, S; Wakamatsu, R; Yashiro, K	1
Gray, R; Rees, JK	1
Fülle, HH; Hellriegel, KP	2
Berthold, F; Creutzig, U; Lampert, F	1
Amadori, S; Ceci, A; Comelli, A; Covelli, A; Madon, E; Mandelli, F; Masera, G; Nespoli, L; Paolucci, G; Zanesco, L	1
Chan, KM; Kessler, G; Matheke, ML	1
Islam, A	1
de Bruïne, FT; Peters, WG; Tham, RT; Willemze, R	1
Ehninger, G; Freund, M; Heil, G; Hoelzer, D; Kurrle, E; Link, H; Mitrou, PS	1
Ehninger, G; Ho, AD; Kaboth, W; Körbling, M; Lipp, T; Meyer, P; Rückle, H; Steinke, B	1
Gassmann, W; Kayser, W; Löffler, H; Schmitz, N	1
Apostol, JV; Kucuk, O	1
Lutz, D	1
Chang, TT; Chou, TC; Clarkson, BD; Colvin, M; Gandola, L; Gulati, SC; Ibrahim, SM; Vega, R; Yopp, J	1
Achterrath, W; Balleisen, L; Büchner, T; Hiddemann, W; Preusser, P; Urbanitz, D	1
Brix, F; Dühmke, E; Euler, HH; Gassmann, W; Gremmel, H; Hebbinghaus, D; Kayser, W; Schaub, J; Schmitz, N; Wüstemann, M	1

Reviews

43 review(s) available for etoposide and Acute Myelogenous Leukemia

Article	Year
Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state. American journal of hematology, 2017, Volume: 92, Issue:9 Topics: Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cladribine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Transplantation Conditioning; Treatment Outcome; Young Adult	2017
Development of a curative treatment within the AML-BFM studies. Klinische Padiatrie, 2013, Volume: 225 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Methotrexate; Multicenter Studies as Topic; Prednisone; Randomized Controlled Trials as Topic; Survival Rate; Thioguanine; Vincristine	2013
[Current therapy for acute myeloid leukemia and acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Discovery; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Molecular Targeted Therapy; Mutation; Recurrence; Tretinoin; Vincristine	2014
A role for epigenetics in the formation of chromosome translocations in acute leukemia. Cancer genetics, 2015, Volume: 208, Issue:5 Topics: Chromatin Assembly and Disassembly; Daunorubicin; DNA Breaks, Double-Stranded; Epigenesis, Genetic; Etoposide; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Translocation, Genetic	2015
Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia. Blood reviews, 2016, Volume: 30, Issue:1 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Biomarkers, Pharmacological; Biotransformation; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Leukemia, Myeloid, Acute; Precision Medicine; Prodrugs	2016
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia. The pharmacogenomics journal, 2016, Volume: 16, Issue:1 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Etoposide; Genetic Association Studies; Humans; Leukemia, Myeloid, Acute; Observational Studies as Topic; Polymorphism, Single Nucleotide; Survival Analysis; WT1 Proteins	2016
Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature. BMC pediatrics, 2016, 07-29, Volume: 16 Topics: Epstein-Barr Virus Infections; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Topoisomerase II Inhibitors	2016
Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia. Clinical pharmacology and therapeutics, 2008, Volume: 84, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Case-Control Studies; Child; Child, Preschool; Drug Hypersensitivity; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Reference Values; Risk Assessment	2008
[Progress in the molecular analysis of infant leukemias]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:10 Topics: Enzyme Inhibitors; Etoposide; Female; Gene Rearrangement; Genetic Predisposition to Disease; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myeloid, Acute; Male; Maternal Exposure; MicroRNAs; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Topoisomerase II Inhibitors	2009
Relapse of acute myeloid leukemia at the pituitary gland: a case report and review of literature. Endocrine pathology, 2012, Volume: 23, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Diabetes Insipidus; Etoposide; Female; Humans; Hypopituitarism; Idarubicin; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Methotrexate; Pituitary Neoplasms; Radiotherapy; Recurrence; Remission Induction; Vision Disorders	2012
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies. Journal of the National Cancer Institute, 2012, Jul-18, Volume: 104, Issue:14 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophosphamide; Dacarbazine; Disseminated Intravascular Coagulation; Doxorubicin; Etoposide; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Prednisone; Procarbazine; Purpura, Thrombocytopenic, Idiopathic; Randomized Controlled Trials as Topic; Receptors, Thrombopoietin; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Viral Vaccines	2012
Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. International journal of environmental research and public health, 2012, Volume: 9, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Etoposide; Humans; Leukemia, Myeloid, Acute; Topoisomerase II Inhibitors	2012
High-dose etoposide in allogeneic stem cell transplantation. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:6 Topics: Adenine Nucleotides; Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Busulfan; Carboplatin; Carmustine; Clinical Trials as Topic; Clofarabine; Cyclophosphamide; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Leukemia; Leukemia, Myeloid, Acute; Lomustine; Mucositis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy, Adjuvant; Severity of Illness Index; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2012
Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius--a pathogen or passenger? Annals of hematology, 2004, Volume: 83, Issue:7 Topics: Actinomycetales; Actinomycetales Infections; Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Translocation; Cefepime; Cephalosporins; Clostridium Infections; Colistin; Cytarabine; Daunorubicin; Drug Therapy, Combination; Etoposide; Fatal Outcome; Hemoptysis; Humans; Hydroxyurea; Immunocompromised Host; Intestinal Mucosa; Leukemia, Myeloid, Acute; Male; Metronidazole; Middle Aged; Neutropenia; Pneumonia, Bacterial; Superinfection; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination	2004
Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2). American journal of hematology, 2005, Volume: 79, Issue:2 Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 5; Cytarabine; Cytogenetic Analysis; Etoposide; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Monosomy; Myelodysplastic Syndromes	2005
Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome. Leukemia & lymphoma, 2005, Volume: 46, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; DNA Helicases; Etoposide; Exodeoxyribonucleases; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; RecQ Helicases; Werner Syndrome; Werner Syndrome Helicase	2005
Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions. DNA repair, 2006, Sep-08, Volume: 5, Issue:9-10 Topics: Antineoplastic Agents, Phytogenic; Chromosome Breakage; Chromosomes, Human, Pair 11; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; Etoposide; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Models, Genetic; Myeloid-Lymphoid Leukemia Protein; Sensitivity and Specificity; Topoisomerase II Inhibitors	2006
Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literature. Annals of hematology, 2008, Volume: 87, Issue:3 Topics: Adult; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 21; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Iodide Peroxidase; Leukemia, Myeloid, Acute; Peroxidase; Propylthiouracil; Remission Induction; Time Factors; Translocation, Genetic; Transplantation, Homologous	2008
Treatment of relapsed acute myeloid leukaemia. Reviews on recent clinical trials, 2006, Volume: 1, Issue:2 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colony-Stimulating Factors; Cytarabine; Etoposide; Humans; Immunity, Innate; Immunologic Factors; Leukemia, Myeloid, Acute; Mitoxantrone; Randomized Controlled Trials as Topic; Secondary Prevention	2006
Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases. Blood, 1995, Nov-01, Volume: 86, Issue:9 Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Lineage; Child; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Mitoxantrone; Neoplasms, Second Primary; Oncogenes; Topoisomerase II Inhibitors; Translocation, Genetic	1995
rHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia. Stem cells (Dayton, Ohio), 1995, Volume: 13, Issue:2 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins	1995
Toxic megacolon complicating chemotherapy for acute myeloid leukaemia. Postgraduate medical journal, 1994, Volume: 70, Issue:830 Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Megacolon, Toxic	1994
Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia. British journal of haematology, 1994, Volume: 86, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cyclophosphamide; Etoposide; Humans; Karyotyping; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Male; Neoplasms, Second Primary; Translocation, Genetic	1994
Etoposide: current status and future perspectives in the management of malignant neoplasms. Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Germinoma; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Sarcoma, Kaposi; Stomach Neoplasms	1994
Pharmacodynamics and long-term toxicity of etoposide. Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl Topics: Child; Etoposide; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Neoplasms; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testicular Neoplasms	1994
Epipodophyllotoxins in the treatment of childhood cancer. Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide	1994
Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers. Leukemia & lymphoma, 1993, Volume: 9, Issue:4-5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneuploidy; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosome Aberrations; Cytarabine; DNA Nucleotidylexotransferase; Etoposide; Female; Gene Rearrangement; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Philadelphia Chromosome; Remission Induction; Vindesine	1993
[A case of secondary leukemia in anaplastic seminoma patient treated with long-term chemotherapy]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1996, Volume: 87, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin; Seminoma; Testicular Neoplasms	1996
[Chemotherapy of relapsed AML and ALL]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Recurrence; Remission Induction; Vinblastine	1996
[Three cases of secondary acute myeloid leukemia after long-term treatment with oral etoposide]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:11 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Second Primary	1996
Mitoxantrone in the treatment of acute myelogenous leukemia: a review. Hematology and cell therapy, 1997, Volume: 39, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Genes, MDR; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Randomized Controlled Trials as Topic	1997
[Acute myelogenous leukemia in elderly patients]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2000, Volume: 37, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Prognosis; Quality of Life; Remission Induction	2000
Bilateral breast relapse in acute myelogenous leukemia. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Breast; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Graft vs Host Disease; Humans; Idarubicin; Immunologic Factors; Interleukin-2; Leukemia, Myeloid, Acute; Leukemic Infiltration; Radiotherapy, High-Energy; Recurrence; Salvage Therapy; Thioguanine; Transplantation Conditioning; Vidarabine	2001
[Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results]. Acta haematologica Polonica, 1992, Volume: 23, Issue:2 Suppl 1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Etoposide; Graft Enhancement, Immunologic; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Transplantation, Homologous	1992
Etoposide in the treatment of leukemias. Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 13 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Etoposide; Humans; Leukemia, Myeloid, Acute	1992
Autotransplants in leukemia: current state, future progress. Leukemia research, 1991, Volume: 15, Issue:9 Topics: Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous; Twins, Monozygotic	1991
Etoposide in acute leukemia. Past experience and future perspectives. Cancer, 1991, Jan-01, Volume: 67, Issue:1 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1991
Etoposide in leukemia. Cancer, 1991, Jan-01, Volume: 67, Issue:1 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute	1991
Etoposide in the management of leukemia: a review. Seminars in oncology, 1991, Volume: 18, Issue:1 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Survival Rate	1991
Etoposide and teniposide in the treatment of acute leukemia. Medical oncology and tumor pharmacotherapy, 1990, Volume: 7, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide	1990
Treatment of relapsed and refractory acute myeloid leukemia in adults. Bone marrow transplantation, 1989, Volume: 4 Suppl 1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Mitoxantrone; Remission Induction	1989
Etoposide: fifteen years experience. Bone marrow transplantation, 1989, Volume: 4 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lomustine; Melphalan; Mitoxantrone	1989
[Ultrahigh-dosage cytostatics--their possible use in acute leukemias?]. Deutsche medizinische Wochenschrift (1946), 1987, Jan-09, Volume: 112, Issue:2 Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Melphalan; Recurrence	1987

Trials

197 trial(s) available for etoposide and Acute Myelogenous Leukemia

Article	Year
Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia. Blood, 2022, 02-24, Volume: 139, Issue:8 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Glycolipids; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Survival Rate	2022
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial. Haematologica, 2023, 01-01, Volume: 108, Issue:1 Topics: Adult; Clinical Trials as Topic; Dexamethasone; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Pilot Projects	2023
Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy. American journal of hematology, 2020, Volume: 95, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cytarabine; Etoposide; Female; Humans; Induction Chemotherapy; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitochondria; Mitoxantrone	2020
Gemtuzumab Ozogamicin in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 02-20, Volume: 38, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Cytarabine; Etoposide; Female; Gemtuzumab; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin; Progression-Free Survival; Prospective Studies; Tretinoin; Young Adult	2020
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia. Cancer, 2020, 03-15, Volume: 126, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Immunoconjugates; Induction Chemotherapy; Ki-1 Antigen; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Recurrence; Young Adult	2020
Efficacy and Safety of Metronomic Chemotherapy Versus Palliative Hydroxyurea in Unfit Acute Myeloid Leukemia Patients: A Multicenter, Open-Label Randomized Controlled Trial. Asian Pacific journal of cancer prevention : APJCP, 2020, Jan-01, Volume: 21, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone; Prognosis; Survival Rate	2020
Outpatient ADE (cytarabine, daunorubicin, and etoposide) is feasible and effective for the first relapse of pediatric acute myeloid leukemia: A prospective, phase II study. Pediatric blood & cancer, 2020, Volume: 67, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Prospective Studies; Recurrence; Survival Rate	2020
The combination of clofarabine, etoposide, and cyclophosphamide shows limited efficacy as a bridge to transplant for children with refractory acute leukemia: results of a monitored prospective study. Pediatric hematology and oncology, 2021, Volume: 38, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Treatment Outcome; Young Adult	2021
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 03-10, Volume: 39, Issue:8 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nucleophosmin; Prognosis; Survival Rate; Young Adult	2021
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Co Pediatric blood & cancer, 2017, Volume: 64, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Child; Child, Preschool; Cyclams; Cytarabine; Etoposide; Female; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, CXCR4; Treatment Outcome; Young Adult	2017
Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study. Leukemia, 2017, Volume: 31, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biomarkers; Cytarabine; Decitabine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Grading; Recurrence; Treatment Outcome; Young Adult	2017
Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials. Cancer, 2017, Oct-01, Volume: 123, Issue:19 Topics: Adolescent; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cladribine; Clinical Protocols; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplasm, Residual; Recurrence; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Young Adult	2017
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML. Clinical epigenetics, 2017, Volume: 9 Topics: Adolescent; Azacitidine; Child; Child, Preschool; Cytarabine; Daunorubicin; Decitabine; DNA Methylation; Epigenesis, Genetic; Etoposide; Female; Humans; Induction Chemotherapy; Infant; Leukemia, Myeloid, Acute; Male; Promoter Regions, Genetic; Treatment Outcome	2017
Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia. Pediatric hematology and oncology, 2017, Volume: 34, Issue:4 Topics: Adenine Nucleotides; Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Survival Rate	2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia. American journal of hematology, 2018, Volume: 93, Issue:2 Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Lenalidomide; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Mitoxantrone; Remission Induction; Salvage Therapy; Survival Analysis	2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition. Investigational new drugs, 2018, Volume: 36, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Mechanistic Target of Rapamycin Complex 1; Middle Aged; Mitoxantrone; Phosphorylation; Pilot Projects; Remission Induction; Signal Transduction; Sirolimus	2018
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease. American journal of hematology, 2019, Volume: 94, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Flavonoids; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Piperidines; Recurrence; Remission Induction; Salvage Therapy; Sirolimus; Topotecan; Tumor Lysis Syndrome	2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine. Leukemia, 2019, Volume: 33, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Etoposide; Female; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Nucleophosmin; Prospective Studies; Young Adult	2019
A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 07-15, Volume: 25, Issue:14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boron Compounds; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Glycine; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Patient Safety; Remission Induction; Salvage Therapy; Treatment Outcome	2019
Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 08-10, Volume: 37, Issue:23 Topics: Adolescent; Adult; Anthracyclines; Child; Child, Preschool; Clofarabine; Etoposide; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Remission Induction; Young Adult	2019
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Apr-01, Volume: 19, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cytarabine; Etoposide; Female; Gene Expression Regulation, Leukemic; Humans; Hydroxamic Acids; Karyotype; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Proteins; Recurrence; Translational Research, Biomedical; Treatment Outcome; Tumor Necrosis Factor Decoy Receptors; Vorinostat; Young Adult	2013
Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study. Leukemia & lymphoma, 2013, Volume: 54, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Pravastatin; Treatment Outcome	2013
Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: a multicenter, randomized control trial in southwest China. Leukemia research, 2013, Volume: 37, Issue:6 Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; China; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Treatment Failure; Treatment Outcome; Young Adult	2013
Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia. Cancer, 2013, Nov-15, Volume: 119, Issue:22 Topics: Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm, Residual; Survival Analysis; Treatment Outcome	2013
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jan-20, Volume: 32, Issue:3 Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Europe; Female; Humans; Induction Chemotherapy; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Risk Assessment; Risk Factors; Treatment Outcome	2014
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808. Cancer, 2014, Apr-01, Volume: 120, Issue:7 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclosporins; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Interleukin-2; Leukemia, Myeloid, Acute; Male; Middle Aged; Recombinant Proteins; Remission Induction; Survival Rate; Treatment Outcome	2014
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents. Annals of hematology, 2014, Volume: 93, Issue:8 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Consolidation Chemotherapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Neoplasm, Residual; Prognosis; Proportional Hazards Models; Remission Induction; Risk; Survival Analysis; Topotecan; Transplantation, Autologous; Treatment Outcome; Vidarabine	2014
Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation. International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Blast Crisis; Bone Marrow; Busulfan; Child; Cyclophosphamide; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphatic Irradiation; Melphalan; Middle Aged; Myelodysplastic Syndromes; Organ Sparing Treatments; Organs at Risk; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Radiotherapy Dosage; Recurrence; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Young Adult	2014
[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Remission Induction	2014
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group. Pediatric blood & cancer, 2014, Volume: 61, Issue:10 Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Pyrazines; Rabbits; Salvage Therapy; Treatment Outcome; Young Adult	2014
Phase I/II study of clofarabine, etoposide, and mitoxantrone in patients with refractory or relapsed acute leukemia. Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:1 Topics: Adenine Nucleotides; Adult; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Recurrence; Remission Induction; Treatment Outcome	2015
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia. British journal of haematology, 2014, Volume: 167, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Fibroblast Growth Factor 7; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Stomatitis	2014
Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML. Cancer, 2015, Jan-15, Volume: 121, Issue:2 Topics: Adult; Aged; Aminoglycosides; Amsacrine; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Gemtuzumab; Humans; Injections; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Risk Assessment; Salvage Therapy; Treatment Outcome; Vidarabine	2015
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia. American journal of hematology, 2015, Volume: 90, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm, Residual; Recurrence; Remission Induction; Survival Analysis	2015
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia. Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:6 Topics: Administration, Intravesical; Adult; Area Under Curve; Busulfan; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Mucositis; Myeloablative Agonists; Recurrence; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2015
Family History and Relapse in Pediatric Acute Myeloid Leukemia. Pediatric blood & cancer, 2015, Volume: 62, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Recurrence; Survival Rate	2015
Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004. Pediatric blood & cancer, 2016, Volume: 63, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Down Syndrome; Etoposide; Female; Humans; Idarubicin; Infant; Infections; Leukemia, Myeloid, Acute; Male; Mitoxantrone	2016
A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia. Blood cancer journal, 2017, 03-10, Volume: 7, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Benzylamines; Cyclams; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Stem Cell Transplantation	2017
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia. American journal of hematology, 2008, Volume: 83, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cohort Studies; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction	2008
Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia. Leukemia research, 2009, Volume: 33, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome	2009
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-ris International journal of radiation oncology, biology, physics, 2009, Mar-01, Volume: 73, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Estramustine; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Paclitaxel; Prostatic Neoplasms; Thromboembolism	2009
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype. Leukemia & lymphoma, 2008, Volume: 49, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid, Acute; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome	2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide. Blood, 2009, May-14, Volume: 113, Issue:20 Topics: Administration, Oral; Age of Onset; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Etoposide; Farnesyltranstransferase; HL-60 Cells; Humans; Jurkat Cells; Leukemia, Myeloid, Acute; Quinolones; Tumor Cells, Cultured; U937 Cells	2009
Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia. Anti-cancer drugs, 2009, Volume: 20, Issue:1 Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Down Syndrome; Doxorubicin; Drug Administration Schedule; Drug Monitoring; Erythrocytes; Etoposide; Female; Guanine Nucleotides; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Registries; Scandinavian and Nordic Countries; Thioguanine; Thionucleotides; Treatment Outcome	2009
Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy. Chinese journal of integrative medicine, 2009, Volume: 15, Issue:3 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberrations; Cytarabine; Daunorubicin; Drugs, Chinese Herbal; Etoposide; Female; Humans; Immunophenotyping; Integrative Medicine; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Treatment Outcome; Young Adult	2009
FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience. American journal of hematology, 2009, Volume: 84, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Pilot Projects; Remission Induction; Vidarabine; Young Adult	2009
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia, 2009, Volume: 23, Issue:12 Topics: Acute Disease; Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Treatment Outcome; Young Adult	2009
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Nov-01, Volume: 15, Issue:21 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Protein Kinases; Recurrence; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2009
Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-01, Volume: 28, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prognosis; Remission Induction; Survival Rate; Thioguanine; Treatment Outcome; Tretinoin; Young Adult	2010
Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group. Pediatric blood & cancer, 2010, Volume: 54, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Child, Preschool; Cyclosporins; Drug Resistance, Multiple; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Young Adult	2010
Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jun-01, Volume: 28, Issue:16 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Combined Modality Therapy; Confidence Intervals; Cytarabine; Cytogenetic Analysis; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Male; Probability; Proportional Hazards Models; Radiotherapy, Adjuvant; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Treatment Outcome	2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. The Lancet. Oncology, 2010, Volume: 11, Issue:6 Topics: Adolescent; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Cytogenetic Analysis; Daunorubicin; Disease-Free Survival; Etoposide; Female; Flow Cytometry; Gemtuzumab; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Neoplasm, Residual; Remission Induction; Survival Rate; Young Adult	2010
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808. Blood, 2010, Sep-02, Volume: 116, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome; Young Adult	2010
Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study. Cancer, 2010, Nov-15, Volume: 116, Issue:22 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Thioguanine	2010
Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy. Annals of hematology, 2011, Volume: 90, Issue:6 Topics: Adult; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Drug Recalls; Drug Resistance, Neoplasm; Etoposide; Female; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Withholding Treatment	2011
Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia. Pharmacological reports : PR, 2011, Volume: 63, Issue:1 Topics: Acetylation; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytochrome P-450 CYP2D6; Daunorubicin; Drug Interactions; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Oxidation-Reduction; Phenotype; Young Adult	2011
Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial. British journal of haematology, 2011, Volume: 155, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Induction Chemotherapy; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Prognosis; Survival Analysis; Thioguanine; Treatment Outcome	2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood, 2011, Dec-01, Volume: 118, Issue:23 Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Prognosis; Prospective Studies; Remission Induction; Transplantation, Autologous; Treatment Outcome; Young Adult	2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia. Blood, 2012, Jan-05, Volume: 119, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; DNA-Binding Proteins; Etoposide; Female; Follow-Up Studies; Guanine Nucleotide Exchange Factors; Humans; Leukemia, Myeloid, Acute; Male; Nuclear Proteins; Pharmacogenetics; Prognosis; Quinolones; Remission Induction; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate	2012
Single-cell pharmacodynamic monitoring of S6 ribosomal protein phosphorylation in AML blasts during a clinical trial combining the mTOR inhibitor sirolimus and intensive chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Mar-15, Volume: 18, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Phosphorylation; Pilot Projects; Ribosomal Protein S6; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2012
Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Chromatography, High Pressure Liquid; Creatinine; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Prospective Studies; Tissue Distribution; Young Adult	2012
A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia. Anticancer research, 2012, Volume: 32, Issue:2 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prospective Studies; Remission Induction; Vinblastine; Vincristine; Young Adult	2012
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood, 2012, Apr-26, Volume: 119, Issue:17 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cyclams; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Receptors, CXCR4; Remission Induction; Salvage Therapy; Survival Rate; Young Adult	2012
Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation. International journal of radiation oncology, biology, physics, 2013, Jan-01, Volume: 85, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Liver; Male; Middle Aged; Organs at Risk; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Recurrence; Stomatitis; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult	2013
Treatment outcome in older patients with childhood acute myeloid leukemia. Cancer, 2012, Dec-15, Volume: 118, Issue:24 Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Transplantation, Autologous; Young Adult	2012
Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report. Leukemia, 2013, Volume: 27, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Etoposide; Exons; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Mutation; Neoplasm Staging; Prognosis; Survival Rate	2013
Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group. Haematologica, 2012, Volume: 97, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Leukocytosis; Male; Survival Rate	2012
Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Cell Count; Bone Marrow Cells; Comorbidity; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Hemoglobins; Humans; Immunophenotyping; Kaplan-Meier Estimate; Karyotyping; Kidney Function Tests; Leukemia, Myeloid, Acute; Liver Function Tests; Logistic Models; Male; Middle Aged; Prognosis; Remission Induction; Risk Factors; Treatment Outcome	2012
Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy. International journal of hematology, 2012, Volume: 96, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Cytarabine; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Karyotype; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Recurrence; Remission Induction; Salvage Therapy; Vidarabine	2012
High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission. Leukemia research, 2013, Volume: 37, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Retrospective Studies; Risk Factors; Survival Rate	2013
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720. Blood, 2002, Aug-15, Volume: 100, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclosporins; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Logistic Models; Male; Middle Aged; Remission Induction	2002
Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Oct-15, Volume: 20, Issue:20 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Bone Marrow; Child; Child, Preschool; Cladribine; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Remission Induction	2002
Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide. Leukemia research, 2003, Volume: 27, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Tretinoin	2003
A homoharringtonine-based regimen for childhood acute myelogenous leukemia. Medical and pediatric oncology, 2003, Volume: 41, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Cytarabine; Disease-Free Survival; Etoposide; Female; Harringtonines; Homoharringtonine; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome	2003
Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-01, Volume: 21, Issue:15 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Prognosis; Survival Rate; Treatment Outcome	2003
Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors. Annals of hematology, 2003, Volume: 82, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Salvage Therapy; Survival Rate	2003
Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells. Leukemia, 2003, Volume: 17, Issue:11 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Child; Cytarabine; Etoposide; fas Receptor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukocyte Count; Leukocytes, Mononuclear; Lymphocyte Depletion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome	2003
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle. European journal of haematology, 2004, Volume: 72, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Idarubicin; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Patient Selection; Recurrence; Statistics, Nonparametric; Survival Rate; Thioguanine; Time Factors	2004
Risk-adapted induction and consolidation therapy in adults with de novo AML aged Annals of hematology, 2004, Volume: 83, Issue:6 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Risk Assessment; Stem Cell Transplantation; Survival Analysis	2004
Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy. Haematologica, 2004, Volume: 89, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Histocompatibility Testing; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Probability; Prospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation Conditioning	2004
CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens. Bone marrow transplantation, 2005, Volume: 35, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Carmustine; CD8-Positive T-Lymphocytes; Cyclophosphamide; Etoposide; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; Humans; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Male; Middle Aged; Salvage Therapy; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2005
Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia. European journal of haematology, 2005, Volume: 74, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Idarubicin; Leukapheresis; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Vidarabine	2005
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience. Leukemia research, 2005, Volume: 29, Issue:6 Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Risk Factors; Survival Analysis; Treatment Outcome	2005
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia, 2005, Volume: 19, Issue:8 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Etoposide; Female; Humans; Idarubicin; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Survival Rate; Treatment Outcome	2005
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-20, Volume: 23, Issue:18 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Proportional Hazards Models; Recurrence; Survival Analysis; Treatment Outcome	2005
Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome. Leukemia & lymphoma, 2005, Volume: 46, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; DNA Helicases; Etoposide; Exodeoxyribonucleases; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; RecQ Helicases; Werner Syndrome; Werner Syndrome Helicase	2005
Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia. Leukemia research, 2006, Volume: 30, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Prospective Studies; Salvage Therapy	2006
Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:10 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diarrhea; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Vomiting, Anticipatory	2005
Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. Leukemia research, 2006, Volume: 30, Issue:4 Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Cytarabine; Daunorubicin; Etoposide; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Recurrence	2006
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. Blood, 2006, Jun-15, Volume: 107, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recombinant Proteins; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Tretinoin	2006
Sequential response-adapted induction and consolidation regimens idarubicin/cytarabine and mitoxantrone/etoposide in adult acute myelogenous leukemia: 10 year follow-up of a study by the Canadian Leukemia Studies Group. Leukemia & lymphoma, 2006, Volume: 47, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Time Factors	2006
Therapeutic strategy of untreated de novo acute myeloid leukemia in the elderly: the efficacy of continuous drip infusion with low dose cytarabine and etoposide. Journal of cancer research and clinical oncology, 2007, Volume: 133, Issue:8 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Treatment Outcome	2007
Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukaemia: a multicentre, phase II study. Drugs & aging, 2007, Volume: 24, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Treatment Outcome	2007
The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients. International journal of hematology, 2008, Volume: 87, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local	2008
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma. British journal of haematology, 2008, Volume: 141, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prognosis; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic; Vincristine	2008
Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia. Anti-cancer drugs, 2008, Volume: 19, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cytarabine; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Topotecan	2008
[Current status of the treatment of recurrent acute myeloblastic leukaemia in adults (author's transl)]. Sangre, 1981, Volume: 26, Issue:5B Topics: Aminoacridines; Amsacrine; Antineoplastic Agents; Azacitidine; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Leukemia, Myeloid, Acute; Mitoguazone; Recurrence	1981
A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study. American journal of clinical oncology, 1984, Volume: 7, Issue:5 Topics: Adult; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Podophyllotoxin	1984
[Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:3 Topics: Aclarubicin; Adolescent; Adult; Aged; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Recurrence	1995
[Peripheral blood stem cell collection with high dose etoposide]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:3 Topics: Adult; Aged; Blood Component Removal; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1995
[Continuous infusion therapy with low dose cytosine arabinoside and etoposide in acute myelogenous leukemia patients hardly tolerable for intensive combination chemotherapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged	1995
Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia. American journal of clinical oncology, 1995, Volume: 18, Issue:5 Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy	1995
Mitoxantrone, etoposide and ara-C vs doxorubicin-DNA, ara-C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparison. European journal of haematology, 1995, Volume: 55, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; DNA Adducts; Doxorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Prednisolone; Recurrence; Survival Analysis; Thioguanine; Vincristine	1995
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results. Annals of hematology, 1993, Volume: 66, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Interleukin-2; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction	1993
Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: a Southwest Oncology Group study. American journal of hematology, 1995, Volume: 48, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Survival Analysis; Thioguanine; United States	1995
[Treatment results of acute nonlymphocytic leukemia in childhood--Kyushu Yamaguchi Children's Cancer Study Group]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Prednisolone; Recurrence; Remission Induction; Survival Rate; Vincristine	1995
The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Australian Leukemia Study Group. Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2 Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Etoposide; Humans; Leukemia, Myeloid, Acute; Life Tables; Prognosis; Proportional Hazards Models; Remission Induction; Survival Analysis; Treatment Outcome	1994
Improved survival for patients with acute myelogenous leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3 Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Prospective Studies; Regression Analysis; Remission Induction; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; United States	1995
Treatment of relapsed and refractory acute myelogenous leukaemia with aclacinomycin A (ACA) and etoposide (VP-16). Leukemia research, 1994, Volume: 18, Issue:9 Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Retrospective Studies	1994
A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial. Leukemia, 1994, Volume: 8, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Survival Analysis	1994
[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90]. Nouvelle revue francaise d'hematologie, 1994, Volume: 36 Suppl 2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Remission Induction	1994
[Results of induction treatment with idarubicin for acute nonlymphoblastic leukemia in adults]. Acta haematologica Polonica, 1994, Volume: 25, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Treatment Outcome	1994
Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. Medical and pediatric oncology, 1994, Volume: 23, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Extremities; Family Health; Female; Humans; Infant; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Meningeal Neoplasms; Myelodysplastic Syndromes; Neoplasms, Second Primary; Odds Ratio; Osteosarcoma; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Risk Factors; Spinal Neoplasms	1994
Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON). Leukemia, 1994, Volume: 8, Issue:1 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction	1994
Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia. Seminars in oncology, 1993, Volume: 20, Issue:6 Suppl 8 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Infant; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Remission Induction; Survival Analysis	1993
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia. Blood, 1993, Jan-15, Volume: 81, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Recurrence; Survival Analysis; Time Factors; Transplantation, Autologous	1993
Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia. Leukemia, 1993, Volume: 7, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cytarabine; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Pilot Projects; Recombinant Proteins	1993
Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia. Leukemia, 1996, Volume: 10, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neutropenia; Pilot Projects; Remission Induction; Survival Rate	1996
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemia. Leukemia & lymphoma, 1995, Volume: 19, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Life Tables; Male; Middle Aged; Mitoxantrone; Remission Induction; Salvage Therapy; Survival Rate	1995
Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia: a preliminary report. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1995, Volume: 56, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Remission Induction	1995
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:5 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local	1996
Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia. Leukemia, 1996, Volume: 10, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Leukemia, Myeloid, Acute; Logistic Models; Male; Middle Aged; Prognosis; Proportional Hazards Models; Remission Induction; Survival Rate; Time Factors; Transplantation, Autologous	1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]. Medizinische Klinik (Munich, Germany : 1983), 1996, Apr-12, Volume: 91 Suppl 3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome	1996
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:8 Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Recurrence; Regression Analysis; Remission Induction; Transplantation, Autologous; Whole-Body Irradiation	1996
Studies to determine if IL-2 can prevent relapses in post-transplant NHL and AML. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-2; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Recurrence; Remission Induction; Whole-Body Irradiation	1996
The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia. Experimental hematology, 1996, Volume: 24, Issue:10 Topics: Adolescent; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Glucocorticoids; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1996
BAVC regimen and autograft for acute myelogenous leukemia in second complete remission. Bone marrow transplantation, 1996, Volume: 18, Issue:4 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leukemia, Myeloid, Acute; Male; Middle Aged; Time Factors; Transplantation Conditioning; Transplantation, Autologous	1996
[Treatment results for unselected patients with acute myelogenous leukemia. During a 10-year period, August 1984 to July 1994]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:9 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Patient Selection; Prednisolone; Remission Induction; Retrospective Studies; Treatment Outcome	1996
Probability of long-term disease-free survival for acute myeloid leukemia patients after first relapse: A single-centre experience. Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Mitoxantrone; Survival Analysis; Treatment Outcome	1996
[Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group (CCLSG)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Prognosis; Remission Induction; Risk Factors; Vincristine	1997
[Short-term intensive treatment for acute myelogenous leukemia (excluding M3 subtype) in adults]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:3 Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Middle Aged; Mitoxantrone; Time Factors; Vinblastine; Vincristine	1997
Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporins; Drug Resistance, Neoplasm; Etoposide; Genes, MDR; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Recurrence	1997
Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:2 Topics: Aclarubicin; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male	1998
[Treatment of children with non-Hodgkin's lymphoma with CCLSG NHL 855/890 protocols long-term outcome and incidence of secondary malignancies]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Prednisolone; Remission Induction; Treatment Outcome; Vincristine	1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group. Leukemia, 1998, Volume: 12, Issue:7 Topics: Aclarubicin; Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Prospective Studies; Remission Induction; Vincristine	1998
Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial. German AML Cooperative Group. Leukemia, 1998, Volume: 12, Issue:10 Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Neutropenia; Prospective Studies; Recurrence; Stomatitis; Survival Rate	1998
Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia. Medical oncology (Northwood, London, England), 1998, Volume: 15, Issue:3 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Survival Analysis	1998
High single dose of mitoxantrone and cytarabine in acute non-lymphocytic leukemia: a pharmacokinetic and clinical study. Therapeutic drug monitoring, 1998, Volume: 20, Issue:6 Topics: Adult; Aged; Amsacrine; Chromatography, High Pressure Liquid; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Time Factors	1998
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC). Advances in experimental medicine and biology, 1999, Volume: 457 Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Cytarabine; Etoposide; Genes, MDR; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Prognosis; Remission Induction; Salvage Therapy	1999
Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:9 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Drug Resistance, Multiple; Etoposide; Female; Flow Cytometry; Genes, MDR; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome	2000
An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome. Leukemia, 2000, Volume: 14, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Down Syndrome; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Probability; Remission Induction; Survival Rate; Time Factors; Treatment Outcome	2000
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:16 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Thrombocytopenia	2000
[Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:8 Topics: Adolescent; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Middle Aged; Prospective Studies	2000
Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium. Medical and pediatric oncology, 2000, Volume: 35, Issue:4 Topics: Adolescent; Alberta; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Missouri; Texas; Transplantation Conditioning; Treatment Outcome	2000
Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia. Leukemia research, 2000, Volume: 24, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Patient Selection; Recurrence; Ventricular Function, Left	2000
Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: a report from the Kyushu-Yamaguchi Children's Cancer Study group in Japan. Pediatric hematology and oncology, 2000, Volume: 17, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Prognosis; Remission Induction; Transplantation, Autologous; Transplantation, Homologous	2000
Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group. Leukemia, 2001, Volume: 15, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Treatment Outcome	2001
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia. Leukemia, 2001, Volume: 15, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Cytarabine; Drug Resistance, Multiple; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone	2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood, 2001, Oct-15, Volume: 98, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Remission Induction; Survival Rate; Time Factors; Transplantation, Autologous; Transplantation, Homologous	2001
Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients. Leukemia & lymphoma, 2001, Volume: 42, Issue:3 Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Infusions, Intravenous; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Survival Rate	2001
Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Blood, 2001, Dec-15, Volume: 98, Issue:13 Topics: Aclarubicin; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 11; Cytarabine; Disease-Free Survival; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histone-Lysine N-Methyltransferase; Humans; Immunophenotyping; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Myeloid-Lymphoid Leukemia Protein; Prognosis; Proto-Oncogenes; Remission Induction; Survival Rate; Transcription Factors; Translocation, Genetic; Treatment Outcome; Vincristine	2001
Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital. Leukemia, 1992, Volume: 6 Suppl 2 Topics: 2-Chloroadenosine; Acute Disease; Adolescent; Adult; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Child, Preschool; Cladribine; Cytarabine; Daunorubicin; Deoxyadenosines; Etoposide; Humans; Infant; Leukemia, Myeloid, Acute; Remission Induction	1992
Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze. Leukemia, 1992, Volume: 6 Suppl 2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Brain; Child; Child, Preschool; Cytarabine; Doxorubicin; Etoposide; Humans; Infant; Leukemia, Myeloid, Acute; Prednisolone; Survival Analysis; Vincristine	1992
Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six cases. International journal of hematology, 1992, Volume: 55, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Drug Synergism; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Recombinant Proteins; Remission Induction	1992
High dose etoposide melphalan, total body irradiation and ABMT for acute myeloid leukemia in first remission. Leukemia, 1992, Volume: 6 Suppl 4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Whole-Body Irradiation	1992
Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood, 1992, Dec-15, Volume: 80, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Survival Analysis; Time Factors	1992
Etoposide in the treatment of leukemias. Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 13 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Etoposide; Humans; Leukemia, Myeloid, Acute	1992
[Effects of alternating as well as long-term intensive polychemotherapy in the remission-maintaining treatment of patients with acute myelocytic leukemia]. Polskie Archiwum Medycyny Wewnetrznej, 1992, Volume: 87, Issue:2 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Thioguanine; Time Factors	1992
Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group study. American journal of clinical oncology, 1992, Volume: 15, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Treatment Outcome	1992
A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA. Annals of hematology, 1992, Volume: 64, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Remission Induction; Thioguanine; Time Factors	1992
Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Drug Combinations; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Nimustine; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Thioguanine; United Kingdom; Vincristine	1990
Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Humans; Infant; Leukemia, Myeloid, Acute; Multicenter Studies as Topic; Pilot Projects; Randomized Controlled Trials as Topic; Remission Induction; Thioguanine; Vincristine	1990
Successful reinduction therapy with amsacrine and cyclocytidine in acute nonlymphoblastic leukemia in children. A report from the Childrens Cancer Study Group. Cancer, 1991, May-01, Volume: 67, Issue:9 Topics: Adolescent; Amsacrine; Ancitabine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Pediatrics; Remission Induction	1991
Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study. Investigational new drugs, 1991, Volume: 9, Issue:2 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Pilot Projects	1991
[Autotransplantation in acute nonlymphoid leukemia]. Haematologica, 1991, Volume: 76 Suppl 3 Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Remission Induction; Transplantation, Autologous	1991
BAVC regimen in CR AML patients. Bone marrow transplantation, 1991, Volume: 7 Suppl 2 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cytarabine; Etoposide; Follow-Up Studies; Graft Survival; Humans; Infant; Italy; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Transplantation, Autologous	1991
Etoposide in leukemia. Cancer, 1991, Jan-01, Volume: 67, Issue:1 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute	1991
Etoposide in the management of leukemia: a review. Seminars in oncology, 1991, Volume: 18, Issue:1 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Survival Rate	1991
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination. Blood, 1991, Apr-15, Volume: 77, Issue:8 Topics: Adult; Aged; Antibodies, Monoclonal; Bone Marrow Transplantation; Cell Line; Colony-Forming Units Assay; Cyclophosphamide; Cytotoxicity, Immunologic; Etoposide; Female; Hematopoietic Stem Cells; Humans; Immunosuppression Therapy; Interleukin-1; Interleukin-3; Leukemia, Myeloid, Acute; Male; Middle Aged; Transplantation, Autologous	1991
Long-term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years. British journal of haematology, 1991, Volume: 77, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Remission Induction; Thioguanine; Vindesine	1991
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark. Leukemia, 1991, Volume: 5, Issue:6 Topics: Aclarubicin; Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cytarabine; Daunorubicin; Denmark; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Regression Analysis; Remission Induction; Survival Rate	1991
[Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols]. Gematologiia i transfuziologiia, 1991, Volume: 36, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany, West; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; Prognosis; Remission Induction; Thioguanine; Time Factors; Vincristine	1991
Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany, West; Humans; Infant; Leukemia, Myeloid, Acute; Life Tables; Multicenter Studies as Topic; Remission Induction; Thioguanine	1990
Treatment of childhood acute nonlymphocytic leukemia: cooperative Austrian-Hungarian study AML-IGCI-84. Haematology and blood transfusion, 1990, Volume: 33 Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Austria; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hungary; Infant; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Life Tables; Male; Multicenter Studies as Topic; Prednisone; Prospective Studies; Remission Induction; Thioguanine; Vincristine	1990
Therapy of acute myelogenous leukemia in adults. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Italy; Leukemia, Myeloid, Acute; Life Tables; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Thioguanine	1990
Consolidation therapy with high-dose cytosine arabinoside: experiences of a prospective study in acute myeloid leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Germany, West; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Life Tables; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Survival Rate	1990
Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Etoposide; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Multicenter Studies as Topic	1990
Mitoxantrone, cytosine arabinoside, and VP-16 in 36 patients with relapsed and refractory acute myeloid leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Germany, West; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Remission Induction; Survival Rate	1990
Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Mitoxantrone; Multicenter Studies as Topic; Remission Induction; Survival Rate; United States	1990
Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group. Blood, 1990, May-15, Volume: 75, Issue:10 Topics: Adolescent; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Germany; Humans; Leukemia, Myeloid, Acute; Male; Multicenter Studies as Topic; Multivariate Analysis; Prognosis; Risk Factors	1990
Chemotherapy of adult acute nonlymphoblastic leukaemia. Haematologia, 1990, Volume: 23, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitolactol; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Tamoxifen	1990
The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia. Cancer, 1990, Sep-15, Volume: 66, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Multicenter Studies as Topic; Pilot Projects; Random Allocation; Remission Induction; Thioguanine	1990
Treatment of pediatric malignant tumors with VP-16. West Japan Pediatric Oncology Group. Acta paediatrica Japonica : Overseas edition, 1990, Volume: 32, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Histiocytosis; Humans; Infant; Leukemia, Myeloid, Acute; Lymphoma; Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1990
Mitoxantrone and constant infusion etoposide for relapsed and refractory acute myelocytic leukemia. American journal of clinical oncology, 1990, Volume: 13, Issue:6 Topics: Adult; Aged; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction	1990
High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study. British journal of cancer, 1990, Volume: 62, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged	1990
Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group. Blood, 1990, Jan-01, Volume: 75, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Multicenter Studies as Topic; Survival Analysis	1990
Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985. Haematology and blood transfusion, 1987, Volume: 30 Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Random Allocation; Remission Induction; Risk; Thioguanine; United Kingdom	1987
The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia. Haematology and blood transfusion, 1987, Volume: 30 Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; England; Etoposide; Humans; Leukemia, Myeloid, Acute; Prednisone; Remission Induction; Thioguanine; Vincristine	1987
Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias. Bone marrow transplantation, 1989, Volume: 4 Suppl 4 Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Whole-Body Irradiation	1989
[Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1988, Nov-21, Volume: 43, Issue:47 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Drug Resistance; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction	1988
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Blut, 1988, Volume: 56, Issue:5 Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Humans; Infections; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Remission Induction; Thrombocytopenia	1988
Mitoxantrone and VP-16 in refractory acute myelogenous leukemia. Haematology and blood transfusion, 1987, Volume: 30 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction	1987
Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia. Haematology and blood transfusion, 1987, Volume: 30 Topics: Aclarubicin; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Naphthacenes; Prospective Studies; Remission Induction	1987
The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis. Haematology and blood transfusion, 1987, Volume: 30 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany, West; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; Prognosis; Remission Induction; Risk; Thioguanine; Vincristine	1987
A comparison of cytokinetically based versus intensive chemotherapy for childhood acute myelogenous leukemia. Haematology and blood transfusion, 1987, Volume: 30 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Remission Induction; Vincristine	1987
Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trial. Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Thioguanine; Vincristine	1987
[Risk groups in acute, non-lymphatic leukemia in childhood. Analysis of the results of the cooperative therapeutic studies AML-BFM 78 and 83]. Onkologie, 1986, Volume: 9, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Prognosis; Risk; Thioguanine	1986

Other Studies

403 other study(ies) available for etoposide and Acute Myelogenous Leukemia

Article	Year
African health sciences, 2021, Volume: 21, Issue:2 Topics: Animals; Antioxidants; Bone Marrow; DNA Damage; Etoposide; Garlic; Leukemia, Myeloid, Acute; Oxidative Stress; Plant Extracts; Rats, Wistar	2021
Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya. Cancer reports (Hoboken, N.J.), 2022, Volume: 5, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Doxorubicin; Etoposide; Fluconazole; Humans; Kenya; Leukemia, Myeloid, Acute; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 03-01, Volume: 40, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Gemtuzumab; Humans; Induction Chemotherapy; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Young Adult	2022
Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma. Medicina (Kaunas, Lithuania), 2021, Dec-29, Volume: 58, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prednisone; Vincristine	2021
Antitumor Effect of Molecules (Basel, Switzerland), 2022, Jun-29, Volume: 27, Issue:13 Topics: Antineoplastic Agents; Boraginaceae; Carcinoma, Hepatocellular; DNA Topoisomerases, Type II; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Naphthoquinones; Oils, Volatile; Reactive Oxygen Species; Topoisomerase II Inhibitors	2022
Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells. Asian Pacific journal of cancer prevention : APJCP, 2022, Jul-01, Volume: 23, Issue:7 Topics: Apoptosis; Cell Line, Tumor; Etoposide; Humans; Inhibitor of Apoptosis Proteins; Leukemia, Myeloid, Acute; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Small Interfering; Survivin	2022
Recurrent Translocations in Topoisomerase Inhibitor-Related Leukemia Are Determined by the Features of DNA Breaks Rather Than by the Proximity of the Translocating Genes. International journal of molecular sciences, 2022, Aug-29, Volume: 23, Issue:17 Topics: DNA; DNA Breaks, Double-Stranded; Etoposide; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Topoisomerase II Inhibitors; Translocation, Genetic	2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML. Blood advances, 2023, 05-09, Volume: 7, Issue:9 Topics: Cell Line; Child; CRISPR-Cas Systems; DNA Helicases; Etoposide; Humans; Leukemia, Myeloid, Acute	2023
Isolated myeloid sarcoma with pericardial and pleural effusions as first manifestation: A case report. Medicine, 2022, Oct-21, Volume: 101, Issue:42 Topics: Adult; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Pleural Effusion; Sarcoma, Myeloid	2022
Treatment outcomes of pediatric acute myeloid leukemia in Western Kenya before and after the implementation of the SIOP PODC treatment guideline. Cancer reports (Hoboken, N.J.), 2023, Volume: 6, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Humans; Kenya; Leukemia, Myeloid, Acute; Retrospective Studies; Treatment Outcome	2023
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party Bone marrow transplantation, 2023, Volume: 58, Issue:11 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Melphalan; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous	2023
High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experience. Leukemia research, 2019, Volume: 85 Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Child; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Recurrence; Retreatment; Treatment Outcome; Young Adult	2019
Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia. Acta haematologica, 2020, Volume: 143, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hemorrhage; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Salvage Therapy; Vidarabine	2020
FLAG and Etoposide as Salvage Treatment in Acute Myeloid Leukemia. Acta haematologica, 2020, Volume: 143, Issue:5 Topics: Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Salvage Therapy	2020
Therapy-related acute myeloid leukemia secondary to histiocytic sarcoma. Minerva medica, 2021, Volume: 112, Issue:5 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasms, Second Primary; Polyethylene Glycols; Prednisone; Sarcoma; Vincristine	2021
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia. European journal of haematology, 2020, Volume: 105, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Management; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Mitoxantrone; Preoperative Care; Prognosis; Recurrence; Treatment Outcome	2020
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia. American journal of hematology, 2020, Volume: 95, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Recurrence; Young Adult	2020
Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML. Pediatrics international : official journal of the Japan Pediatric Society, 2020, Volume: 62, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Ifosfamide; Japan; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Rhabdomyosarcoma, Alveolar	2020
Novel Approach for Bone Marrow Transplantation Conditioning in Acute Myelogenous Leukemia not Responding to the Induction Therapy Using Etoposide Carried in Lipid Core Nanoparticles: A Pilot Clinical Study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2020, Volume: 26, Issue:11 Topics: Adult; Aged; Bone Marrow; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Lipids; Middle Aged; Nanoparticles; Pilot Projects; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult	2020
Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG). Pediatric blood & cancer, 2020, Volume: 67, Issue:12 Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Core Binding Factors; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Infant; Japan; Leukemia, Myeloid, Acute; Male; Mutation; Prognosis; Remission Induction; Retrospective Studies; Societies, Medical; Stem Cell Transplantation; Survival Rate	2020
Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report. Current medical research and opinion, 2020, Volume: 36, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Pyrimidines; Remission Induction; Transplantation, Autologous	2020
A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine. International journal of molecular sciences, 2020, Sep-16, Volume: 21, Issue:18 Topics: Adenosine Triphosphate; Alarmins; Antineoplastic Agents; Calreticulin; Cell Line, Tumor; Cytarabine; Daunorubicin; Dendritic Cells; Etoposide; Extracellular Space; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Humans; Immunogenic Cell Death; Leukemia, Myeloid, Acute; Lymphocyte Activation; Neoplasm Proteins; Organelles; Protein Transport; T-Lymphocyte Subsets; Vidarabine	2020
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study. Pediatric blood & cancer, 2021, Volume: 68, Issue:1 Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Transplantation, Homologous; Vidarabine	2021
A pediatric case of acute myeloid leukemia with KMT2A gene rearrangement t(10;11) and 16p11.2 microdeletion syndrome. Pediatric blood & cancer, 2021, Volume: 68, Issue:2 Topics: Antineoplastic Agents; Autistic Disorder; Child; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 16; Cytarabine; Daunorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histone-Lysine N-Methyltransferase; Humans; Intellectual Disability; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 3; Myeloid-Lymphoid Leukemia Protein; Vault Ribonucleoprotein Particles	2021
Prognostic Factors in Childhood Acute Myeloid Leukemia; Experience from A Developing Country. Cancer reports (Hoboken, N.J.), 2020, Volume: 3, Issue:5 Topics: Adolescent; Child; Child, Preschool; Consolidation Chemotherapy; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Malnutrition; Neutropenia; Pakistan; Prognosis; Progression-Free Survival; Risk Assessment; Risk Factors; Sepsis; Survival Rate	2020
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide. PloS one, 2020, Volume: 15, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cell Line, Tumor; Computer Simulation; Cytarabine; Datasets as Topic; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Ontology; Humans; Inhibitory Concentration 50; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Nonlinear Dynamics; Precision Medicine; Prognosis; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System; Tretinoin	2020
Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re-induction chemotherapy. Cancer medicine, 2021, Volume: 10, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cladribine; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Induction Chemotherapy; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate	2021
Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites. Genes, chromosomes & cancer, 2021, Volume: 60, Issue:12 Topics: Binding Sites; CCCTC-Binding Factor; Cell Cycle Proteins; Chondroitin Sulfate Proteoglycans; Chromosomal Proteins, Non-Histone; Chromosome Aberrations; Cohesins; DNA Breaks, Double-Stranded; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Gene Rearrangement; Genome, Human; HeLa Cells; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Male; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Poly-ADP-Ribose Binding Proteins	2021
Escalated anthracycline dose in adult AML. The Lancet. Oncology, 2017, Volume: 18, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome	2017
Looking up for AML in Down syndrome. Blood, 2017, 06-22, Volume: 129, Issue:25 Topics: Cytarabine; Down Syndrome; Etoposide; Humans; Leukemia, Myeloid, Acute	2017
Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review. Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:14 Topics: Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Middle Aged; Translocation, Genetic	2017
Unexpected diagnosis of appendicitis in a paediatric patient with febrile neutropaenia and acute myeloid leukaemia. BMJ case reports, 2017, Aug-07, Volume: 2017 Topics: Antineoplastic Combined Chemotherapy Protocols; Appendicitis; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Febrile Neutropenia; Humans; Incidental Findings; Leukemia, Myeloid, Acute; Male; Tomography, X-Ray Computed	2017
Acute myeloid leukaemia masquerading as a primary CNS tumour. BMJ case reports, 2017, Aug-11, Volume: 2017 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Central Nervous System Neoplasms; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; fms-Like Tyrosine Kinase 3; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Sarcoma, Myeloid; Treatment Outcome	2017
Anthracycline-induced acute myocarditis and ventricular fibrillation arrest. American journal of hematology, 2018, Volume: 93, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cardiopulmonary Resuscitation; Chest Pain; Combined Modality Therapy; Cytarabine; Defibrillators, Implantable; Echocardiography; Etoposide; Heart Arrest; Humans; Idarubicin; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Ventricular Fibrillation	2018
A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nature communications, 2018, 01-03, Volume: 9, Issue:1 Topics: Algorithms; Antineoplastic Agents; Biomarkers, Tumor; Cell Line; Datasets as Topic; DNA Helicases; Drug Resistance, Neoplasm; Etoposide; Humans; Leukemia, Myeloid, Acute; Machine Learning; Nuclear Proteins; Precision Medicine; Topoisomerase II Inhibitors; Transcription Factors	2018
MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death. Upsala journal of medical sciences, 2018, Volume: 123, Issue:1 Topics: Adult; Apoptosis; Cell Line, Tumor; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Core Binding Factor Alpha 2 Subunit; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; MicroRNAs; Oncogene Proteins, Fusion; RUNX1 Translocation Partner 1 Protein; Translocation, Genetic	2018
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells. Advances in biological regulation, 2018, Volume: 68 Topics: Cell Survival; Cells, Cultured; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases	2018
Mutations in the P10 region of procaspase-8 lead to chemotherapy resistance in acute myeloid leukemia by impairing procaspase-8 dimerization. Cell death & disease, 2018, 05-01, Volume: 9, Issue:5 Topics: Aged; Antineoplastic Agents, Phytogenic; Base Sequence; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Biomarkers, Tumor; Caspase 8; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Leukemic; Genes, Reporter; Green Fluorescent Proteins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Protein Multimerization; Proto-Oncogene Proteins c-bcl-2; Signal Transduction	2018
Characteristics of adult patients treated for acute myeloid leukemia with inv 16 in Casablanca (Morocco). Bulletin du cancer, 2018, Volume: 105, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Chromosome Inversion; Chromosomes, Human, Pair 16; Core Binding Factor beta Subunit; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Leukocytosis; Longitudinal Studies; Male; Middle Aged; Morocco; Myosin Heavy Chains; Oncogene Proteins, Fusion; Prognosis; Young Adult	2018
Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia: A retrospective cohort study. Medicine, 2018, Volume: 97, Issue:39 Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cohort Studies; Cytarabine; Daunorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Harringtonines; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vidarabine; Young Adult	2018
Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy. Life sciences, 2019, Mar-15, Volume: 221 Topics: Adult; Apoptosis; Cell Proliferation; Coculture Techniques; Drug Resistance, Neoplasm; Etoposide; Exosomes; Female; Humans; Interleukin-8; Leukemia, Myeloid, Acute; Male; Mesenchymal Stem Cells; Primary Cell Culture; Protective Agents; Tumor Cells, Cultured	2019
Regulation of drug metabolizing enzymes in the leukaemic bone marrow microenvironment. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:6 Topics: Bone Marrow; Bone Marrow Cells; Cell Line; Cell Line, Tumor; Cytarabine; Cytochrome P-450 CYP3A; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Inactivation, Metabolic; Leukemia, Myeloid, Acute; Stromal Cells; Tumor Microenvironment; Up-Regulation	2019
Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 112 Topics: Alarmins; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Etoposide; Extracellular Space; HL-60 Cells; HMGB1 Protein; Humans; Leukemia, Myeloid, Acute; Necrosis; NF-kappa B; Signal Transduction	2019
Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia. International journal of hematology, 2019, Volume: 110, Issue:2 Topics: Abnormal Karyotype; Adolescent; Allografts; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Gene Expression Regulation, Leukemic; Genes, Mitochondrial; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Mitochondrial Proteins; Neoplasm Proteins; Prognosis; Progression-Free Survival; Prospective Studies; Real-Time Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm	2019
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach. British journal of haematology, 2019, Volume: 186, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Mitoxantrone; Mutation; Neoplasm Proteins; Neoplasm, Residual; Nuclear Proteins; Nucleophosmin; Recurrence; Salvage Therapy; Survival Rate	2019
Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States. Cancer, 2013, May-15, Volume: 119, Issue:10 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Health Resources; Hospitals, Pediatric; Humans; Induction Chemotherapy; Infant; Leukemia, Myeloid, Acute; Logistic Models; Male; Odds Ratio; Poisson Distribution; Risk Assessment; Risk Factors; Thioguanine; Treatment Outcome; United States	2013
EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells. PloS one, 2013, Volume: 8, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Daunorubicin; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; MDS1 and EVI1 Complex Locus Protein; Mice; Myeloid Cells; Proto-Oncogenes; Transcription Factors; Up-Regulation	2013
Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncology reports, 2013, Volume: 29, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosome Aberrations; Core Binding Factors; Cytarabine; Disease-Free Survival; Etoposide; Exons; Female; Humans; Idarubicin; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Prognosis; Proto-Oncogene Proteins c-kit; Retrospective Studies; Stem Cell Transplantation; Young Adult	2013
Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia. Journal of human genetics, 2013, Volume: 58, Issue:6 Topics: Adolescent; Adult; Aged; Busulfan; Chromosome Mapping; Cytarabine; Disease-Free Survival; DNA; Etoposide; Female; Follow-Up Studies; Genetic Loci; Genotype; Glutathione Transferase; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Membrane Transport Proteins; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Remission Induction; Young Adult	2013
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nature communications, 2013, Volume: 4 Topics: Aclarubicin; Animals; Anthracyclines; Antineoplastic Agents; Apoptosis; Blast Crisis; Cell Line, Tumor; Cell Survival; Chromatin; DNA; DNA Damage; Doxorubicin; Etoposide; Heart; Histones; Humans; Intercalating Agents; Leukemia, Myeloid, Acute; Mice; Mice, Nude; Nucleic Acid Conformation; Nucleosomes; Organ Specificity; Transcriptome	2013
Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission. International journal of hematology, 2013, Volume: 98, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Autografts; Busulfan; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Rate; Transplantation Conditioning	2013
Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status. American journal of hematology, 2013, Volume: 88, Issue:12 Topics: Aged; Aged, 80 and over; Allografts; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Comorbidity; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Etoposide; Female; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Risk; Severity of Illness Index; Treatment Outcome	2013
Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients. Chemotherapy, 2013, Volume: 59, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Treatment Outcome	2013
[Exudative pericardial effusion and oligoarthritis in a patient newly diagnosed with myelodysplastic syndrome]. Medicina clinica, 2014, Jul-07, Volume: 143, Issue:1 Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Arthritis; Azacitidine; Cytarabine; Disease Progression; Etoposide; Fatal Outcome; Hepatomegaly; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Serositis	2014
Facts about FCE (fludarabine, cytarabine, etoposide) in acute myeloid leukemia. Acta haematologica, 2014, Volume: 131, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Salvage Therapy; Vidarabine	2014
The combination of fludarabine, cytarabine and etoposide is an active and well-tolerated regimen in relapsed/refractory acute myeloid leukemia. Acta haematologica, 2014, Volume: 131, Issue:4 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Retrospective Studies; Salvage Therapy; Secondary Prevention; Survival Analysis; Vidarabine	2014
siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Proliferation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Inhibitor of Apoptosis Proteins; Leukemia, Myeloid, Acute; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Survivin; Tumor Cells, Cultured	2013
Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide. European journal of haematology, 2014, Volume: 92, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Recurrence; Salvage Therapy; Treatment Outcome; Young Adult	2014
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood, 2014, Mar-13, Volume: 123, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Young Adult	2014
Characteristics and clinical evolution of patients with acute myeloblastic leukemia in northeast Mexico: an eight-year experience at a university hospital. Acta haematologica, 2014, Volume: 132, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hospitals, University; Humans; Infant; Infusions, Intravenous; Injections, Spinal; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Mexico; Middle Aged; Mitoxantrone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult	2014
The effect of quercetin on oxidative DNA damage and myelosuppression induced by etoposide in bone marrow cells of rats. Acta biochimica Polonica, 2014, Volume: 61, Issue:1 Topics: Animals; Antioxidants; Apoptosis; Bone Marrow Cells; DNA Damage; Etoposide; Humans; Leukemia, Myeloid, Acute; Oxidation-Reduction; Quercetin; Rats	2014
The influence of curcumin on the action of etoposide in a rat acute myeloid leukemia cell line. Folia medica Cracoviensia, 2013, Volume: 53, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Curcumin; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Leukemia, Myeloid, Acute; Mice; Rats	2013
After the treated mole. Blood, 2014, May-01, Volume: 123, Issue:18 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunophenotyping; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Second Primary; Pregnancy; Trophoblasts; Vincristine	2014
The ROS/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs. Cell reports, 2014, Jun-26, Volume: 7, Issue:6 Topics: Animals; Antineoplastic Agents; Apoptosis; Cytarabine; Daunorubicin; Disease Models, Animal; Etoposide; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Nude; Microarray Analysis; Reactive Oxygen Species; SUMO-1 Protein; U937 Cells; Xenograft Model Antitumor Assays	2014
Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol. International journal of hematology, 2014, Volume: 100, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Child; Child, Preschool; Cytarabine; Etoposide; Female; fms-Like Tyrosine Kinase 3; Gene Duplication; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome	2014
Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies. British journal of haematology, 2014, Volume: 167, Issue:3 Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cytarabine; Daunorubicin; Drug Therapy, Combination; Egg Hypersensitivity; Etoposide; Female; Food Hypersensitivity; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Intestinal Diseases; Leukemia, Myeloid, Acute; Liver Diseases; Male; Middle Aged; Nut Hypersensitivity; Seafood; Tacrolimus; Transplantation Conditioning; Vidarabine	2014
Eccrine poromatosis in a patient with acute myeloid leukemia following chemotherapy. Dermatology online journal, 2014, Nov-15, Volume: 20, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Poroma; Stem Cell Transplantation; Sweat Gland Neoplasms	2014
Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement. Haematologica, 2015, Volume: 100, Issue:3 Topics: Antineoplastic Agents; Biomarkers, Tumor; Child; Child, Preschool; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Core Binding Factor Alpha 2 Subunit; Cytarabine; Drug Monitoring; Etoposide; Female; Humans; Idarubicin; Induction Chemotherapy; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Mutation; Neoplasm, Residual; Proto-Oncogene Proteins; RUNX1 Translocation Partner 1 Protein; Survival Analysis; Transcription Factors; Translocation, Genetic	2015
The dual effect of curcumin on etoposide action in leukemic and healthy bone marrow cells of rats with acute myeloid leukemia. Folia medica Cracoviensia, 2014, Volume: 54, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Marrow; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Leukemia, Myeloid, Acute; Rats; Rats, Inbred BN	2014
Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group. Pediatric blood & cancer, 2015, Volume: 62, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child Health Services; Child, Preschool; Comparative Effectiveness Research; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Health Information Systems; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Outcome and Process Assessment, Health Care; Young Adult	2015
Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia. Cancer letters, 2015, Oct-01, Volume: 366, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Doxorubicin; Drug Synergism; Etoposide; HL-60 Cells; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Naphthoquinones; Survivin	2015
Clinical outcomes of patients with acute myeloid leukemia: evaluation of genetic and molecular findings in a real-life setting. Blood, 2015, Oct-08, Volume: 126, Issue:15 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Cytogenetic Analysis; Etoposide; Female; fms-Like Tyrosine Kinase 3; Follow-Up Studies; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Staging; Nuclear Proteins; Nucleophosmin; Prognosis; Survival Rate; Thioguanine; Young Adult	2015
Fertility After Treatment With High Dose Melphalan in Women With Acute Myelogenous Leukemia. Pediatric blood & cancer, 2016, Volume: 63, Issue:2 Topics: Adolescent; Adult; Anthracyclines; Consolidation Chemotherapy; Cytarabine; Etoposide; Female; Fertility; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Melphalan; Myeloablative Agonists; Survivors; Transplantation Conditioning; Young Adult	2016
Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60). Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2015, Volume: 75 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily B; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transfection	2015
Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Dec-20, Volume: 33, Issue:36 Topics: Adolescent; Anthracyclines; Antineoplastic Agents; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Disease-Free Survival; Etoposide; Female; Germany; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Induction Chemotherapy; International Cooperation; Kaplan-Meier Estimate; Karyotype; Leukemia, Myeloid, Acute; Male; Molecular Targeted Therapy; Mutation; Predictive Value of Tests; Proto-Oncogene Proteins c-kit; ras Proteins; Retrospective Studies; Translocation, Genetic; Transplantation, Homologous; Treatment Outcome	2015
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma, 2016, Volume: 57, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Chromosome Aberrations; Cytarabine; Drug Monitoring; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Retreatment; Staurosporine; Treatment Outcome; Young Adult	2016
Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species. Drug design, development and therapy, 2016, Volume: 10 Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Curcumin; Etoposide; Female; HL-60 Cells; Humans; Inhibitor of Apoptosis Proteins; Leukemia, Myeloid, Acute; Male; Middle Aged; NF-kappa B; Oxidative Stress; Rats; Rats, Inbred BN; Reactive Oxygen Species; Survivin	2016
Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia. Leukemia & lymphoma, 2016, Volume: 57, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retreatment; Treatment Outcome; Young Adult	2016
siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells. Cellular and molecular biology (Noisy-le-Grand, France), 2016, May-30, Volume: 62, Issue:6 Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Cell Count; Cell Proliferation; Cell Survival; Down-Regulation; Drug Interactions; Etoposide; Flow Cytometry; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; RNA, Messenger; RNA, Small Interfering; Survivin; Transfection; U937 Cells	2016
Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse. Oncology research, 2016, Volume: 24, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytogenetic Analysis; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Survival Analysis; Treatment Outcome; Young Adult	2016
[Therapy-Related Acute Myeloid Leukemia Following Etoposide Based Chemotherapy in Germ Cell Tumor]. Hinyokika kiyo. Acta urologica Japonica, 2016, Volume: 62, Issue:5 Topics: Adult; Antineoplastic Agents, Phytogenic; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms	2016
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia. The Journal of clinical investigation, 2016, 10-03, Volume: 126, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Granulocyte Precursor Cells; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Mitochondria; Single-Cell Analysis	2016
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma. Pediatric blood & cancer, 2017, Volume: 64, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cytarabine; Dacarbazine; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Iodobenzenes; Leukemia, Myeloid, Acute; Male; Paraganglioma; Radiation Tolerance; Temozolomide	2017
Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia. Haematologica, 2017, Volume: 102, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Survival Analysis; Thioguanine; Tumor Suppressor Protein p53	2017
Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study. Pediatric blood & cancer, 2017, Volume: 64, Issue:10 Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Core Binding Factors; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Induction Chemotherapy; Japan; Leukemia, Myeloid, Acute; Mitoxantrone; Proto-Oncogene Proteins c-kit; Recurrence; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome; Vidarabine	2017
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Oct-01, Volume: 26, Issue:28 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Busulfan; Cytarabine; Daunorubicin; Etoposide; Female; fms-Like Tyrosine Kinase 3; Genes, Wilms Tumor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Nucleophosmin; Prognosis; Proportional Hazards Models; Statistics, Nonparametric	2008
Mucoepidermoid carcinoma of the submandibular gland after chemotherapy in a child. Auris, nasus, larynx, 2009, Volume: 36, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Busulfan; Carcinoma, Mucoepidermoid; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Image Processing, Computer-Assisted; Leukemia, Myeloid, Acute; Male; Neck Dissection; Neoplasms, Second Primary; Positron-Emission Tomography; Submandibular Gland Neoplasms; Thioguanine; Tomography, X-Ray Computed; Transplantation Conditioning	2009
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Oct-20, Volume: 26, Issue:30 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm, Residual; Prognosis; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome	2008
Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia. European journal of pharmacology, 2008, Sep-04, Volume: 591, Issue:1-3 Topics: Antineoplastic Agents, Phytogenic; Benzimidazoles; Cell Cycle Proteins; Cell Division; Etoposide; G2 Phase; Humans; Leukemia, Myeloid, Acute; Mitosis; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Thiophenes; U937 Cells	2008
Expression and role of DJ-1 in leukemia. Biochemical and biophysical research communications, 2008, Oct-24, Volume: 375, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Oncogene Proteins; Protein Biosynthesis; Protein Deglycase DJ-1; PTEN Phosphohydrolase; RNA, Messenger; RNA, Small Interfering; Up-Regulation	2008
The management of prolonged, isolated hyperbilirubinemia following cytarabine-based chemotherapy for acute myeloid leukaemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2009, Volume: 15, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Hyperbilirubinemia; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Time Factors	2009
Secondary leukemia in a child conceived using in vitro fertilization. Pediatrics international : official journal of the Japan Pediatric Society, 2008, Volume: 50, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Dactinomycin; Etoposide; Fertilization in Vitro; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Vincristine	2008
Life-threatening conjunctival presentation of myeloid sarcoma. Clinical & experimental ophthalmology, 2008, Volume: 36, Issue:8 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Conjunctival Neoplasms; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Sarcoma, Myeloid; Skin Neoplasms	2008
Future research directions for the treatment of AML. Clinical advances in hematology & oncology : H&O, 2008, Volume: 6, Issue:11 Topics: Antineoplastic Agents; Azacitidine; Biomedical Research; Carbazoles; Carboplatin; Cytarabine; Daunorubicin; Decitabine; Enzyme Inhibitors; Etoposide; Flavonoids; Furans; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Piperidines; Quinolones; Staurosporine; Topotecan; Tretinoin	2008
Acute myelogenous leukemia presenting as acute infectious meningitis in a 7-year-old boy. Clinical pediatrics, 2009, Volume: 48, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Ceftriaxone; Child; Chromosomes, Human, Pair 10; Cytarabine; Daunorubicin; Diagnosis, Differential; Escherichia coli Infections; Etoposide; Flow Cytometry; Gemtuzumab; Humans; Injections, Spinal; Leukemia, Myeloid, Acute; Male; Meningitis, Bacterial; Patient Transfer; Spinal Puncture; Trisomy	2009
Auto-SCT for AML in second remission: CALGB study 9620. Bone marrow transplantation, 2009, Volume: 44, Issue:6 Topics: Adult; Aged; Aging; Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ideal Body Weight; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation, Autologous; Treatment Outcome; Treatment Refusal; Young Adult	2009
Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis. Pediatric blood & cancer, 2009, Volume: 53, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Male; Neoplasms, Second Primary	2009
Metnase mediates chromosome decatenation in acute leukemia cells. Blood, 2009, Aug-27, Volume: 114, Issue:9 Topics: Antigens, Neoplasm; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromosomes; DNA; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Gene Expression Regulation, Leukemic; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Mitosis; Models, Biological	2009
Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine. Clinical lymphoma & myeloma, 2009, Volume: 9, Issue:4 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Multiple Myeloma; Remission Induction; Thioguanine	2009
Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells. Leukemia research, 2010, Volume: 34, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Cell Line, Tumor; Cytarabine; Cytotoxins; Daunorubicin; Drug Evaluation, Preclinical; Drug Synergism; Etoposide; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Models, Biological; Nitrophenols; Peptide Initiation Factors; Piperazines; Protein Biosynthesis; Protein Synthesis Inhibitors; Sulfonamides; Triterpenes; U937 Cells	2010
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. Acta pharmacologica Sinica, 2009, Volume: 30, Issue:10 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Idarubicin; Immunosuppressive Agents; Leukemia; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Mucositis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Retrospective Studies; Risk Factors; Semustine; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation	2009
Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy. PloS one, 2009, Nov-05, Volume: 4, Issue:11 Topics: Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Cell Differentiation; Cell Proliferation; Cellular Senescence; Cytarabine; Daunorubicin; Etoposide; Genes, ras; Humans; Leukemia, Myeloid, Acute; Mutation; ras Proteins; Tumor Suppressor Protein p53	2009
Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia. Annals of hematology, 2010, Volume: 89, Issue:7 Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Recurrence; Time Factors; Translocation, Genetic	2010
Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience. American journal of hematology, 2010, Volume: 85, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Injections, Spinal; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemic Infiltration; Male; Meninges; Middle Aged; Mitoxantrone; Testis; Young Adult	2010
Toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus in a patient with pancytopenia. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2010, Volume: 12, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cross Infection; Cytarabine; Etoposide; Fatal Outcome; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Methicillin-Resistant Staphylococcus aureus; Multiple Organ Failure; Pancytopenia; Shock, Septic; Staphylococcal Infections	2010
A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide. Leukemia, 2010, Volume: 24, Issue:5 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cells, Cultured; Chromosomes, Human; DNA Methylation; Etoposide; Humans; Hydroquinones; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Lymphocytes; Melphalan; Mutagens	2010
Orbital mass as a presenting sign of acute leukemia. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2010, Volume: 45, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Idarubicin; Infant; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Orbital Neoplasms	2010
Dietary factors and the risk for acute infant leukemia: evaluating the effects of cocoa-derived flavanols on DNA topoisomerase activity. Experimental biology and medicine (Maywood, N.J.), 2010, Volume: 235, Issue:1 Topics: Cacao; Cell Line; Diet; Dimerization; Etoposide; Female; Flavonoids; HL-60 Cells; Humans; Infant; Leukemia, Myeloid, Acute; Pregnancy; Prenatal Exposure Delayed Effects; Quercetin; Risk Factors; Topoisomerase II Inhibitors	2010
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY. Bone marrow transplantation, 2011, Volume: 46, Issue:2 Topics: Adult; Busulfan; Cyclophosphamide; Cytomegalovirus; Etoposide; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Middle Aged; Transplantation Conditioning; Treatment Outcome; Virus Activation	2011
Acute myeloid leukaemia diagnosed by intra-oral myeloid sarcoma. A case report. Head and neck pathology, 2010, Volume: 4, Issue:2 Topics: Aged; Antineoplastic Agents; Biopsy; Diagnosis, Differential; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Multiple Primary; Sarcoma, Myeloid	2010
A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule. Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Polyethylene Glycols; Prognosis; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Young Adult	2010
Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results. American journal of hematology, 2010, Volume: 85, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Chromosome Aberrations; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologous; Vidarabine; Young Adult	2010
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine	2011
Distinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3kinase response profiles in human acute myelogenous leukemia. PloS one, 2010, Aug-25, Volume: 5, Issue:8 Topics: Apoptosis; DNA Damage; Etoposide; Humans; Intracellular Space; Janus Kinases; Leukemia, Myeloid, Acute; Phosphatidylinositol 3-Kinases; Signal Transduction; STAT Transcription Factors; Staurosporine	2010
Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Etoposide; Gene Expression Profiling; Humans; I-kappa B Proteins; Leukemia, Myeloid, Acute; Lymphocytes; Oligonucleotide Array Sequence Analysis; Pyrimidines	2011
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience. American journal of hematology, 2010, Volume: 85, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Failure; Young Adult	2010
Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells. Blood, 2011, Jan-13, Volume: 117, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cytarabine; Cytosine; Daunorubicin; Etoposide; Female; Flavonoids; Flow Cytometry; Gene Expression Profiling; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Piperidines; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Vidarabine; Young Adult	2011
Salvaging AML with CLAG: novel option, or more of the same? Leukemia research, 2011, Volume: 35, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome	2011
Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens. Leukemia research, 2011, Volume: 35, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult	2011
Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cholecystectomy; Cytarabine; Etoposide; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gallbladder; Heparin, Low-Molecular-Weight; Humans; Idarubicin; Infarction; Kidney; Lebanon; Leukemia, Myeloid, Acute; Male; Protein C; Protein C Deficiency; Remission Induction; Splenectomy; Splenic Infarction; Thrombosis; Tretinoin	2011
Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy. Leukemia research, 2011, Volume: 35, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Survival Rate; Treatment Outcome; Vidarabine; Young Adult	2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Leukemia, 2011, Volume: 25, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome	2011
Siblings presenting with progressive congenital aleukemic leukemia cutis. Pediatric blood & cancer, 2011, Volume: 57, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Humans; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Siblings; Skin Neoplasms; Thioguanine	2011
ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia. Leukemia, 2011, Volume: 25, Issue:7 Topics: Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Chromosome Aberrations; Disease Progression; DNA Methylation; Etoposide; Female; Humans; Interferon Regulatory Factors; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Proteins; Promoter Regions, Genetic	2011
Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma. Acta haematologica, 2011, Volume: 126, Issue:2 Topics: Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Dioxoles; Etoposide; Fatal Outcome; Female; Gene Deletion; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Sarcoma, Ewing; Tetrahydroisoquinolines; Topoisomerase Inhibitors; Trabectedin; Young Adult	2011
New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia. American journal of hematology, 2011, Volume: 86, Issue:7 Topics: Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2011
Etoposide quinone is a redox-dependent topoisomerase II poison. Biochemistry, 2011, Jun-28, Volume: 50, Issue:25 Topics: Antigens, Neoplasm; Benzoquinones; Catechols; Dithiothreitol; DNA Adducts; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Stability; Etoposide; Humans; Leukemia, Myeloid, Acute; Oxidation-Reduction; Reducing Agents	2011
Myeloid sarcoma in a child with acute myeloblastic leukaemia. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2011, Volume: 21, Issue:6 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Child; Cytosine; Daunorubicin; Etoposide; Exophthalmos; Humans; Leukemia, Myeloid, Acute; Male; Paranasal Sinus Neoplasms; Parotid Gland; Sarcoma, Myeloid	2011
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia. Cancer, 2012, Jan-15, Volume: 118, Issue:2 Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Risk Assessment; Risk Factors	2012
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group. Cancer, 2012, Feb-01, Volume: 118, Issue:3 Topics: Adolescent; Adult; Aminoglycosides; Amsacrine; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Gemtuzumab; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Neoplasm Staging; Pilot Projects; Prognosis; Survival Rate; Young Adult	2012
Reversal of leukostasis-related pulmonary distress syndrome after leukapheresis and low-dose chemotherapy in acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Sep-10, Volume: 29, Issue:26 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Leukocytosis; Male; Respiratory Distress Syndrome	2011
Improving the outcomes of elderly patients with acute myeloid leukemia in a Brazilian University Hospital. Clinics (Sao Paulo, Brazil), 2011, Volume: 66, Issue:8 Topics: Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Brazil; Cytogenetic Analysis; Etoposide; Female; Hospitals, University; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Palliative Care; Prognosis; Retrospective Studies; Thioguanine; Treatment Outcome	2011
Unexpected pancytopenia following treatment of acute lymphoblastic leukemia. American journal of hematology, 2012, Volume: 87, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 9; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Erythropoiesis; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Pancytopenia; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic; Vincristine	2012
[Resistance of leukemia KG1a cells with positive N-cadherin in phase G(0) against killing activity of VP16]. Zhongguo shi yan xue ye xue za zhi, 2011, Volume: 19, Issue:5 Topics: Antigens, CD; Apoptosis; Cadherins; Cell Line, Tumor; Etoposide; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Resting Phase, Cell Cycle	2011
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia. Leukemia research, 2012, Volume: 36, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytogenetics; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult	2012
Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML). Annals of hematology, 2012, Volume: 91, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Middle Aged; Posterior Leukoencephalopathy Syndrome; Young Adult	2012
Phospho-specific flow: fixating on the target. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Mar-15, Volume: 18, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Ribosomal Protein S6; Sirolimus; TOR Serine-Threonine Kinases	2012
Are low-intensity induction strategies better for older patients with acute myeloid leukemia? Leukemia research, 2012, Volume: 36, Issue:4 Topics: Aged; Aged, 80 and over; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Daunorubicin; Etoposide; Female; Gemtuzumab; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Oxides; Quinolones; Remission Induction; Retrospective Studies; Treatment Outcome	2012
Inhibition of OCTN2-mediated transport of carnitine by etoposide. Molecular cancer therapeutics, 2012, Volume: 11, Issue:4 Topics: Acetylcarnitine; Adolescent; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Carnitine; Cell Culture Techniques; Cell Line; Child; Etoposide; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Male; Mice; Organic Cation Transport Proteins; Solute Carrier Family 22 Member 5; Swine; Transfection	2012
Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity. Proceedings of the National Academy of Sciences of the United States of America, 2012, Jun-05, Volume: 109, Issue:23 Topics: Chromatin Immunoprecipitation; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Fluorescence; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Micronucleus Tests; Models, Biological; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Translocation, Genetic	2012
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole	2013
Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. Clinical biochemistry, 2012, Volume: 45, Issue:16-17 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cytarabine; Daunorubicin; Etoposide; Gene Expression; Gene Expression Regulation, Neoplastic; Hepatomegaly; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Middle Aged; Multivariate Analysis; Muscle Proteins; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-2; Splenomegaly; Treatment Outcome; Up-Regulation; Young Adult	2012
Probable cytarabine-induced acral erythema: report of 2 pediatric cases. Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis	2013
[Genetic prognostic factors in childhood acute myeloid leukemia]. Klinische Padiatrie, 2012, Volume: 224, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Cytarabine; DNA Mutational Analysis; Etoposide; Female; fms-Like Tyrosine Kinase 3; Genes, Wilms Tumor; Genetic Markers; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Karyotyping; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Nuclear Proteins; Nucleophosmin; Prognosis; Survival Rate; Translocation, Genetic	2012
Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin. Nanotechnology, 2012, Oct-12, Volume: 23, Issue:40 Topics: Amines; Antineoplastic Agents, Phytogenic; Cell Survival; Drug Liberation; Etoposide; Humans; K562 Cells; Leukemia, Myeloid, Acute; Lipids; Nanoconjugates; Nanoparticles; Particle Size; Spermine; Transferrin	2012
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report. Acta haematologica, 2013, Volume: 129, Issue:1 Topics: Alleles; Antineoplastic Agents; Bone Marrow Neoplasms; Drug Therapy, Combination; Etoposide; Humans; Janus Kinase 2; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Mutation; Myeloproliferative Disorders; Pancreatic Neoplasms	2013
Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience. Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:6 Topics: Adolescent; Busulfan; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous	2013
[Neutropenia and fever of unknown origin]. Praxis, 2012, Nov-28, Volume: 101, Issue:24 Topics: Algorithms; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Etoposide; Fever of Unknown Origin; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prognosis; Testicular Neoplasms; Young Adult	2012
Outcome of poor response paediatric AML using early SCT. European journal of haematology, 2013, Volume: 90, Issue:3 Topics: Adolescent; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Early Medical Intervention; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Idarubicin; Induction Chemotherapy; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Myeloablative Agonists; Thioguanine; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2013
A case of acantholytic dermatosis and leukemia cutis: cause or effect? The American Journal of dermatopathology, 2002, Volume: 24, Issue:3 Topics: Acantholysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Leukemic Infiltration; Male; Skin; Skin Neoplasms; Treatment Outcome	2002
A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma. Journal of Korean medical science, 2002, Volume: 17, Issue:4 Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow Cells; Carmustine; Chromosome Aberrations; Chromosomes, Human, Pair 11; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Pelvis; Pregnancy; Pregnancy Complications, Neoplastic; Transplantation, Autologous	2002
Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis. American journal of hematology, 2002, Volume: 71, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Confusion; Cytarabine; Etoposide; Fatal Outcome; Female; Gemtuzumab; Humans; Idarubicin; Immunotherapy; Leukapheresis; Leukemia, Myeloid, Acute; Leukocytosis; Middle Aged; Mitoxantrone; Myocardial Infarction; Recurrence; Remission Induction; Salvage Therapy; Sialic Acid Binding Ig-like Lectin 3; Therapeutics; Vidarabine	2002
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission. Blood, 2003, Feb-15, Volume: 101, Issue:4 Topics: Adolescent; Amsacrine; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Carmustine; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neutrophils; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2003
Contribution of the induction of heme oxygenase-1 to etoposide-induced apoptosis in acute myeloblastic leukemia. Haematologica, 2003, Volume: 88, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Drug Resistance, Neoplasm; Enzyme Induction; Etoposide; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Leukemia, Myeloid, Acute; Membrane Proteins; Tumor Cells, Cultured	2003
Long-term outcomes of acute myeloid leukemia in adults in Pakistan. JPMA. The Journal of the Pakistan Medical Association, 2002, Volume: 52, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pakistan; Remission Induction; Survival Analysis; Treatment Outcome	2002
Efficacy of SCH66336, a farnesyl transferase inhibitor, in conjunction with imatinib against BCR-ABL-positive cells. Molecular cancer therapeutics, 2003, Volume: 2, Issue:3 Topics: Alkyl and Aryl Transferases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Division; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Farnesyltranstransferase; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Interleukin-3; Leukemia, Myeloid, Acute; Piperazines; Piperidines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Transfection; Treatment Outcome; Tumor Cells, Cultured	2003
Severe hyperglycemia as a complication of big ICE chemotherapy in a patient with acute myeloblastic leukemia. Haematologia, 2002, Volume: 32, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Cytarabine; Etoposide; Female; Humans; Hyperglycemia; Idarubicin; Insulin; Leukemia, Myeloid, Acute; Recurrence; Time Factors	2002
[High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bradycardia; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Remission Induction	2003
Acute myeloid leukemia presenting as non-neutropenic colitis in an infant. Journal of pediatric gastroenterology and nutrition, 2003, Volume: 37, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Colitis; Colon; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Immunohistochemistry; Infant; Leukemia, Myeloid, Acute; Leukemic Infiltration; Leukocyte Common Antigens; Peroxidase; Sigmoidoscopy; Thioguanine	2003
Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly. Haematologica, 2003, Volume: 88, Issue:12 Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Etoposide; Gemtuzumab; Humans; Idarubicin; Immunotoxins; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Salvage Therapy; Transplantation, Autologous	2003
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia. Haematologica, 2004, Volume: 89, Issue:1 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Combinations; Etoposide; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous	2004
A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5). Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jun-15, Volume: 10, Issue:12 Pt 1 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Time Factors; Treatment Outcome	2004
[Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Lineage; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Remission Induction	2004
Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Nov-01, Volume: 22, Issue:21 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Chi-Square Distribution; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Incidence; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Logistic Models; Male; Mitoxantrone; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Survival Rate	2004
A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001. Journal of experimental & clinical cancer research : CR, 2004, Volume: 23, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Tretinoin	2004
Acute myeloid leukemia in the elderly: etoposide when anthracyclins are contraindicated. Leukemia & lymphoma, 2005, Volume: 46, Issue:3 Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Contraindications; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Retrospective Studies; Survival Analysis	2005
[Relationship between bcl-X(L) expression and sensitivity to chemotherapy in acute myeloid leukemic cells]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 1997, Volume: 18, Issue:11 Topics: Adolescent; Adult; Apoptosis; bcl-X Protein; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Middle Aged; RNA, Messenger; Transcription, Genetic; Young Adult	1997
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer. Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous	2005
Use of MLL/GRAF fusion mRNA for measurement of minimal residual disease during chemotherapy in an infant with acute monoblastic leukemia (AML-M5). Genes, chromosomes & cancer, 2005, Volume: 43, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; DNA-Binding Proteins; Etoposide; GTPase-Activating Proteins; Histone-Lysine N-Methyltransferase; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Myeloid-Lymphoid Leukemia Protein; Neoplasm, Residual; Oncogene Proteins, Fusion; Proto-Oncogenes; RNA, Messenger; Transcription Factors	2005
Increase in Ara-C cytotoxicity in the presence of valproate, a histone deacetylase inhibitor, is associated with the concurrent expression of cyclin D1 and p27(Kip 1) in acute myeloblastic leukemia cells. Leukemia research, 2005, Volume: 29, Issue:11 Topics: Butyrates; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cytarabine; Enzyme Inhibitors; Etoposide; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Valproic Acid	2005
Granulocytic sarcoma of the heart: extramedullary relapse of acute myeloblastic leukemia after allogeneic stem cell transplantation successfully treated by chemotherapy alone. Leukemia & lymphoma, 2005, Volume: 46, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Heart Neoplasms; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Remission Induction; Sarcoma, Myeloid; Transplantation, Homologous	2005
mTOR regulates cell survival after etoposide treatment in primary AML cells. Blood, 2005, Dec-15, Volume: 106, Issue:13 Topics: Animals; Cell Survival; Culture Media; Etoposide; Humans; Leukemia, Myeloid, Acute; Mice; Protein Kinases; Sirolimus; Stem Cells; Time Factors; TOR Serine-Threonine Kinases; Tumor Cells, Cultured	2005
Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide--AcSDKP. BMC cancer, 2005, Sep-20, Volume: 5 Topics: Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Cell Proliferation; Cytarabine; Daunorubicin; DNA; Etoposide; Flow Cytometry; Fluorescent Dyes; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydrocarbons, Chlorinated; Leukemia; Leukemia, Myeloid, Acute; Microscopy, Fluorescence; Oligopeptides; Organic Chemicals; Radiation-Protective Agents	2005
Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum. Bone marrow transplantation, 2005, Volume: 36, Issue:12 Topics: Adult; Antineoplastic Agents; Bone Marrow Cells; Central Nervous System; Cytarabine; Disease Progression; Etoposide; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid, Acute; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinum; Polyploidy; Prognosis; Stem Cell Transplantation; Tomography, X-Ray Computed	2005
Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer research, 2005, Nov-15, Volume: 65, Issue:22 Topics: Apoptosis; bcl-2-Associated X Protein; Benzhydryl Compounds; Benzoquinones; Combined Modality Therapy; Cytarabine; Drug Synergism; Etoposide; HL-60 Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; K562 Cells; Lactams, Macrocyclic; Leukemia, Myeloid, Acute; Mitochondria; Protein Conformation; Pyrrolidinones; Rifabutin; RNA, Small Interfering	2005
[A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2005, Volume: 96, Issue:7 Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Testicular Neoplasms	2005
The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen. Pediatric blood & cancer, 2006, Volume: 47, Issue:7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2006
A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene, 2006, Oct-26, Volume: 25, Issue:50 Topics: Adenine; Apoptosis; Cell Proliferation; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Enzyme Activation; Etoposide; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Isoforms; Quinazolines	2006
Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells. Leukemia research, 2006, Volume: 30, Issue:11 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Structure-Activity Relationship; Thiazolidinediones; Troglitazone; U937 Cells	2006
[Drug sensitivity of tumor cells in varieties of acute childhood leukemia]. Voprosy onkologii, 2005, Volume: 51, Issue:5 Topics: Antigens, CD34; Antineoplastic Agents; Apoptosis; Asparagine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Cells, Cultured; Vincristine	2005
Caspase-10 involvement in cytotoxic drug-induced apoptosis of tumor cells. Oncogene, 2006, Dec-07, Volume: 25, Issue:58 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosomes; Apoptotic Protease-Activating Factor 1; Caspase 10; Caspases; Cell Line, Tumor; Enzyme Activation; Etoposide; Humans; Leukemia, Myeloid, Acute; Mitochondria; Recurrence; Signal Transduction	2006
Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia. Cancer research, 2006, Sep-15, Volume: 66, Issue:18 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Deoxyribonucleases; Etoposide; Gene Rearrangement; HT29 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Knockout; Myeloid-Lymphoid Leukemia Protein	2006
Acute myelogenous leukemia associated with Ollier disease. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 21; Cytarabine; Daunorubicin; Enchondromatosis; Etoposide; Gemtuzumab; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplastic Syndromes, Hereditary; Translocation, Genetic	2008
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. Leukemia, 2006, Volume: 20, Issue:12 Topics: DNA Repair; Drug Resistance, Neoplasm; Etoposide; fms-Like Tyrosine Kinase 3; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Phenotype; Phosphorylation; Protein Kinase Inhibitors; Rad51 Recombinase; RNA, Small Interfering; STAT5 Transcription Factor; Staurosporine; Tandem Repeat Sequences	2006
Increased mortality with FLA compared with ADE chemotherapy in high-risk AML. Blood, 2006, Dec-01, Volume: 108, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome	2006
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. Leukemia, 2007, Volume: 21, Issue:5 Topics: Apoptosis; Cyclin-Dependent Kinase Inhibitor p27; Cytarabine; Down-Regulation; Etoposide; HL-60 Cells; Humans; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pyrimidines; Pyrroles; Receptor, IGF Type 1	2007
Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2). Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Core Binding Factor Alpha 2 Subunit; Cytarabine; Cytogenetic Analysis; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Nucleic Acid Hybridization; Oncogene Proteins, Fusion; Polymerase Chain Reaction; RUNX1 Translocation Partner 1 Protein; Translocation, Genetic	2008
Translocation (X;10) in a child with therapy-related acute myeloid leukemia following chemotherapy for Ewing's Sarcoma. Cancer genetics and cytogenetics, 2007, Oct-15, Volume: 178, Issue:2 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 10; Chromosomes, Human, X; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Sarcoma, Ewing; Translocation, Genetic	2007
[A short duration treatment with intensive consolidation therapy for patients with acute myelogenous leukemia--13 year experience in a single institute]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Evidence-Based Medicine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Quality of Life; Retrospective Studies; Survival Rate; Vincristine	2007
Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A. Cancer, 2008, Feb-01, Volume: 112, Issue:3 Topics: Adolescent; Adult; Aging; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Etoposide; Female; Humans; Idarubicin; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Prognosis; Risk Factors; Survival Analysis; Treatment Outcome	2008
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia. Blood, 2008, Mar-01, Volume: 111, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Apoptosis; Aurora Kinases; bcl-2-Associated X Protein; Bone Marrow Cells; Caspases; Cell Division; Cell Line, Tumor; Child; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Etoposide; Female; fms-Like Tyrosine Kinase 3; G2 Phase; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Piperazines; Protein Serine-Threonine Kinases	2008
Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Time Factors; Transplantation, Autologous; Treatment Outcome	2008
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations. Leukemia, 2008, Volume: 22, Issue:6 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Bone Marrow; Cell Nucleus; Cytarabine; Cytoplasm; Daunorubicin; Electrophoretic Mobility Shift Assay; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Leukemic; Humans; Immunoprecipitation; Leukemia, Myeloid, Acute; Mutation; NF-kappa B; Nuclear Proteins; Nucleophosmin; Tumor Cells, Cultured	2008
Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols. Saudi medical journal, 2008, Volume: 29, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Retrospective Studies; Saudi Arabia; Survival Rate; Treatment Outcome; Vidarabine	2008
Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer. Leukemia research, 2008, Volume: 32, Issue:9 Topics: Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; CA-19-9 Antigen; Carboplatin; Core Binding Factors; Diagnosis, Differential; Etoposide; Female; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Lipase; Magnetic Resonance Imaging; Pancreatic Neoplasms; Sarcoma, Myeloid	2008
Remission induction in acute myeloid leukaemia with oral etoposide. Lancet (London, England), 1982, Dec-11, Volume: 2, Issue:8311 Topics: Administration, Oral; Aged; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Podophyllotoxin	1982
Treatment of the blast crisis of chronic myelogenous leukemia with 5-azacitidine and VP-16-213. Cancer treatment reports, 1982, Volume: 66, Issue:2 Topics: Adult; Aged; Azacitidine; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Podophyllotoxin	1982
A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer research, 1983, Volume: 43, Issue:2 Topics: Antineoplastic Agents; Cell Line; Cell Survival; Doxorubicin; Drug Evaluation, Preclinical; Eosine Yellowish-(YS); Etoposide; Fluorouracil; Hematoxylin; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Melphalan; Neoplasms; Staining and Labeling	1983
[Combined therapy with AMSA and etoposide (VP 16-213) in refractory acute myeloid leukemia. A phase I study]. Onkologie, 1984, Volume: 7, Issue:4 Topics: Aminoacridines; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Leukemia, Myeloid, Acute	1984
High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia. Cancer clinical trials, 1980, Volume: 3, Issue:4 Topics: Adult; Antineoplastic Agents; Child; Drug Evaluation; Esophagitis; Etoposide; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Nausea; Pilot Projects; Podophyllotoxin; Vomiting	1980
Subacute and chronic myelomonocytic leukemia. Haematology and blood transfusion, 1981, Volume: 27 Topics: Bone Marrow; Cells, Cultured; Clone Cells; Diagnosis, Differential; Etoposide; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Mercaptopurine; Muramidase; Prognosis; Transcobalamins	1981
Acute myelogenous leukemia: successful treatment of relapse with cytosine arabinoside, VP 16-213, vincristine and vinblastine (A-triple-V). European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:8 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Thrombocytopenia; Vinblastine; Vincristine	1982
Pharmacokinetics of mitoxantrone, etoposide and cytosine arabinoside in leukemic cells during treatment of acute myelogenous leukemia--relationship to treatment outcome and bone marrow toxicity. Leukemia research, 1995, Volume: 19, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Treatment Outcome	1995
[Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Etoposide; Fatal Outcome; Female; Humans; Killer Cells, Natural; Leukemia, Myeloid, Acute; Melphalan; Multiple Myeloma; Neoplasms, Second Primary; Prednisolone	1995
High-performance liquid chromatography with fluorometric detection for monitoring of etoposide and its cis-isomer in plasma and leukaemic cells. Journal of chromatography. B, Biomedical applications, 1995, Jul-21, Volume: 669, Issue:2 Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Etoposide; Humans; Isomerism; Lactones; Leukemia, Myeloid, Acute; Protein Binding; Reproducibility of Results; Spectrometry, Fluorescence; Tumor Cells, Cultured	1995
Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1995, Volume: 24, Issue:5 Topics: Acute Kidney Injury; Aged; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Epirubicin; Etoposide; Fatal Outcome; Fusarium; Gingival Diseases; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Maxillary Diseases; Mercaptopurine; Mycoses; Necrosis; Prednisolone; Ulcer; Vindesine	1995
Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. Journal of the National Cancer Institute, 1993, Jan-06, Volume: 85, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Translocation, Genetic	1993
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. Journal of the National Cancer Institute, 1993, Jan-06, Volume: 85, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Remission Induction; Salvage Therapy; Testicular Neoplasms; Vinblastine	1993
Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts. Blood, 1993, Feb-01, Volume: 81, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Cytarabine; Daunorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Non-Hodgkin; Macrophage Colony-Stimulating Factor; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Time Factors; Transplantation, Autologous	1993
[Ischemic hepatitis due to anthracycline-induced cardiac insufficiency in a patient with acute myelocytic leukemia (M0)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cytarabine; Doxorubicin; Etoposide; Female; Hepatitis; Humans; Ischemia; Leukemia, Myeloid, Acute; Liver; Remission Induction	1995
VP-16-mediated cytotoxicity is modulated by interleukin-3 in a growth factor-dependent leukemic cell line. Leukemia, 1994, Volume: 8, Issue:12 Topics: Apoptosis; Blotting, Northern; Blotting, Western; Cell Death; DNA Topoisomerases, Type II; Etoposide; Genes, myc; Humans; Interleukin-3; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation	1994
The price of success. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3 Topics: Aged; Carcinoma, Non-Small-Cell Lung; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasms, Second Primary	1995
Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies. Bone marrow transplantation, 1994, Volume: 14, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Recurrence; Time Factors; Transplantation, Homologous; Whole-Body Irradiation	1994
Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood, 1994, Jan-15, Volume: 83, Issue:2 Topics: Amsacrine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Daunorubicin; DNA Damage; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Molecular Weight	1994
Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia. Leukemia, 1994, Volume: 8, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Agents; Cladribine; Cytarabine; Daunorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Fluoresceins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Tumor Cells, Cultured	1994
Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs. Leukemia & lymphoma, 1994, Volume: 13, Issue:1-2 Topics: Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Phospholipid Ethers; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Analysis; Whole-Body Irradiation	1994
VP-16 and the treatment of histiocytosis. European journal of pediatrics, 1994, Volume: 153, Issue:5 Topics: Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute	1994
[Secondary leukemia after etoposide treatment involved MLL gene rearrangement]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1994, Volume: 35, Issue:6 Topics: Chromosomes, Human, Pair 11; Etoposide; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Lymphoma, T-Cell; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic	1994
Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach. The Journal of clinical investigation, 1994, Volume: 94, Issue:3 Topics: Animals; Cell Line; Clone Cells; Cytotoxicity, Immunologic; Etoposide; Gamma Rays; Humans; Immunosuppression Therapy; Immunotherapy, Adoptive; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Myeloid, Acute; Lymphocyte Transfusion; Mice; Mice, SCID; Polymerase Chain Reaction; Transplantation, Heterologous; Tumor Cells, Cultured	1994
Carboplatin and etoposide in acute myeloid leukemia. Leukemia, 1994, Volume: 8, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged	1994
[Dose escalation study of high dose etoposide in autologous hematopoietic stem cell transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Transplantation, Autologous	1993
Epipodophyllotoxins and secondary leukaemia. Lancet (London, England), 1993, Oct-02, Volume: 342, Issue:8875 Topics: Etoposide; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Podophyllotoxin	1993
Combination of mitoxantrone and etoposide in the treatment of myelodysplastic syndromes transformed into acute myeloid leukemia. Leukemia & lymphoma, 1994, Volume: 12, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes	1994
Langerhans cell histiocytosis and etoposide: risks vs. benefits. Medical and pediatric oncology, 1994, Volume: 23, Issue:2 Topics: Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors	1994
Acute leukemia in association with Langerhans cell histiocytosis. Medical and pediatric oncology, 1994, Volume: 23, Issue:2 Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Retrospective Studies; Surveys and Questionnaires; Vinblastine; Vincristine	1994
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood, 1993, Nov-01, Volume: 82, Issue:9 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Etoposide; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Whole-Body Irradiation	1993
In vivo accumulation of etoposide in peripheral leukemic cells in patients treated for acute myeloblastic leukemia; relation to plasma concentrations and protein binding. Leukemia & lymphoma, 1993, Volume: 10, Issue:4-5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Blood Proteins; Cytarabine; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplastic Stem Cells; Protein Binding; Serum Albumin; Topoisomerase II Inhibitors	1993
Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary. Leukemia & lymphoma, 1993, Volume: 11, Issue:1-2 Topics: Adult; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Topoisomerase II Inhibitors; Translocation, Genetic	1993
Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia. Cancer genetics and cytogenetics, 1993, Oct-15, Volume: 70, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Banding; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 4; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Translocation, Genetic	1993
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia, 1993, Volume: 7, Issue:12 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosome Aberrations; Cisplatin; Cohort Studies; Denmark; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Female; Germinoma; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms; Neoplasms, Second Primary; Regression Analysis; Risk	1993
Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: failure to detect evidence of apoptosis in vivo. European journal of haematology, 1994, Volume: 52, Issue:1 Topics: Adolescent; Apoptosis; Child; Child, Preschool; DNA Damage; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Cells, Cultured	1994
Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment. Leukemia, 1994, Volume: 8, Issue:2 Topics: Adult; Aged; Animals; Blotting, Southern; Chromosomes, Human, Pair 11; Drosophila; Etoposide; Female; Gene Rearrangement; Genes, Regulator; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Sequence Homology, Nucleic Acid; Translocation, Genetic	1994
[Short-term intensive consolidation chemotherapy in the treatment of acute nonlymphocytic leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:2 Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Survival Rate; Vinblastine; Vincristine	1994
[Full-term pregnancy in a patient diagnosed with acute leukemia treated with a protocol including VP-16]. Medicina clinica, 1993, May-15, Volume: 100, Issue:19 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome	1993
Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update. Seminars in oncology, 1993, Volume: 20, Issue:4 Suppl 4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Middle Aged; Premedication; Remission Induction; Survival Analysis; Transplantation, Autologous; Treatment Outcome	1993
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer research, 1993, Sep-01, Volume: 53, Issue:17 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Etoposide; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Molecular Weight; NAD; Peptide Fragments; Poly(ADP-ribose) Polymerases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protease Inhibitors	1993
Changes in the oral microflora during cytotoxic chemotherapy in children being treated for acute leukemia. Oral surgery, oral medicine, and oral pathology, 1993, Volume: 76, Issue:2 Topics: Adolescent; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Candida albicans; Candidiasis, Oral; Chi-Square Distribution; Child; Child, Preschool; Chlorhexidine; Colony Count, Microbial; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Mouth; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Streptococcus mutans; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine	1993
Treatment of relapsing and refractory adult acute myeloid leukemia according to in vitro clonogenic leukemic cell drug sensitivity. Leukemia & lymphoma, 1993, Volume: 10, Issue:1-2 Topics: Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Pilot Projects; Prospective Studies; Recurrence; Salvage Therapy; Tumor Stem Cell Assay	1993
Orbito-ocular granulocytic sarcoma (OOGS) and acute myeloblastic leukemia (AML) with duplication of Philadelphia chromosome. Cancer genetics and cytogenetics, 1993, Volume: 69, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Eye Neoplasms; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Multigene Family; Neoplasms, Multiple Primary; Orbital Neoplasms; Philadelphia Chromosome; Thioguanine	1993
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group. Leukemia, 1993, Volume: 7, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction	1993
On the interaction between cytosine arabinoside and etoposide in vivo and in vitro. European journal of haematology, 1993, Volume: 50, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cytarabine; Drug Interactions; Etoposide; Humans; In Vitro Techniques; Kinetics; Leukemia, Myeloid, Acute; Phosphorylation	1993
High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma. The American journal of pediatric hematology/oncology, 1993, Volume: 15, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 11; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Life Tables; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Risk; Vincristine	1993
Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposide. Leukemia & lymphoma, 1993, Volume: 9, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction	1993
Re: "Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)" by Viana et al. Medical and pediatric oncology, 1993, Volume: 21, Issue:5 Topics: Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary	1993
Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Fungemia; Fungi; Humans; Intestinal Mucosa; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Mycoses; Remission Induction; Retrospective Studies	1995
Idarubicin in combination with cytarabine and VP-16 in the treatment of post myelodysplastic syndrome acute myeloblastic leukemia (MDS-AML). Leukemia & lymphoma, 1995, Volume: 19, Issue:5-6 Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction	1995
Intensive induction and consolidation chemotherapy in a young woman with acute myeloid leukemia and severe chronic renal failure. Annals of hematology, 1996, Volume: 72, Issue:5 Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Contraindications; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Kidney Failure, Chronic; Leukemia, Myeloid, Acute; Mitoxantrone	1996
Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines. Leukemia, 1996, Volume: 10 Suppl 3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Daunorubicin; DNA Topoisomerases, Type II; Etoposide; Humans; Hydrogen-Ion Concentration; Idarubicin; Leukemia, Myeloid, Acute; Podophyllotoxin; Precipitin Tests; Topoisomerase II Inhibitors	1996
Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines. Leukemia, 1996, Volume: 10, Issue:7 Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Blast Crisis; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Humans; Hydrogen-Ion Concentration; Idarubicin; Isoenzymes; Leukemia, Myeloid, Acute; Poly-ADP-Ribose Binding Proteins; Prognosis; Tumor Cells, Cultured	1996
[Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Doxorubicin; Epirubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic	1996
A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage. A pilot study. Cancer, 1996, Aug-01, Volume: 78, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Remission Induction; Risk Factors	1996
Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11). Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 20; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Eosinophilia; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Remission Induction; Translocation, Genetic	1996
Secondary acute myelogenous leukemia following treatment with oral etoposide. American journal of hematology, 1996, Volume: 53, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Estramustine; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Prostatic Neoplasms	1996
Ultrafiltration and subsequent high performance liquid chromatography for in vivo determinations of the protein binding of etoposide. Cancer letters, 1996, Aug-23, Volume: 106, Issue:1 Topics: Antineoplastic Agents; Blood Proteins; Chromatography, High Pressure Liquid; Dialysis; Etoposide; Humans; Leukemia, Myeloid, Acute; Reference Values; Teniposide; Ultrafiltration	1996
Higher in vivo protein binding of etoposide in children compared with adult cancer patients. Cancer letters, 1996, Aug-23, Volume: 106, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Child; Child, Preschool; Etoposide; Female; Histiocytic Sarcoma; Humans; Infant; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Oligodendroglioma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Reference Values; Serum Albumin	1996
In vitro effects of etoposide purging on natural killer cells. Journal of hematotherapy, 1995, Volume: 4, Issue:6 Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Purging; Cell Differentiation; Cell Division; Etoposide; Female; Humans; Killer Cells, Natural; Leukemia, Myeloid, Acute; Tumor Cells, Cultured	1995
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies. Annals of the Academy of Medicine, Singapore, 1996, Volume: 25, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine	1996
Topoisomerase activities in undifferentiated acute myeloblastic leukemias and monocytic differentiated leukemias. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1997, Volume: 143 Topics: Bone Marrow; Daunorubicin; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; Humans; Idarubicin; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Topoisomerase II Inhibitors	1997
[The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 9; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Mitoxantrone; Neoplasm, Residual; Oncogene Proteins; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prednisolone; Recombinant Fusion Proteins; RNA, Messenger; Translocation, Genetic	1997
Acute abdomen due to endometriosis as a diagnostic and therapeutic challenge in the treatment of acute myelocytic leukemia. Annals of hematology, 1997, Volume: 74, Issue:1 Topics: Abdomen, Acute; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Endometriosis; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged	1997
Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: implications for gene therapy. Cancer research, 1997, Mar-01, Volume: 57, Issue:5 Topics: Animals; Cell Cycle; Cell Survival; Cricetinae; DNA Fragmentation; Etoposide; G2 Phase; Genetic Therapy; Leukemia, Myeloid, Acute; Mice; Mitosis; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1997
The pharmacokinetics and toxicity of two application schedules with high-dose VP-16 in patients receiving an allogeneic bone marrow transplantation. Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Evaluation Studies as Topic; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute	1996
Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. International journal of cancer, 1997, Mar-28, Volume: 71, Issue:1 Topics: Adolescent; Adult; Age Factors; Austria; Child; Child, Preschool; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cohort Studies; Etoposide; Female; Follow-Up Studies; Germany; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Italy; Leukemia, Myeloid, Acute; Male; Netherlands; Risk Assessment; Sex Factors; Switzerland; Translocation, Genetic	1997
Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus. Leukemia, 1997, Volume: 11, Issue:4 Topics: Amsacrine; Antineoplastic Agents; Base Sequence; Cell Line; Dactinomycin; DNA Damage; DNA, Neoplasm; Doxorubicin; Etoposide; Genes, abl; Humans; Leukemia, Myeloid, Acute; Molecular Sequence Data; Monocytes; Restriction Mapping; Topoisomerase II Inhibitors; Translocation, Genetic	1997
Secondary acute myelogenous leukemia following safe exposure to etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:4 Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Child; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary	1997
The role of VP-16 in autologous bone marrow transplantation for acute myeloblastic leukemia. The Journal of the Association of Physicians of India, 1996, Volume: 44, Issue:4 Topics: Adult; Antineoplastic Agents, Phytogenic; Bone Marrow Purging; Bone Marrow Transplantation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Transplantation Conditioning; Transplantation, Autologous	1996
Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia, 1997, Volume: 11, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Topoisomerase II Inhibitors	1997
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies. Experimental hematology, 1997, Volume: 25, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cyclophosphamide; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Neoplasm, Residual; Tumor Cells, Cultured	1997
[Acute myeloblastic leukemia showing pronounced skin infiltration during administration of low-dose cytarabine and etoposide with granulocyte colony-stimulating factor]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:9 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Skin	1997
Secondary ANLL with t(11;19)(q23;p13) following etoposide and cisplatin for ovarian germ cell tumor. Indian journal of cancer, 1997, Volume: 34, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 19; Cisplatin; Etoposide; Female; Germinoma; Humans; Leukemia, Myeloid, Acute; Ovarian Neoplasms; Translocation, Genetic	1997
Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide. Journal of experimental & clinical cancer research : CR, 1997, Volume: 16, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Child; Cyclosporine; Drug Resistance, Multiple; Etoposide; Female; Growth Inhibitors; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured	1997
New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis. Bone marrow transplantation, 1998, Volume: 21, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosome Aberrations; Combined Modality Therapy; Etoposide; Female; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Retrospective Studies; Transplantation, Autologous; Whole-Body Irradiation	1998
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia, 1998, Volume: 12, Issue:3 Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Erythrocytes; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Metabolic Clearance Rate; Methyltransferases; Models, Biological; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Regression Analysis; Serum Albumin; Time Factors	1998
Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer. International journal of oncology, 1998, Volume: 13, Issue:1 Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Breast Neoplasms; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Recurrence; Risk Factors	1998
A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with DNA-topoisomerase II inhibitors, etoposide and mitoxantrone, and the alkylating agent, cyclophosphamide. International journal of hematology, 1998, Volume: 67, Issue:2 Topics: Alkylating Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 21; Cosmids; Cyclophosphamide; DNA Probes; DNA Topoisomerases, Type II; Etoposide; Female; Gene Deletion; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Middle Aged; Mitoxantrone; Prednisone; Topoisomerase II Inhibitors; Translocation, Genetic	1998
Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy. Leukemia research, 1998, Volume: 22, Issue:5 Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Argentina; Bone Marrow Cells; Child, Preschool; Cytarabine; Down Syndrome; Etoposide; Female; Humans; Idarubicin; Infant; Karyotyping; Leukemia, Myeloid, Acute; Male; Retrospective Studies; Treatment Outcome	1998
Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis. Oncogene, 1998, Jun-04, Volume: 16, Issue:22 Topics: Apoptosis; Bone Marrow; Caspase 2; Caspase 3; Caspase 7; Caspases; Colonic Neoplasms; Cysteine Endopeptidases; Etoposide; HL-60 Cells; HT29 Cells; Humans; Leukemia, Myeloid, Acute; Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Up-Regulation	1998
[Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Vindesine	1998
[Successful treatment with idarubicin in a pediatric case of t(8;21) acute myelogenous leukemia with additional chromosomal abnormalities at relapse]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Recurrence; Remission Induction; Translocation, Genetic; Treatment Outcome	1998
[Cytarabine-induced pericarditis]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:11 Topics: Aged; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pericarditis	1998
Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL. British journal of haematology, 1999, Volume: 105, Issue:2 Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; DNA Damage; DNA Topoisomerases, Type II; Etoposide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged	1999
Sodium and potassium excretion changes and bone marrow recovery after chemotherapy. Stem cells (Dayton, Ohio), 1999, Volume: 17, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Multiple Myeloma; Potassium; Sodium	1999
The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia. Advances in experimental medicine and biology, 1999, Volume: 457 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Etoposide; Female; Humans; Idarubicin; Immunohistochemistry; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Proteins; Predictive Value of Tests; Prognosis; Survival Rate; Tretinoin; Vault Ribonucleoprotein Particles	1999
In vitro cytotoxic drug activity and in vivo pharmacokinetics in childhood acute myeloid leukemia. Advances in experimental medicine and biology, 1999, Volume: 457 Topics: Amsacrine; Antineoplastic Agents; Blast Crisis; Bone Marrow; Cell Survival; Child; Cytarabine; Doxorubicin; Drug Screening Assays, Antitumor; Erythrocytes; Etoposide; Humans; Leukemia, Myeloid, Acute; Recurrence; Scandinavian and Nordic Countries; Thioguanine	1999
Aphidicolin markedly increases the in vitro sensitivity to ara-C of blast cells from patients with AML. Advances in experimental medicine and biology, 1999, Volume: 457 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Aphidicolin; Blast Crisis; Bone Marrow Cells; Cell Survival; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Leukemia, Myeloid, Acute; Tumor Cells, Cultured	1999
Effects of CSFS and their combinations with chemotherapeutic agents (CH) on leukemic blasts (LB) in children (MTT-assay). Advances in experimental medicine and biology, 1999, Volume: 457 Topics: Adolescent; Adult; Antineoplastic Agents; Blast Crisis; Bone Marrow Cells; Child; Child, Preschool; Colony-Stimulating Factors; Cytarabine; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infant; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1999
Acute myelogenous leukemia after treatment for malignant germ cell tumors in children. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:10 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Infant; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Risk Factors; Vinblastine	1999
Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion. Bone marrow transplantation, 1999, Volume: 24, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Interferon-gamma; Killer Cells, Natural; Leukemia, Myeloid, Acute; Male; Middle Aged; Skin; T-Lymphocyte Subsets	1999
Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stress. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Glutamate-Cysteine Ligase; Humans; Leukemia, Myeloid, Acute; Oxidative Stress; Sensitivity and Specificity; Tumor Cells, Cultured	1999
Etoposide-induced apoptosis is not associated with the fas pathway in acute myeloblastic leukemia cells. Leukemia research, 2000, Volume: 24, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Cycloheximide; Etoposide; Fas Ligand Protein; fas Receptor; Humans; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Tumor Cells, Cultured	2000
[Cytoprotective effect of amifostine in children during induction therapy according to BFM-83: report on cases]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4 Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Retrospective Studies	1998
Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. British journal of haematology, 2000, Volume: 108, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase 3; Caspases; Cytochrome c Group; Drug Resistance, Neoplasm; Enzyme Induction; Enzyme Inhibitors; Etoposide; Humans; Leukemia, Myeloid, Acute; Membrane Potentials; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Superoxide Dismutase; Tumor Cells, Cultured	2000
Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines. Molecules and cells, 2000, Feb-29, Volume: 10, Issue:1 Topics: Alkynes; Antineoplastic Agents; Camptothecin; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glutathione Transferase; Glycine; Humans; Leukemia, Myeloid, Acute; Metallothionein; Paraquat; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase; Tumor Cells, Cultured; Vincristine	2000
Acute myeloblastic leukemia secondary to myelodysplasia (MDS-AML): a comparison of remission induction with three drugs versus standard two-drugs induction. Leukemia & lymphoma, 2000, Volume: 36, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Idarubicin; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Remission Induction	2000
Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome? Leukemia, 2000, Volume: 14, Issue:5 Topics: Antineoplastic Agents; Blast Crisis; Cell Survival; Child; Cytarabine; Dexamethasone; Down Syndrome; Doxorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine; Treatment Outcome; Tumor Cells, Cultured	2000
Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: implication of granzyme B and perforin. Blood, 2000, Sep-01, Volume: 96, Issue:5 Topics: Antigens, CD34; Antineoplastic Agents; Cell Survival; Coumarins; Cytarabine; Cytotoxicity Tests, Immunologic; Daunorubicin; DNA, Antisense; Edetic Acid; Etoposide; Flow Cytometry; Granzymes; HeLa Cells; Humans; Isocoumarins; Jurkat Cells; K562 Cells; Leukemia, Myeloid, Acute; Magnesium Chloride; Membrane Glycoproteins; Perforin; Pore Forming Cytotoxic Proteins; Serine Endopeptidases; Tumor Cells, Cultured; U937 Cells	2000
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects. Leukemia, 2000, Volume: 14, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Treatment Outcome	2000
High-dose chemotherapy and autologous stem cell rescue for acute myeloid leukemia remains a safe, effective, and valid option. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Melphalan; Middle Aged; Platelet Count; Recombinant Proteins; Reproducibility of Results; Safety; Survival Rate; Transplantation, Autologous	2000
A pilot study of busulfan, cyclophosphamide and etoposide followed by autologous transplantation for acute myeloid leukemia in remission. Acta haematologica, 2000, Volume: 104, Issue:2-3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pilot Projects; Recurrence; Remission Induction; Transplantation, Autologous	2000
In vitro topo II--DNA complex accumulation and cytotoxicity of etoposide in leukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia. Leukemia research, 2001, Volume: 25, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged	2001
Total body irradiation before allogeneic bone marrow transplantation: is more dose better? International journal of radiation oncology, biology, physics, 2001, Mar-15, Volume: 49, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2001
Ectopic expression of MyD118/Gadd45/CR6 (Gadd45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis. International journal of oncology, 2001, Volume: 18, Issue:4 Topics: Antigens, Differentiation; Apoptosis; Blotting, Northern; Blotting, Western; Carrier Proteins; Cell Cycle; DNA Damage; DNA Repair; Etoposide; Flow Cytometry; GADD45 Proteins; Gene Expression Regulation; Genetic Vectors; Humans; Intracellular Signaling Peptides and Proteins; Isopropyl Thiogalactoside; Leukemia, Myeloid, Acute; Lung Neoplasms; Mitogen-Activated Protein Kinases; Nucleic Acid Synthesis Inhibitors; Oxidative Stress; Protein Biosynthesis; Proteins; Transfection; Tumor Cells, Cultured	2001
Topoisomerase II inhibitor induced leukemia in a patient with AIDS. AIDS (London, England), 2001, Feb-16, Volume: 15, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors	2001
Determination of etoposide in human plasma and leukemic cells by high-performance liquid chromatography with electrochemical detection. Journal of chromatography. B, Biomedical sciences and applications, 2001, Jun-05, Volume: 757, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Electrochemistry; Etoposide; Humans; Leukemia, Myeloid, Acute; Quality Control; Reproducibility of Results; Sensitivity and Specificity	2001
Leukemia cutis in an elderly patient treated with low dose cytosine arabinoside and etoposide. Leukemia & lymphoma, 2001, Volume: 40, Issue:3-4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Exanthema; Humans; Immunophenotyping; Leukemia; Leukemia, Myeloid, Acute; Male	2001
Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Medical and pediatric oncology, 2001, Volume: 37, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Neoplasms, Second Primary	2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience. Leukemia, 2001, Volume: 15, Issue:9 Topics: Acute Disease; Adolescent; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Inversion; Chromosomes, Human, Pair 16; Cladribine; Combined Modality Therapy; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Prognosis; Treatment Outcome	2001
p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death. Leukemia research, 2001, Volume: 25, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Etoposide; Humans; Leukemia, Myeloid, Acute; Mutation; Oxidation-Reduction; Poly(ADP-ribose) Polymerases; Protein Conformation; Tumor Suppressor Protein p53	2001
Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Nov-01, Volume: 19, Issue:21 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Retinal Neoplasms; Retinoblastoma	2001
And the sun keeps shining. The Journal of pediatrics, 2001, Volume: 139, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Etoposide; Female; Hair Follicle; Humans; Idarubicin; Leukemia, Myeloid, Acute	2001
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood, 2002, Jan-01, Volume: 99, Issue:1 Topics: Amsacrine; Anthracyclines; Antineoplastic Agents; Busulfan; Cell Survival; Child; Child, Preschool; Cytarabine; Down Syndrome; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Thioguanine; Vincristine	2002
Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone marrow transplantation, 2002, Volume: 29, Issue:4 Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Count; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Cytogenetics; Disease-Free Survival; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Prognosis; Translocation, Genetic; Transplantation, Autologous	2002
Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Encephalitis, Viral; Etoposide; Fatal Outcome; Female; Fetal Blood; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Immunocompromised Host; Korsakoff Syndrome; Leukemia, Myeloid, Acute; Recurrence; Roseolovirus Infections; Transplantation Conditioning; Transplantation, Homologous; Virus Activation	2001
Treatment and outcome of infants with acute myeloid leukemia. Blood, 2002, Apr-01, Volume: 99, Issue:7 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Infant; Leukemia, Myeloid, Acute; Survival Rate; Time Factors; Treatment Outcome	2002
Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes. Leukemia, 2002, Volume: 16, Issue:4 Topics: Amino Acid Chloromethyl Ketones; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carrier Proteins; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Down-Regulation; Electrophoretic Mobility Shift Assay; Epithelial Cells; Etoposide; Humans; Interleukin-6; Intracellular Signaling Peptides and Proteins; Janus Kinase 1; Leukemia, Myeloid, Acute; Phosphorylation; Protein Transport; Protein-Tyrosine Kinases; Repressor Proteins; Signal Transduction; Smad3 Protein; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tyrosine	2002
Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia. Cancer treatment reports, 1977, Volume: 61, Issue:8 Topics: Adolescent; Adult; Antineoplastic Agents; Azacitidine; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Vinblastine	1977
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors]. Schweizerische medizinische Wochenschrift, 1975, Oct-18, Volume: 105, Issue:42 Topics: Adenocarcinoma; Bronchial Neoplasms; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Remission, Spontaneous	1975
Letter: Epipodophyllotoxin VP 16213 in acute non-lymphoblastic leukaemia. British medical journal, 1975, Oct-25, Volume: 4, Issue:5990 Topics: Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Thioguanine; Vincristine	1975
[The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination]. Schweizerische medizinische Wochenschrift, 1976, Sep-18, Volume: 106, Issue:38 Topics: Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Thioguanine; Vincristine	1976
Secondary leukaemias after epipodophyllotoxins. Lancet (London, England), 1992, Sep-12, Volume: 340, Issue:8820 Topics: Adult; Child; Etoposide; Humans; Karyotyping; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1992
[Treatment of elderly patients with hematological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:11 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Vincristine	1992
ABEP as primary chemotherapy for Hodgkin's disease. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:10 Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Vincristine	1992
Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapy. Journal of internal medicine, 1992, Volume: 232, Issue:5 Topics: Actuarial Analysis; Adolescent; Adult; Age Factors; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Bone Marrow Transplantation; Cause of Death; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Middle Aged; Norway; Recurrence; Remission Induction; Survival Analysis; Survival Rate; Thioguanine	1992
Serial changes of the serum macrophage colony-stimulating factor level after cytoreductive chemotherapy. International journal of hematology, 1992, Volume: 55, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Macrophage Colony-Stimulating Factor; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Predictive Value of Tests; Prednisone; Remission Induction; Vindesine	1992
Sensitivity of fresh acute myeloid leukemia cells to etoposide: relationship with cell growth characteristics and DNA single-strand breaks. Blood, 1992, Sep-01, Volume: 80, Issue:5 Topics: Cell Division; Cell Survival; DNA Damage; DNA, Single-Stranded; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Recombinant Proteins; Tumor Cells, Cultured; Tumor Stem Cell Assay	1992
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow. Bone marrow transplantation, 1992, Volume: 10, Issue:2 Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Survival Rate	1992
[Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Remission Induction; Testicular Neoplasms	1992
Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation. Bone marrow transplantation, 1992, Volume: 9, Issue:5 Topics: Bone Marrow Transplantation; Busulfan; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Graft vs Host Disease; Hematopoiesis; Humans; Incidence; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1992
Secondary pre-leukaemia and etoposide. Lancet (London, England), 1991, Nov-16, Volume: 338, Issue:8777 Topics: Etoposide; Humans; Leukemia, Myeloid, Acute; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Neural Tube Defects	1991
Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells. Cancer research, 1990, Nov-15, Volume: 50, Issue:22 Topics: Blotting, Northern; Cyclophosphamide; Daunorubicin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Gene Expression; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured	1990
Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2). Cancer genetics and cytogenetics, 1992, Volume: 58, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 4; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Remission Induction; Translocation, Genetic	1992
[Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children]. Sangre, 1991, Volume: 36, Issue:1 Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Evaluation Studies as Topic; Female; Humans; Infant; Leukemia, Myeloid, Acute; Life Tables; Male; Methotrexate; Mitoxantrone; Remission Induction; Survival Rate; Thioguanine; Transplantation, Autologous; Transplantation, Homologous	1991
Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia. Cancer, 1991, Aug-15, Volume: 68, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Survival Rate	1991
[Long-term oral administration of etoposide (VP-16) for the patients with refractory or relapsed acute non-lymphocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1991, Volume: 32, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Time Factors	1991
[Gastroenterologic findings in graft versus host disease after allogenic bone marrow transplantation]. Zeitschrift fur Gastroenterologie, 1991, Volume: 29, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Infant, Newborn; Intestinal Mucosa; Leukemia, Myeloid, Acute; Liver; Pregnancy; Pregnancy Complications, Neoplastic; Sigmoidoscopy	1991
[Effectiveness of etoposide on reactive histiocytosis and refractory state to platelet transfusion during therapy of leukemia: case report]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1991, Volume: 32, Issue:9 Topics: Blood Component Transfusion; Child; Etoposide; Female; Histiocytosis; Humans; Leukemia, Myeloid, Acute; Platelet Transfusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1991
Granulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapy. Annals of hematology, 1991, Volume: 63, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Remission Induction; Time Factors	1991
Combination therapy with mitoxantrone and etoposide in adult acute myelogenous leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Evaluation; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Remission Induction	1990
Anti-CD33 monoclonal antibody and etoposide/cytosine arabinoside combinations for the ex vivo purification of bone marrow in acute nonlymphocytic leukemia. Blood, 1991, Jan-15, Volume: 77, Issue:2 Topics: Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Separation; Cell Survival; Colony-Forming Units Assay; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Humans; Immunotherapy; In Vitro Techniques; Leukemia, Myeloid, Acute; Sialic Acid Binding Ig-like Lectin 3; Tumor Stem Cell Assay	1991
High-dose cytosine arabinoside and etoposide in the treatment of relapsed or refractory adult leukemia. American journal of clinical oncology, 1991, Volume: 14, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Survival Rate	1991
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia. Blood, 1991, May-01, Volume: 77, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Etoposide; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction	1991
First and second complete remissions in a HIV positive patient following remission induction therapy for acute non-lymphoblastic leukaemia. Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; HIV Seropositivity; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Remission Induction; Substance Abuse, Intravenous	1991
Factors affecting the outcome of autologous bone marrow transplantation. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Whole-Body Irradiation	1991
Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Survival Rate	1991
Etoposide in remission induction of adult acute myeloid leukemia. Acta haematologica, 1990, Volume: 83, Issue:2 Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Humans; Leukemia, Myeloid, Acute; Remission Induction; Retrospective Studies; Thioguanine; Time Factors	1990
Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bone marrow transplantation, 1990, Volume: 5, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Preoperative Care; Radiotherapy, High-Energy; Remission Induction; Stomatitis; Whole-Body Irradiation	1990
Infusion of high doses of undiluted etoposide through central venous catheters during preparation for bone marrow transplantation. Cancer investigation, 1990, Volume: 8, Issue:1 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Bone Marrow Transplantation; Carcinoma, Non-Small-Cell Lung; Catheterization, Central Venous; Colonic Neoplasms; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Middle Aged; Neoplasms	1990
Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report. Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Middle Aged; Time Factors	1990
Induction chemotherapy for newly diagnosed acute myeloid leukaemia using a regime containing cytosine arabinoside, daunorubicin and etoposide. Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Survival Rate	1990
[Low dose continuous infusion therapy with etoposide (VP-16) and cytosine arabinoside (Ara-C) for a patient with refractory acute myelogenous leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Remission Induction	1990
In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213). Bone marrow transplantation, 1990, Volume: 5, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Cell Survival; Cyclophosphamide; Etoposide; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; Middle Aged; Neoplastic Stem Cells; Tumor Stem Cell Assay	1990
Continuous infusion diaziquone and etoposide: a phase I study in adult patients with acute leukemia. Leukemia, 1990, Volume: 4, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Blast Crisis; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1990
Mitoxantrone, etoposide and cytarabine in the treatment of acute nonlymphocytic leukemia. Oncology, 1990, Volume: 47, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone	1990
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; France; Humans; Leukemia, Myeloid, Acute; Life Tables; Middle Aged; Neutropenia; Survival Rate	1990
High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. Haematology and blood transfusion, 1990, Volume: 33 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Etoposide; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Transplantation, Autologous	1990
Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia. Cancer, 1990, Jun-15, Volume: 65, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction	1990
BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. Blood, 1990, Jun-15, Volume: 75, Issue:12 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Middle Aged; Survival Analysis	1990
High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission. Cancer, 1990, Aug-15, Volume: 66, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocytes; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate	1990
Growth of hemopoietic cells after incubation with VP 16-213. Folia haematologica (Leipzig, Germany : 1928), 1989, Volume: 116, Issue:3-4 Topics: Bone Marrow; Cell Division; Cell Survival; Etoposide; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Macrophages	1989
[Chemotherapy of adult ANLL]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:8 Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction; Survival Rate; Vincristine	1989
Mitoxantrone and etoposide: an effective regimen for refractory or relapsed acute myelogenous leukemia. European journal of haematology, 1989, Volume: 43, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood; Drug Evaluation; Etoposide; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Recurrence; Remission Induction; Time Factors	1989
Amsacrine, cytarabine and etoposide in the treatment of bad prognosis acute myeloid leukemia. Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Survival Rate	1989
Treatment of refractory acute leukaemia with aclacinomycin A. Bone marrow transplantation, 1989, Volume: 4 Suppl 3 Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1989
Preliminary results of an induction combination regimen including fractionated anthracycline. Bone marrow transplantation, 1989, Volume: 4 Suppl 3 Topics: Aclarubicin; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged	1989
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. Bone marrow transplantation, 1989, Volume: 4 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Evaluation Studies as Topic; Freezing; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Organ Preservation; Postoperative Complications; Preoperative Care; Transplantation, Autologous	1989
Autologous bone marrow transplantation in patients with AML in second complete remission (CR). Bone marrow transplantation, 1989, Volume: 4 Suppl 1 Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Evaluation Studies as Topic; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Remission Induction; Transplantation, Autologous	1989
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide. Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence	1989
Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL). Bone marrow transplantation, 1989, Volume: 4 Suppl 1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Remission Induction	1989
Acute nonlymphocytic leukemia with basophilic differentiation and t(9,11)(p22,q23) in a child. American journal of hematology, 1989, Volume: 31, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Basophils; Cell Differentiation; Chromosome Banding; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Etoposide; Humans; Infant; Leukemia, Myeloid, Acute; Male; Translocation, Genetic	1989
["AB-Triple V" therapy of relapsed or refractory acute myelogenous leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:2 Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Vinblastine; Vincristine; Vindesine	1989
Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells. Experimental hematology, 1989, Volume: 17, Issue:7 Topics: Cell Survival; Etoposide; Hematopoiesis; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Interphase; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Tumor Cells, Cultured; Tumor Stem Cell Assay	1989
Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer research, 1989, Nov-01, Volume: 49, Issue:21 Topics: Antineoplastic Agents; Camptothecin; Cell Line; Cell Nucleus; Dinitrophenols; DNA Damage; DNA, Neoplasm; Etoposide; Humans; Kinetics; Leukemia, Myeloid, Acute; Nuclear Proteins; Tumor Cells, Cultured	1989
Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells. Cancer research, 1987, Dec-15, Volume: 47, Issue:24 Pt 1 Topics: Alkynes; Amsacrine; Animals; Antineoplastic Agents; Cell Line; Cell Survival; Diamines; DNA; DNA Damage; DNA Topoisomerases, Type II; Eflornithine; Etoposide; Humans; Leukemia L1210; Leukemia, Myeloid, Acute; Mice; Ornithine Decarboxylase Inhibitors; Polyamines; Tumor Cells, Cultured	1987
Enhancement of etoposide-induced cytotoxicity by cyclosporin A. Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:3 Topics: Animals; Cells, Cultured; Cisplatin; Cyclosporins; Doxorubicin; Drug Interactions; Etoposide; Humans; Lethal Dose 50; Leukemia L1210; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasm Transplantation; Neoplasms, Germ Cell and Embryonal; Radiation, Ionizing	1986
Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. Blood, 1988, Volume: 72, Issue:5 Topics: Adolescent; Adult; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Graft vs Host Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Middle Aged; Prognosis; Whole-Body Irradiation	1988
Intraarticular and intraperitoneal administration of etoposide in haematological malignancy. Cancer chemotherapy and pharmacology, 1988, Volume: 21, Issue:2 Topics: Aged; Etoposide; Female; Humans; Injections, Intra-Articular; Injections, Intraperitoneal; Knee Joint; Leukemia, Myeloid, Acute; Male; Middle Aged	1988
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia. Blood, 1988, Volume: 71, Issue:4 Topics: Aclarubicin; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes; Neoplasm Recurrence, Local; Remission Induction	1988
Factor X deficiency during treatment of relapsed acute myeloid leukaemia with amsacrine. Clinical and laboratory haematology, 1988, Volume: 10, Issue:2 Topics: Adult; Amsacrine; Blood Transfusion; Drug Therapy, Combination; Etoposide; Factor IX; Factor X; Factor X Deficiency; Humans; Hypoprothrombinemias; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Prothrombin; Prothrombin Time	1988
Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging. Leukemia research, 1987, Volume: 11, Issue:11 Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cell Survival; Clone Cells; Cyclophosphamide; Cytarabine; Etoposide; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Melphalan; Transplantation, Autologous; Tumor Cells, Cultured	1987
Autologous bone marrow transplantation for patients with acute myelogenous leukemia in complete remission. Annals of the New York Academy of Sciences, 1987, Volume: 511 Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Evaluation Studies as Topic; Humans; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Postoperative Complications; Remission Induction; Transplantation, Autologous	1987
Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction	1988
Efficacy and clinical cross-resistance of a new combination therapy (AMSA/VP16) in previously treated patients with acute nonlymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:3 Topics: Adolescent; Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Resistance; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Count	1986
Combination therapy with mitoxantrone and etoposide in refractory acute myelogenous leukemia. Cancer treatment reports, 1986, Volume: 70, Issue:8 Topics: Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone	1986
[Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A]. Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1986, Volume: 134, Issue:8 Topics: Aclarubicin; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Naphthacenes; Thioguanine	1986
Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors. Cancer research, 1987, Jan-01, Volume: 47, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute	1987
[Phase II study of etoposide (VP-16) in the form of intravenous injection for malignant lymphomas and acute leukemias: Hanshin Cooperative Study Group for Hematological Disorders]. Gan no rinsho. Japan journal of cancer clinics, 1987, Volume: 33, Issue:1 Topics: Adult; Aged; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Injections, Intravenous; Leukemia; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged	1987
m-AMSA and VP-16 combinations in the treatment of acute myeloid leukemia. British journal of haematology, 1987, Volume: 65, Issue:2 Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute	1987
["A-triple-V" in refractory or relapsed acute myelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1987, Volume: 28, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Vinblastine; Vincristine	1987
4-Demethoxydaunorubicin (idarubicin) in relapsed and refractory acute myeloid leukemia. Haematology and blood transfusion, 1987, Volume: 30 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male	1987
Effective remission induction in children with recurrent acute myeloid leukemia by mAMSA, Ara-C, and VP 16. Haematology and blood transfusion, 1987, Volume: 30 Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Remission Induction; Time Factors	1987
Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:9 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Remission Induction; Thioguanine	1987
Interference of the chemotherapeutic agent etoposide with the direct phosphotungstic acid method for uric acid. Clinical chemistry, 1987, Volume: 33, Issue:11 Topics: Etoposide; False Positive Reactions; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Phosphotungstic Acid; Urate Oxidase; Uric Acid	1987
Pattern of bone marrow regeneration following chemotherapy for acute myeloid leukemia. Journal of medicine, 1987, Volume: 18, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Regeneration; Thioguanine	1987
Pulmonary complications of cytosine-arabinoside therapy: radiographic findings. AJR. American journal of roentgenology, 1987, Volume: 149, Issue:1 Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lung; Lymphoma, Non-Hodgkin; Prednisone; Radiography; Remission Induction; Respiratory Insufficiency	1987
Age adapted induction and intensified consolidation therapy in acute myelogenous leukemia. Onkologie, 1986, Volume: 9, Issue:3 Topics: Aclarubicin; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes; Prognosis	1986
Mitoxantrone and VP-16 in refractory acute myelogenous leukemia. Onkologie, 1986, Volume: 9, Issue:3 Topics: Adolescent; Adult; Aged; Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Resistance; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone	1986
Idarubicin in refractory acute leukemia. Onkologie, 1986, Volume: 9, Issue:3 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Resistance; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Infusions, Parenteral; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged	1986
Aclacinomycin-A in the induction treatment of childhood AML. Onkologie, 1986, Volume: 9, Issue:3 Topics: Aclarubicin; Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infusions, Parenteral; Leukemia, Myeloid, Acute; Male; Naphthacenes; Thioguanine	1986
Amsacrine and etoposide induced paralytic ileus in a patient with acute myelomonocytic leukemia. Journal of surgical oncology, 1985, Volume: 28, Issue:3 Topics: Aged; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Podophyllotoxin	1985
[Various induction therapies in older patients with acute myeloid leukemias]. Wiener klinische Wochenschrift, 1985, Feb-01, Volume: 97, Issue:3 Topics: Aclarubicin; Adolescent; Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Danazol; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes; Tamoxifen	1985
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis. Cancer research, 1985, Volume: 45, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Computers; Cyclophosphamide; Drug Synergism; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin	1985
[AMSA/etoposide (VP 16-213). A phase I/II study in refractory acute myeloid leukemia]. Onkologie, 1985, Volume: 8, Issue:3 Topics: Aminoacridines; Aminoglutethimide; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Danazol; Drug Evaluation; Drug Resistance; Etoposide; Humans; Leukemia, Myeloid, Acute; Tamoxifen	1985
[Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center]. Deutsche medizinische Wochenschrift (1946), 1985, Sep-27, Volume: 110, Issue:39 Topics: Acyclovir; Adolescent; Adult; Amphotericin B; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Etoposide; Female; Graft Survival; Graft vs Host Disease; Herpes Genitalis; HLA Antigens; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Nystatin; Prednisolone; Tissue Donors; Whole-Body Irradiation	1985